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SUMMARY 
 
 Neutrophils represent a key component of organism's innate immunity. They are 
able to sense bacterial infection, migrate to its source, and destroy the invading 
pathogen. The vast array of neutrophil activities is controlled by an elaborated net of 
signal transduction cascades, linking surface receptors with the cell interior and 
regulating cell responses to the extracellular milieu.  
 Chemoattractants like fMLP or interleukin-8 activate neutrophil receptors 
coupled to trimeric G proteins. The latter signal to phosphoinositide 3-kinase γ (PI3Kγ), 
an enzyme phosphorylating D3-position of PIP2 and also possessing a protein kinase 
activity. To elucidate the role of PI3Kγ in neutrophil signalling, we analyzed neutrophil 
functions in PI3Kγ knock-out mice. Several responses to chemoattractants were 
impaired in PI3Kγ -/- neutrophils. After priming with lipopolysaccharide, wild type but 
not knock-out neutrophils responded to fMLP with a production of oxygen radicals. 
Chemoattractant-induced cell adhesion and actin polymerization were reduced in PI3Kγ-
null neutrophils. Finally, chemotaxis of neutrophils in vitro and in vivo was impaired, 
resulting in reduced protection of PI3Kγ knock-out mice from infecting bacteria. These 
data demonstrate a crucial role of PI3Kγ in neutrophil responses in inflammation. They 
also put forward the enzyme as a promising target for the development of anti-
inflammatory drugs. 
 Regulated in time and space rearrangements of actin cytoskeleton are crucial to 
exert such cell activities as chemotaxis, adhesion, and phagocytosis. To characterize 
biochemically signalling to actin polymerization, we designed a cell-free system from 
the cytosol of human neutrophils. In this system addition of GTPγS, a non-hydrolyzable 
analogue of GTP, induced massive actin polymerization and cross-linking. This effect 
was due to constitutive activation of small Rho family GTP-binding proteins, proving 
their role in the control of neutrophil actin cytoskeleton. Rho-protein induced actin 
polymerization was shown to require a plasma membrane-associated guanine nucleotide 
exchange factor(s). It was also shown to be exerted via a kinase-independent 
mechanism, excluding a multitude of proposed downstream targets of Rho proteins in 
the induction of actin polymerization in the neutrophil cytosol. We suggested that Rac 
and Cdc42 could not be the proteins mediating the effect of GTPγS. In contrast, we 
found that Rho and a CIP4-binding protein could initiate actin polymerization. These 
data are an important contribution to the molecular dissecting of cell signalling to actin 
cytoskeleton, and the established cell-free system will provide more insights into the 
mechanisms of cell activation. 
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RESUME 
 Des neutrophiles représentent le composant principal de l'immunité innée des 
organismes. Ils sont capables détecter des infections bactériennes, de migrer vers ces 
dernieres afin de détruire les pathogènes envahisseurs. La vaste palette des activités des 
neutrophiles est contrôlée par un réseau élaboré de cascades de signalisation, qui lient 
des récepteurs de la surface avec l'intérieur des cellules régulant ainsi les réponses 
cellulaires au milieu environnant.  
 Des agents chimiotactiques comme le fMLP ou l'interleukin-8 agissent sur les 
neutrophiles par l'intermediaire de récepteurs liés aux proteins G trimériques capable 
d'activer la phosphoinositide 3-kinase de type γ (PI3Kγ), enzyme phosphorylant la 
position D3 du PIP2 et possédant  une activité protéine kinase. Pour élucider le rôle de 
PI3Kγ dans la signalisation des neutrophiles, nous avons utilisé des souris délétées du 
gène codant pour la PI3Kγ (PI3Kγ -/-). Nous avons pu montré une diminution des 
réponses des neutrophiles PI3Kγ-/- à des agents chimiotactiques. En effet, après un 
"priming" avec du lipopolysaccharide, la production de radicaux oxygénés induite par le 
fMLP était abolie. Après  induction par des agents chimiotactiques, l'adhésion et la 
polymérisation d'actine des neutrophiles PI3Kγ-/- étaient réduites. Enfin,  le 
chimiotactisme des neutrophiles in vitro  et in vivo  était diminué, induisant ainsi une 
protection réduite des souris PI3Kγ -/- contre l'infection bactérienne. Ces données 
montrent un rôle crucial de la PI3Kγ dans les réponses inflammatoires des neutrophiles 
et ouvrent des perspectives quant au développement de nouvelles drogues ayant pour 
cible la PI3Kγ . 
 Les  réarrangements du cytosquelette d'actine sont des évènements 
indispensables  pour des activités cellulaires comme le chimiotactisme, l'adhésion, et la 
phagocytose. Pour caractériser biochimiquement  la signalisation conduisant à la 
polymérisation d'actine, nous avons mis au point un système in vitro  utilisant le 
cytoplasme de neutrophiles humains dans lequel l'ajout de GTPγS (analogue non 
hydrolysable du GTP) induisait la polymérisation et la formation de réseaux d'actine. 
Nous avons pu montré que cet effet dépendait de l'activation des petites proteines G de 
la famille Rho, elles-même sous le controle de facteurs d'échanges nucléotidiques (GEF) 
membranaires, montrant ainsi leur rôle dans le controle du cytosquelette d'actine des 
neutrophiles. De façon surprenante, cette signalisation est indépendante de kinases, 
excluant l'implication de nombreuses cibles des protéines Rho dans l'initiation de la 
polymétisation d'actine. Nous avons suggéré que l'effet du GTPγS n'était pas induit par 
Rac et Cdc42, mais par Rho et une protéine liée à CIP4 . L'ensemble de ces données 
ainsi que la mise au point d'un système in vitro,  contribuent à une meilleure 
compréhension des mécanismes moléculaires impliqués dans la signalisation conduisant 
au cytosquelette d'actine.  
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SIGNAL TRANSDUCTION IN NEUTROPHIL MOTILITY 
 
I. Physiology and morphology of neutrophil motility. 
  
 Neutrophils (polymorphonuclear leukocytes) constitute more than half of 
circulating white blood cells in humans and provide a major defence system against 
microorganisms. Their crucial role in innate immunity is highlighted by severe 
susceptibility to bacterial infections in patients with neutrophil disorders, such as 
various forms of neutropenia (Sievers and Dale, 1996), leukocyte adhesion deficiency 
(Lipnick et al., 1996), or chronic granulomatous disease (Thrasher et al., 1994). On the 
other hand, hyperactivated neutrophils cause pathologies. Reperfusion injury (Williams, 
1994), vasculitis (Savage and Rees, 1994), adult respiratory distress syndrome (Hasleton 
and Roberts, 1999), or glomerulonephritis (Lefkowith, 1997) evidence the medical 
importance of neutrophil overactivation.  
 Neutrophils possess a large armament of antibacterial activities, including 
phagocytosis (Kwiatkowska and Sobota, 1999), production of oxygen radicals (Segal  
and Shatwell, 1997), and secretion of various degrading enzymes (Gullberg et al., 1997). 
Resting nonadherent neutrophils are circular cells of about 7 µm in diameter (Worthen 
et al., 1989). Upon stimulation, they markedly change their shape, forming asymmetric 
protrusions called pseudopodia, which serve for cell migration when in contact with 
substratum.  Physiologically, before migration through a tissue to the source of 
infection, a circulating neutrophil has to cross the blood vessel endothelium (Fig. 1). 
This preferentially happens in the postcapillary venules and involves several steps 
(Springer, 1995): attachment to and rolling on the endothelium, followed by firm 
adhesion and finally transendothelial migration or diapedesis. For the latter the 
neutrophil has to pull itself between endothelial cells through a hole which is several 
times narrower than the neutrophil diameter, a phenomenon demonstrating remarkable 
flexibility of neutrophil membranes and the cytoskeleton (Fig. 1).  
 Actin cytoskeleton is absolutely required for cell crawling, which is the main 
type of cell motility in muticellular organisms. Newly polymerized actin filaments are 
enriched in the leading edge of a migrating cell (Fechheimer and Zigmond, 1983; 
Valerius et al., 1981), and pseudopod formation correlates temporarily with increases in 
filamentous actin (Wymann et al., 1990). Prevention of actin polymerization abolishes 
chemotaxis (Carter, 1967; Becker et al., 1972; Zigmond and Hirsch, 1972; Norgauer et 
al., 1988). These and other data have led to a widely accepted model that actin 
polymerization is the driving force of the cell leading edge protrusion (Condeelis, 1993; 
Elson et al., 1999).  
 Neutrophil motility has been modelled in vitro on two-dimensional surfaces or in 
three-dimensional gels. These studies and investigation of neutrophils in suspension 
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have revealed striking periodicities in neutrophil behaviour upon stimulation (reviewed 
in Coates, 1996). When stimulated in suspension, neutrophils change their shape every 8 
seconds (Wymann et al., 1987). This is reflected by an eight second periodicity in 
neutrophil motility on a substratum (Franke and Gruler, 1994; Hartman et al., 1994), and 
is achieved by oscillatory protrusion and retraction of pseudopodia. In addition to this 
small-scale oscillations, crawling neutrophils also pause and re-establish the direction of 
migration every 45-60 seconds, which is mediated by cell repolarization and probably 
necessary for the correct gradient perception (Coates et al., 1996). Thus neutrophil 
migration seems to be timed by two superimposed molecular clocks enabling cell 
response to a multitude of stimuli.  
 
II. Chemoattractants and receptors in neutrophil motility. 
 
1. "Non-classical" chemoattractants and their receptors. 
 In vitro studies have identified a multitude of agents inducing neutrophil 
chemotaxis (directed migration) or chemokinesis (random migration) . Although 
"classical" chemoattractants bind to G protein- coupled receptors, there are other 
reported chemotactic or chemokinetic molecules which act on different receptors.  
 In addition to their well-known role in hematopoesis (Tarr, 1996; Anderlini et 
al., 1996) granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage 
colony-stimulating factor (GM-CSF) were reported to activate chemokinesis but not 
chemotaxis in neutrophils (Smith et al., 1994; Yong, 1996; Harakawa et al., 1997). 
These cytokines bind to monomeric (G-CSF) or heterodimeric (GM-CSF) non-catalytic 
receptors which in turn activate Ser/Thr/Tyr kinases called the Janus kinases (Jaks) (Ihle 
et al., 1995).  
 TNFα induces neutrophil chemotaxis (Ming et al., 1987; Lukacs et al., 1995; 
Loike et al., 1995) via activation of TNF receptor clustering and signal transduction 
through multiple protein-protein interactions. Neutrophils possess two TNF receptors 
(Menegazzi et al., 1994), a p75 TNF receptor (CD120b) propagates the signal through 
TNF-receptor- associated proteins, while death-domain proteins are involved in signal 
transduction by a p55 receptor (CD120a) (Bazzoni and Beutler, 1996; Wallach et al., 
1999). It is not known which pathway induces neutrophil chemotaxis, although p55 
receptor was recently shown to modulate chemotactic responses in macrophages 
(Peppelenbosch et al., 1999). Conflicting reports exist on whether lymphotoxin (TNFβ), 
which shares the same p75 TNF receptor with TNFα, is chemotactic for neutrophils 
(Newman and Wilkinson, 1989; Mrowietz et al., 1989). Recently, soluble Fas ligand has 
been shown to induce neutrophil chemotaxis (Seino et al., 1998; Ottonello et al., 1999). 
Fas (Apo1/ CD95) is another representative of TNF-like receptors and when activated 
induces apoptosis in many cells upon signalling through death domain proteins 
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(reviewed in Wallach et al., 1999). The chemotactic activity of the Fas ligand has been 
shown to occur at concentrations incapable of inducing neutrophil apoptosis (Ottonello 
et al., 1999), and through a death domain- independent mechanism (Seino et al., 1998).  
 The most potent chemoattractant for neutrophils identified so far, inducing 
chemotaxis at femtomolar concentrations, is the transforming growth factor β (TGFβ), 
an agonist for a receptor tyrosine kinase (for a review see Hubbard, 1999). TGFβ is a 
"pure" chemoattractant since unlike classical chemoattractants it does not stimulate 
other neutrophil activities besides chemotaxis (Reibman et al., 1991; Hannigan et al., 
1998). Surprisingly, TGFβ-directed chemotaxis is sensitive to pertussis toxin (Haines et 
al., 1993), implying an involvement of trimeric G proteins, also crucial for the signalling 
induced by "classical" chemoattractants (see below). Among other agonists for receptors 
of the receptor tyrosine kinase superfamily, platelet-derived growth factor (Thelen et al., 
1995) and insulin (Oldenborg and Sehlin, 1998) were reported to display on neutrophils 
chemotactic and chemokinetic effects, respectively.  
 
2. G protein- coupled receptor agonists as neutrophil chemoattractants. 
 Based on their molecular nature, one could distinguish five classes of "classical" 
leukocytes chemoattractants, acting through G protein- coupled (serpentine, seven-
transmembrane helix) receptors (Boulay et al., 1997) (Fig. 2). These would include 1) 
N-formylated peptides such as fMLP derived from bacterial proteins (Panaro and 
Mitolo, 1999); 2) platelet- activating factor (PAF) produced by activated platelets, 
neutrophils and other cells (Hanahan, 1986); 3) leukotriene B4 (LTB4) derived from 
arachidonic acid metabolism and produced by various myeloid cells (Crooks et al., 
1998); 4) C5a anaphylotoxin obtained after cleavage of the complement protein C5 
(Gerard and Gerard, 1994), and 5) chemokines, a family of proteins of 68 to 103 amino 
acids with four conserved cysteines linked by disulphide bonds, which are produced 
locally in many tissues (Baggiolini, 1998). Based on whether the first two cysteines are 
adjacent or separated by one amino acid, CC and CXC chemokine subfamilies are 
defined (Moser et al., 1998). At excessive concentrations, these chemoattractants induce 
wide range of responses on neutrophils, including phagocytosis, respiratory burst, 
degranulation, intracellular Ca2+ rises, and protein synthesis, while chemotaxis requires 
the lowest, typically nanomolar, concentrations of the stimulators. 
 Schematic structures of the representatives of the five groups of neutrophil 
chemoattractants are shown on Fig. 2. The receptors for many of these molecules are 
cloned. Besides the apparent differences of their ligands, all of them belong to the same 
subfamily of seven-transmembrane helix receptors based on sequence homologies 
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(Bockaert and Pin, 1999). In addition to features typical to serpentine receptors as an 
extracellular N- and intracellular C- terminus, seven transmembrane domains (TM), and 
extracellular (e1-e3) and intracellular (i1-i3) loops (see Fig. 3, (Baldwin, 1993; Unger et 
al., 1997)), the chemoattractant receptors share other structural similarities. These 
include an S-S bridge between e1 and e2, multiple Ser/Thr phosphorylation sites in the 
C-terminus, highly acidic N-terminus, basic sequences in the short i3, and the unusually 
small for the serpentine receptor size (ca. 350 amino acids) (Murphy, 1994; Bockaert 
and Pin, 1999). High affinity ligand binding is mediated by the extracellular face of the 
receptor, namely by the N-terminus (binding of C5a to the C5aR (Mery et al., 1994), IL-
8 to the CXCR1 (Gayle et al., 1993; Ahuja et al., 1996), or MCP-1 to the CCR2 
(Monteclaro and Charo, 1996 )), by the e1 (fMLP binding by FPR (Quehenberger et al., 
1997)), e2 (binding of GROα and NAP2 by the CXCR2 (Ahuja et al., 1996), or e3 
(binding of MIP-1α by the CCR1 (Monteclaro and Charo, 1996)). In addition to the high 
affinity ligand binding site on the N-terminus, the existence of low affinity sites on the 
extracellular loops has been demonstrated for some chemoattractant receptors (Ahuja et 
al., 1996; Monteclaro and Charo, 1996). Interestingly, these low affinity sites have been 
shown to be sufficient for signal transduction through the receptor (Ahuja et al., 1996; 
Monteclaro and Charo, 1996). These data might indicate that no matter where on the 
receptor the high affinity ligand binding site is, ligand interaction with the extracellular 
loops of the receptor will be crucial for the activation of the latter. This seems 
reasonable since G protein-coupled receptor activation is mediated by a change in 
relative orientation of the transmembrane domains, especially of TM3 and TM6 
(Bourne, 1997; Farrens et al., 1996; Baranski et al., 1999). This reorientation depends 
on conserved Asp in TM2 and AspArgTyr tripeptide at the TM3-i2 interface (Bockaert 
and Pin, 1999; Scheer et al., 1996; Parent et al., 1996) and unmasks G protein-binding 
sites of the i2 (Schreiber et al., 1994; Xie et al., 1997), i3 (Carlson et al., 1996), or the 
C-terminus (Schreiber et al., 1994).  
 
 
III. Signalling downstream of G protein-coupled chemoattractant  receptors in 
neutrophils. 
 
1. Activation of trimeric G proteins. 
 Signalling through chemoattractant serpentine receptors in neutrophils is 
sensitive to pertussis toxin (Becker et al., 1985; Goldman et al., 1985; Lad et al., 1986), 
indicating the involvement of Gi trimeric G proteins, including Giα2 and Giα3, 
downstream from the receptors (Wu et al., 1993). Trimeric G proteins are membrane-
bound complexes consisting of GDP-binding α-subunit and the βγ unit (Hamm and 
Gilchrist, 1996). Upon serpentine receptor activation, the Gαβγ heterotrimer binds to the 
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receptor, mainly through the α-subunit (Bourne, 1997). This induces GDP to GTP 
exchange on the α-subunit, resulting in dissociation of the βγ heterodimer from Gα-
GTP. When GTP is hydrolyzed to GDP and phosphate due to intrinsic GTPase activity 
of the α-subunit, the G protein complex reassociates and is ready to receive a new signal 
(Hamm and Gilchrist, 1996).  
 Unlike believed previously, probably not the GTP-loaded α-subunit, but the βγ 
heterodimer of the trimeric G proteins transduces the signal from seven transmembrane 
helix receptors to chemotaxis in motile cells (Parent and Devreotes, 1999). Important 
experiments confirming that were done in cultured lymphocyte- or fibroblast-like cells 
transfected with serpentine receptors. Addition of respective agonists induced 
chemotaxis of these cells, which was completely prevented by pertussis toxin or by  βγ-
sequestering proteins Gα of transducin or βARK-ct (Neptune and Bourne, 1997; Arai et 
al., 1997). In contrast, agonist-induced intracellular calcium mobilization, inhibition of 
adenylate cyclase, or MAPK activation were only partially decreased by the proteins 
(Neptune and Bourne, 1997; Arai et al., 1997). As soon as Gβγ is released, Giα is not 
required for activation of chemotaxis (Neptune et al., 1999). The pivotal role of βγ 
heterodimers has been demonstrated in signalling to chemotaxis of D. discoideum and 
directed growth in yeasts (Jin et al., 1998; Nern and Arkowitz, 1998). Finally, certain 
mutations of the β3 subunit can enhance neutrophil chemotaxis (Virchow et al., 1999).  
 
2. Signalling downstream from trimeric G proteins. 
 Among different targets reported for the βγ heterodimer (Clapham and Neer, 
1997), we will discuss the ones which might have relevance for neutrophil chemotaxis 
(see Fig. 3). These will include phospholipases Cβ, PI-3 kinase γ, and various pleckstrin 
homology (PH) domain proteins.  
 
2.1. Phospholipase Cβ - protein kinase C pathway. 
 Phospholipases Cβ, namely PLCβ1-3, but not PLCβ4, can interact directly with 
and be activated by βγ heterodimers (Clapham and Neer, 1997) through the PH domain 
or a region in the catalytic domain (Wang et al., 1999; Katan, 1998). Giα, unlike α-
subunits of some pertussis toxin-insensitive G proteins, can not activate PLCβ (Katan, 
1998). PLCβ catalyzes hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to 
inositol 3,4,5-trisphosphate (IP3) and diacylglycerol (DAG) (Katan, 1998). The latter 
can activate classical (α,β,γ) and novel (δ,ε,η,θ), but not atypical (τ,ζ), isoforms of 
protein kinase C (PKC) (Mellor and Parker, 1998). PLCβ2 is expressed in hematopoetic 
cells (Park et al., 1992) and is responsible for 90% of the fMLP-induced IP3 production 
and consequently 70% of the [Ca2+] rise in neutrophils (Jiang et al., 1997). The fMLP-
induced respiratory burst is ten-fold decreased in the PLCβ2 gene-
13 
  
 
 
 
 
 
Fig. 3. A scheme of signalling events initiated by activation of a seven-transmembrane helix receptor. 
Only the βγ-mediated signalling is shown. See text for description. Gα-GDP and Gα-GTP: GDP or 
GTPbound α subunit of trimeric G proteins. βγ: βγ subunits of the trimeric G proteins. PLCβ: 
phospholipase Cβ. PIP2: phosphatidylinositol 4,5-bisphosphate. IP3: inositoltrisphosphate. DAG: 
diacylglycerol. PKCs: protein kinases C. PI3Kγ: phosphatidylinositol 3-kinase γ. PIP3: 
phosphatidylinositol 3,4,5-trisphosphate. PH: pleckstrin homology domain. PDK: phosphoinositide-
dependent kinase. PKB: protein kinase B. GEFs: guanine nucleotide exchange factors. 
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less neutrophils (Jiang et al., 1997), supporting the key role of DAG-stimulated PKCs in 
the respiratory burst activation (Babior, 1995). However, despite a prevention of the 
αMβ2 (Mac-1, CD11b/CD18) integrin upregulation, neutrophil chemotaxis to fMLP or 
IL-8 was not impaired by PLCβ2 gene deletion (Jiang et al., 1997). This confirms 
previous reports that PIP2 breakdown is not necessary for neutrophil chemotaxis 
(Bengtsson et al., 1988; Perez et al., 1989). Hence, any role of DAG-dependent PKCs in 
chemotaxis signalling in neutrophils downstream from PLCβ2 can be excluded. Reports 
of neutrophil chemotaxis sensitivity to PKC inhibitors (Niggli and Keller, 1993; 
Laudanna et al., 1998; Xiao et al., 1998) can thus be explained proposing an 
involvement of PKC isoform(s) in some signalling events located further downstream. 
Since neutrophils can chemotax efficiently even when intracellular [Ca2+] rises are 
prevented (Perez et al., 1989), Ca2+- insensitive novel or atypical PKCs might be 
involved in chemotaxis. Of these, expression of PKC δ and ζ has been observed in 
neutrophils (Kent et al., 1996; Stasia et al., 1990). Broad range inhibitors blocking PKC 
δ but not ζ were shown to prevent chemoattractant-induced polarization but not actin 
polymerization of neutrophils (Niggli and Keller, 1991; Niggli and Keller, 1993; Xiao et 
al., 1998). Neutrophils translocate PKC δ to the particulate fraction 45 seconds after 
fMLP stimulation (Kent et al., 1996), coinciding with the time of cell polarity 
development (see Coates, 1996). In contrast, PKC ζ was shown to control neutrophil 
chemotaxis at the actin polymerization level and to be translocated to the plasma 
membrane within 10 seconds after cell stimulation (Laudanna et al., 1998). These data 
might indicate that different PKC isoforms regulate neutrophil chemotaxis at different 
levels: PKC ζ involved in switching on the immediate motile response, and a novel PKC 
like PKC δ regulating the choice of the migrating neutrophil where to go. However, 
these roles of PKCs must lie quite downstream in the signalling cascades, and might be 
controlled by PDK-1 or small GTPases (see below).  
 
2.2. PI-3 kinase γ pathway. 
 Phosphoinositide 3-kinases (PI3Ks) are lipid kinases catalyzing phosphate 
addition to the third position of inositol ring of phosphatidylinositol (PI), PI-4-P, and PI-
4,5-P2 (Wymann and Pirola, 1998). The best-studied PI-3 kinase, PI3Kα, is implicated 
in a variety of signalling cascades downstream from receptor tyrosine kinases (Wymann 
and Pirola, 1998). In contrast, PI3Kγ, which is strongly expressed in hematopoetic cells 
including neutrophils (Bernstein et al., 1998; Hirsch et al., in press), is proposed to be 
activated by G protein- coupled receptors (Stephens et al., 1994; Stoyanov et al., 1995). 
This is mediated by the βγ heterodimers; their binding to and activation of PI3Kγ can be 
achieved directly (Stoyanov et al., 1995; Leopoldt et al., 1998) or through the PI3Kγ 
adapter protein, p101 (Stephens et al., 1997; Krugmann et al., 1999).  
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 The mechanism of PI3Kγ activation by the Gβγ may be a mere translocation of 
PI3Kγ to the plasma membrane, where it gets access to its lipid substrates. Indeed, 
targeting of PI3Kγ to the membrane was sufficient for the constitutive PIP3 production 
(Bondeva et al., 1998). However, the ability of PI3Kγ to phosphorylate proteins has 
recently been shown necessary and sufficient in signalling leading to MAPK activation 
(Bondeva et al., 1998). The detailed mechanism of activating the Ser-Thr protein kinase 
activity of PI3Kγ is not clear, but it rather requires a cytosolic than a membrane 
localization of the PI3Kγ (Bondeva et al., 1998; Wymann et al., 1999). It has been 
recently proposed that PI3Kγ may serve as a functional homologue of the Ste5 yeast 
scaffold protein (Lopez-Ilasaca et al., submitted; Lopez-Ilasaca et al., 1997; Rubio et al., 
1997). Ste5 is indispensible for the G protein- coupled receptor pheromone signalling in 
yeast. Through multiple protein-protein interactions, Ste5 organises a complex of 
Saccharomyces cerevisiae MEKK, MEK, and MAPK, which activates MAPK and leads 
to initiation of the mating process in yeasts (Choi et al., 1994).  
 A highly specific for PI3Ks covalent inhibitor wortmannin (Wymann et al., 
1996; Stoyanova et al., 1997) was used to assess PI3K involvement in neutrophil 
functions. Wortmannin could inhibit fMLP-induced actin polymerization (Arcaro and 
Wymann, 1993) and cross-linking (Niggli and Keller, 1997) by ca. 20% and 50%, 
respectively. Wortmannin was also shown to inhibit IL-8- induced neutrophil adhesion 
(Knall et al., 1996). Depending on the experimental set-up, neutrophil motility can be 
wortmannin-insensitive (fMLP and IL-8 as stimuli, (Thelen et al., 1995)), completely 
prevented by wortmannin (IL-8 (Knall et al., 1997) or fMLP (Niggli and Keller, 1997) 
as stimuli), or reduced by 50% by the inhibitor (MIP-2, CINC-1, and PAF as stimuli, 
(Xiao et al., 1998)). Among other neutrophil responses to chemoattractants, respiratory 
burst and exocytosis have been shown wortmannin- sensitive (Arcaro and Wymann, 
1993; Baggiolini et al., 1987).  
 Activation of PI3Ks other than PI3Kγ by trimeric G proteins has been proposed 
(Katada et al., 1999; Vicente-Manzanares et al., 1999). To clarify the role of PI3Kγ in 
chemoattractant-induced neutrophil responses, we have generated PI3Kγ gene-deficient 
mice (Hirsch et al., in press). PI3Kγ -/- neutrophils completely lack chemoattractant-
induced PIP3 production and PKB activation, and fMLP-induced respiratory burst is 
also strongly affected in PI3Kγ-null cells. Upon stimulation with IL-8 and fMLP, these 
cells polymerize less actin and adhere worse to fibronectin than wild-type neutrophils 
(Hirsch et al., in press; Katanaev and Wymann, unpublished). Most importantly, 
chemotaxis in vitro and in vivo is severely impaired in PI3Kγ-null neutrophils and 
macrophages, demonstrating a crucial role of PI3Kγ in cell motility (Hirsch et al., in 
press).  
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2.3. PH domain- containing kinases. 
 Several proteins possess a ca. 100- amino acid-long domain called pleckstrin 
homology (PH) domain (Shaw, 1996). PH domains of different proteins have a week 
sequence homology, but a high degree of conservation of the 3D structure (Rebecchi 
and Scarlata, 1998). Some PH domains have been shown to interact with phosphorylated 
lipids, including the products of PI3 kinases  and βγ heterodimers of trimeric G proteins 
(Shaw, 1996; Bottomley et al., 1998). They can thus occupy upstream positions in 
signalling cascades to transduce signals from G proteins or phospholipid kinases to the 
cytoplasm.  
 
2.3.1. PH domain- containing serine/threonine protein kinases. 
 Phosphoinositide-dependent kinase-1 (PDK-1) (Belham et al., 1999) has been 
shown to possess a PH domain which is indispensable for its activation by the lipid 
products of PI3K (Alessi et al., 1997; Currie et al., 1999). PDK-1 has been proposed to 
phosphorylate PKCs (Chou et al., 1998; Le Good et al., 1998; Dutil et al., 1998), 
including PKC δ and ζ, whose possible role in controlling neutrophil chemotaxis was 
discussed in section 2.1. PDK-1 contributes to the activation of p70S6K (Alessi et al., 
1998), PKA (Cheng et al., 1998), and PKB (Alessi et al., 1997; Stephens et al., 1998). 
The latter, which is activated in neutrophils upon their stimulation with chemoattractants 
(Hirsch et al., in press), can also be directly activated via its PH domain by the lipid 
products of PI3K (Klippel et al., 1997; Franke et al., 1997). Neutrophil and macrophage 
PKB activation by chemoattractants is lost in PI3Kγ gene knock-out mice (Hirsch et al., 
in press). Whether this is the reason for a decrease in chemotactic properties of PI3Kγ-
null cells (see above) remains to be elucidated.  
 
2.3.2. PH domain- containing tyrosine kinases. 
 The Tec family of cytoplasmic PH domain- containing tyrosine kinases includes 
Tec, Btk (Bruton's tyrosine kinase), Itk (Tsk), Bmx, and Txk kinases (reviewed in Neet 
and Hunter, 1996). These proteins are predominantly expressed in hematopoetic cells 
where their primary role is believed to be the control of cell differentiation downstream 
from cytokine or similar receptors (Satterthwaite et al., 1998). PH domains of Tsk and 
Btk have been shown to interact with and to be responsible for kinase activation by βγ 
heterodimers of trimeric G proteins (Tsukada et al., 1994; Langhans-Rajasekaran et al., 
1995). Phospholipid binding by the Btk PH domain was also shown (Fukuda et al., 
1996; Rameh et al., 1997). Although Tec is expressed in a wide range of hematopoetic 
cells including neutrophils (Mano et al., 1990), and Bmx is predominantly expressed in 
granulocytes (Kaukonen et al., 1996; Weil et al., 1997), their role in neutrophil 
signalling is not clear. Tec family protein kinases could potentially be involved in 
chemotaxis signalling downstream of Gβγ or PI3Kγ, which would explain the reports of 
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sensitivity of neutrophil migration to tyrosine kinase inhibitors (Gaudry et al., 1992; 
Yasui et al., 1994; Xiao et al., 1998).  
 
 
IV. Role of small GTP-binding proteins of the Rho family in neutrophil motility. 
 
1. Rho family G proteins, their regulators, and the actin cytoskeleton control. 
 Rho family of GTPases together with Ras-, Rab-, Ran-, and Arf-like proteins 
constitutes the superfamily of small GTP-binding proteins. The mammalian Rho family 
currently includes Rho (RhoA-C), Rac (Rac1-3), and Rnd (Rnd1-3) isoforms, as well as 
RhoG, Cdc42, TC10, RhoD, RhoG, and RhoH proteins (for a recent review, see 
Aspenström, 1999a). As other G proteins, Rho family members are active when bound 
to GTP. Hydrolyzing it to GDP, they become inactivated, while GDP to GTP exchange 
renders them active again. This on-off switch is controlled by several regulatory proteins 
(reviewed in Van Aelst and D'Souza-Schorey, 1997). GTPase activating proteins 
(GAPs) stimulate the GTP hydrolysis on Rho proteins and convert them to the switched-
off state. The opposite role is played by guanine nucleotide exchange factors (GEFs) 
which facilitate the GDP to GTP substitution on Rho proteins. Finally, guanine 
nucleotide dissociation inhibitors (GDIs) are able to "freeze" Rho proteins in GDP- and, 
with a lower affinity, GTP-bound forms, counteracting the effects of other regulators. 
Additionally, GDIs can shuttle the Rho proteins from or to the plasma membrane, an 
important site of their action (Olofsson, 1999).  
 Several functions of Rho proteins were found in different cells. Transcription 
regulation by Rac and Cdc42 via the control of Jun kinase is rather ubiquitous (Symons, 
1996), while some other activities, like granulocyte respiratory burst activation by Rac 
isozymes (Bokoch, 1994), are more restricted. However, the overwhelming role of Rho 
proteins, established in all eukaryotic cells tested, is the control of the actin cytoskeleton 
(Hall, 1998; Ridley, 1999). The classical pattern of the cytoskeleton regulation by Rho 
proteins has been obtained in studies with fibroblasts. In this system, cell stimulation 
with a seven transmembrane helix receptor agonist LPA induces formation of stress 
fibres, thick long bundles of actin-myosin filaments necessary for firm cell adhesion to 
the substratum. The action of LPA could be mimicked by microinjection of 
constitutively active form of RhoA protein; moreover, inhibiting RhoA could prevent 
stress fibre formation by LPA (Ridley and Hall 1992). Fibroblast stimulation with 
growth factors or a seven transmembrane helix receptor agonist bombesin induced 
lamellopodia and membrane ruffling, key structures in cell motility, and this action was 
shown to be transduced by Rac1 protein (Ridley et al., 1992). Finally, another 
serpentine receptor ligand bradykinin induces long finger-like protrusions called 
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filopodia in fibroblasts, and Cdc42 was identified as a key regulator of this phenomenon 
(Kozma et al., 1995; Nobes et al., 1995).  
 The differential action of Rho, Rac, and Cdc42 on the fibroblast actin 
cytoskeleton was reproduced in other cell systems, such as neurones, epithelial and mast 
cells (Norman et al., 1994; Ridley et al., 1995; Kozma et al., 1997). By microinjection 
studies in macrophages, Ridley and coworkers have demonstrated that macrophage 
motility in GM-CSF gradients was inhibited by counteracting Rho and Rac proteins, 
while Cdc42 block could prevent the gradient perception by the motile macrophage but 
not the motility per ce (Allen et al., 1998). As in fibroblasts, Cdc42 was shown to 
control filopodia formation in macrophages, and Rho and Rac were inducing stress 
fibres and lamellopodia, respectively (Allen et al., 1997).  
 In neutrophils, Rac, Rho, and Cdc42 were reported activated and partially 
translocated to the plasma membrane upon cell stimulation with seven transmembrane 
helix receptor agonists (Quinn et al., 1993; Bokoch et al., 1994; Benard et al., 1999). 
Several neutrophil functions dependent on the actin network have been shown to be 
under regulation of Rho proteins. Inhibition of Rho by C3 toxin eliminates neutrophil 
chemotaxis (Stasia et al., 1991) by adhesion impairment (Laudanna et al., 1996). In 
addition to trimeric G proteins, a role of a small G protein in fMLP- or GTPγS- induced 
actin polymerization was suggested by studies in permeabilized neutrophils (Therrien 
and Naccache, 1989; Redmond et al., 1994). In a cell-free system from neutrophil 
cytosol this small G protein was shown to belong to the Rho family, since it was 
inactivated by recombinant RhoGDI and Clostridium difficile toxin B, both specific 
inhibitors of Rho family proteins (Katanaev and Wymann, 1998a). The molecular nature 
of this G protein was suggested to be (Zigmond et al., 1997) or to be not (Katanaev and 
Wymann, 1998a) identical to Cdc42. In intact cells, using gene inactivation by 
homologous recombination, a crucial role of Rac2 in transducing fMLP, LTB4, and IL-8 
signalling to actin polymerization and chemotaxis was demonstrated (Roberts et al., 
1999). Additionally, neutrophil rolling on Glycam-1 was deficient in Rac2-less 
neutrophils (Roberts et al., 1999), in agreement with previous results obtained with T 
lymphocytes (Brenner et al., 1997). Altogether these data highlight a key role of Rho 
family proteins in transducing signalling to chemotaxis in neutrophils, supporting the 
results obtained with other leukocytes (Sanchez-Madrid et al., 1999; Reif and Cantrell, 
1998).  
 
2. Connecting serpentine receptor activation to Rho proteins. 
 How is activation of G protein- coupled receptors linked to Rho family proteins? 
Several possibilities exist, although none of them have been proved to be involved in 
chemotaxis signalling in mammalian cells. An intriguing connection between the α 
subunit of G13 protein and Rho has been recently proposed (Kozasa et al., 1998; Hart et 
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al., 1998). There, the direct binding of p115 RhoGEF to G13α has been shown to 
stimulate the p115 RhoGEF-mediated GDP-GTP exchange on Rho (Hart et al., 1998). 
The interaction is achieved via the p115 RhoGEF's RGS (Regulators of G protein 
Signalling) domain, which can activate GTP hydrolysis on Gα12 and Gα13 (Kozasa et 
al., 1998). p115 RhoGEF plays a crucial role in Rho activation downstream from Gα13 
during development (Barrett et al., 1997). However, as explained above, Gi but not G12 
or G13 trimeric G proteins signal to chemotaxis in neutrophils; moreover, their βγ 
subunits are crucial for chemotaxis.  
 Most GEFs for Rho family proteins identified so far contain a PH domain 
(Cerione and Zheng, 1996), which is necessary for the cellular functioning of GEFs Dbl 
(Zheng et al., 1996), Lbc (Olson et al., 1997), and Tiam-1 (Michiels et al., 1997). The 
Dbl PH domain was shown to bind Gβγ in vitro (Mahadevan et al., 1995), and in vivo, 
but this binding was not sufficient for Dbl activation (Nishida et al., 1999). In 
transfected COS-7 fibroblasts, chemoattractant receptor signalling to actin 
polymerization was proposed to be mediated by a Gβγ-PI3Kγ-Vav-Rac pathway, 
implicating the PH domain of the GEF Vav in its coupling to PI3Kγ (Ma et al., 1998). 
Although PH domains of the Rho GEFs Tiam-1 (Rameth et al., 1997) and Vav (Han et 
al., 1998) were shown to bind lipid products of PI3 kinases, this binding occurs with 
relatively low affinity and specificity (Bottomley et al., 1998; Lemmon, 1999) and is not 
confirmed in physiologic assays (Isakoff et al., 1998; Lemmon, 1999).  
 In yeasts, a connection of Gβγ with Cdc24, the GEF for the small G protein 
Cdc42, regulates the directed growth (Nern and Arkowitz, 1998). This connection is 
achieved by a multiprotein assembly where the pivotal role is played by a scaffold 
protein Far1 (Butty et al., 1998). This essential protein binds Cdc24 recognizing a 
stretch of amino acids which is also present in mammalian Dbl and lies outside of the 
PH and Dbl homology domains (Nern and Arkowitz, 1998; Butty et al., 1998). No 
functional homologues of Far1 are identified up to now in higher eukaryotes. However, 
recent data on the ability of certain proteins (Nef, EPS8-E3B1) to activate Rac and 
Cdc42 by PH domain-independent interactions with their exchange factors Vav (Fackler 
et al., 1999) and Sos-1 (Scita et al., 1999) indicates that a link between trimeric and 
small G proteins mediated by protein-protein interactions might be involved in 
chemotaxis signalling in mammalian cells. 
  
3. Connecting Rho proteins with the actin cytoskeleton in chemotaxis. 
 Several dozens of putative Rho protein targets has been identified (Van Aelst 
and D'Souza-Schorey, 1997; Aspenström, 1999b), and more appear every month. Some 
were proposed based on physical interactions in two hybrid systems, others established 
in functional assays. Despite of the abundance of the announced Rho protein effectors, 
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few links to the actin rearrangements were clearly described. We will concentrate on 
some Rho protein-actin cytoskeleton connections discovered recently, which could have 
implications in signal transduction to chemotaxis in motile cells.  
 
3.1. Rac and Rho can control actin binding proteins by regulation of PIP2 synthesis (Fig. 
4). 
 Rho and Rac were shown to regulate PI(4,5)P2 synthesis in fibroblasts and 
platelets, respectively (Chong et al., 1994; Hartwig et al., 1995). This is achieved by a 
physical interaction of a type I phosphatidylinositol-4-phosphate (PIP) 5-kinase with the 
small GTPases, which occurs in vitro in a GTP-independent manner (Tolias et al., 1995; 
Ren et al., 1996). In vivo, Rac and PIP5-kinase form a multiprotein complex including 
also a diacylglycerol kinase and RhoGDI (Tolias et al., 1998). These findings are 
important since a multitude of actin binding proteins are regulatable by 
phosphoinositides in general and PIP2 specifically (reviewed in Janmey, 1994). For 
example, capping proteins gelsolin and CapZ are dissociated from actin filaments under 
certain conditions in vitro by addition of PIP2 micelles, allowing fast barbed end actin 
polymerization (Janmey et al., 1987; Heiss and Cooper, 1991). Moreover,  
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Fig. 4. Rac and Rho GTPases regulate activity of PIP (phosphatidylinositol-4-phosphate) 5-
kinase, inducing production of PIP2, which in turn controls the activity of many actin-binding 
proteins via their phospholipid-binding domains.  
 
phosphoinositide delivery to permeabilized platelets induced cellular F-actin decapping 
(Hartwig et al., 1995), while overexpression of PIP5-kinase in fibroblasts led to massive 
actin polymerization (Shibasaki et al., 1997). A link between Rac and gelsolin was 
reported based on an inability of fibroblasts from gelsolin knock-out mice to exert Rac-
transduced cytoskeletal changes (Azuma et al., 1998). These data have led to a model, 
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where Rho GTPase constitutive interaction with the PIP5-kinase results upon cell 
activation in increased production of PIP2 which in turn may decap actin filaments 
allowing their elongation at the plasma membrane (Carpenter et al., 1999; Janmey, 
1998). However, in contrast to platelets, most of the cells including neutrophils respond 
with a rapid decrease and not increase of PIP2 when stimulated (Korchak et al., 1985). 
While local increases in PIP2 upon neutrophil stimulation are not excluded, this model 
remains neither proved nor disproved for neutrophils.  
 
3.2. Rac and Rho can stabilize actin filaments inducing phosphorylation of cofilin (Fig. 
5). 
 Cofilin is an essential protein ubiquitously expressed in eukaryotes (see 
(Bamburg et al., 1999) for a review). In Dictiostelium amoebae, cofilin overexpression 
stimulated cell migration (Aizawa et al., 1996). Cofilin and other members of its family 
are unique in its ability to increase the treadmilling of actin filaments (Carlier and 
Pantaloni, 1997). Additionally, cofilin was shown to severe actin filaments, creating  
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Fig. 5. Rac via PAK (p21-activated kinase) and Rho via Rho-kinase phosphorylate LIM kinase 
(LIMK), which in turn phosphorylates cofilin on Ser3. This leads to cofilin inactivation and 
prevention of depolymerization of actin filaments.  
 
free barbed ends (Maciver et al., 1991). Cofilin activities are controlled by 
phosphorylation on Ser3 (Moriyama et al., 1996). The kinase phosphorylating and 
inactivating cofilin was demonstrated to be the LIM-kinase 1, (Arber et al., 1998; Yang 
et al., 1998), a protein defective in Wiliams syndrome patients (Frangiskakis et al., 
1996). Overexpression of LIMK-1 in transfected cells led to accumulation of actin  
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cytoskeleton and reversed cofilin-induced actin depolymerization, moreover, LIMK-1 
mediated actin rearrangements downstream from Rac and insulin (Arber et al., 1998; 
Yang et al., 1998). Rac-induced activation of LIMK-1 is indirect and may be mediated 
by PAK1, a long-known target of Rac and Cdc42 (see (Daniels and Bokoch, 1999) for a 
review). Chemoattractants induce rapid activation of several PAK isoforms and their 
translocation to lamellopodia in neutrophils (Huang et al., 1988; Dharmawardhane et al., 
1999). PAK1 was shown to phosphorylate LIMK-1 and thus increase its ability to 
phosphorylate cofilin; Rac and Cdc42 were able to stimulate the PAK1 association with 
LIMK-1 (Edwards et al., 1999). Moreover, dominant negative LIMK-1 interfered with 
the Cdc42-, Rac-, and PAK1- induced cytoskeletal changes in BHT cells (Edwards et 
al., 1999). In addition to Rac and Cdc42, Rho was also shown to induce cofilin 
phosphorylation in cultured cells via LIMK-1; this effect is mediated by Rho-induced 
activation of Rho-kinase (also called ROCK, or ROCK I, or ROKα) which in turn 
phosphorylates LIMK-1 (Maekawa et al., 1999). Thus, in cell cultures different Rho 
proteins seem to converge their signalling pathways to stimulate LIMK-1 and deactivate 
cofilin, which may lead to prevention of F-actin depolymerization and result in F-actin 
increase. To produce different phenotypes, this pathway must be accompanied with 
other pathways which are used differently by different Rho proteins. In highly motile 
cells like neutrophils half of cofilin is phosphorylated under resting conditions and cell 
stimulation leads to its rapid dephosphorylation (Okada et al., 1996). This is 
accompanied by cofilin redistribution from the cytoplasm to F-actin rich membrane 
ruffles (Heyworth et al., 1997; Djafarzadeh et al., 1997), where its activity might be 
required for rapid reorganization of actin cytoskeleton.  
 
3.3. Regulation of myosin phosphorylation by Rho proteins (Fig. 6). 
 Myosins are motor proteins indispensable for muscle contraction, cellular 
trafficking, and cell motility (Harrington and Rodgers, 1984; Warrick and Spudich, 
1987). Disruption of myosin II in D. discoideum leads to defects in cytokinesis and fruit 
body development (Knecht and Loomis, 1987; De Lozanne and Spudich, 1987), while 
yeast myosins are crucial for cytokinesis and actin cytoskeleton organization (Goodson 
et al., 1996; Kitayama et al., 1997). In a chemotacting neutrophil, myosin is localized in 
the lamellopodue (Valerius et al., 1981), but is excluded from the filopodia (Takubo and 
Tatsumi, 1997). Myosin inhibitors prevent neutrophil transmigration across colonic 
epithelial cells (Hofman et al., 1999) and oscillatory shape changes in neutrophils 
stimulated with LTB4 and PAF (Rengan and Omann, 1999). Phosphorylation has been 
shown to control the activities of all myosins studied so far. In case of the myosin II 
light chain (MLC), its phosphorylation on Ser19 results in an increase of the actin-
activated ATPase activity of the myosin and thus in stimulated contraction (Tan et al., 
1992). In motile cells (Adelstein 1973; Kuczmarski and Spudich, 1980) including 
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neutrophils (Fechheimer and Zigmond, 1983), MLC is phosphorylated upon stimulation, 
implying a role of myosin phosphorylation in cell migration. The phosphorylation state 
of MLC has been shown to be controlled by several enzymes, Rho-kinase, an effector of 
Rho, being one of them (Amano et al., 1996; Kureishi et al., 1997). Rho-kinase has also 
another way of stimulating MLC phosphorylation: it can phosphorylate MLC 
phosphatase, rendering it inactive (Kimura et al., 1996). Importantly, Rho-kinase is 
present in neutrophils and mediates  
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Fig. 6. Regulation of the myosin phosphorylation status by Rho GTPases. Rho-activated Rho-
kinase can induce phosphorylation of Ser19 of the myosin II light chain either directly or 
phosphorylating and thus inhibiting the myosin light chain phosphatase (MLCP). Increase in 
the myosin II light chain phosphorylation leads to an increase in myosin-dependent 
contractility. An opposite action is played by Rac, which through PAK (p21-activated kinase) 
can inhibit the myosin light chain kinase (MLCK).  
 
chemoattractant-induced MLC phosphorylation in these cells (Niggli, 1999). Moreover, 
pharmacological approaches have suggested that Rho-kinase activation is necessary for 
neutrophil polarization and chemokinesis (Niggli, 1999). The differential regulation of 
MLC phosphorylation may also explain the long-observed fact that Rho on one hand 
and Rac or Cdc42 on the other have antagonistic effects on cytoskeleton in many 
systems. Indeed, a recent work has shown that PAK, an effector of Rac and Cdc42, 
inactivates MLC kinase (Sanders et al., 1999), the major regulator of MLC 
phosphorylation identified in a multitude of cell types (Tan et al., 1992). Thus the 
myosin II- based contractility can be counterregulated by the Rac/Cdc42-PAK and Rho-
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Rho-kinase pathways, which might operate such a complex phenomenon as cell 
motility.  
 
3.4. Kinase-independent regulation of actin cytoskeleton. 
 In the examples listed above, lipid or protein kinases were proposed to be 
downstream targets of Rho proteins. In addition to the above-mentioned, a tyrosine 
kinase (Ridley and Hall, 1994), PKCζ (Laudanna et al., 1998), and others (Aspenstrom, 
1999b) were proposed to act downstream of Rho proteins in different systems. However, 
in permeabilyzed neutrophils GTPγS induces actin polymerization in a manner 
apparently independent from ATP (Redmond et al., 1994). Similarly, in a cell-free 
system from neutrophil cytosol, lipid and protein kinases are not involved in propagation 
of the signal from Rho proteins to actin polymerization (Katanaev and Wymann, 1998a). 
Several non-kinase targets of Rho proteins have been proposed (reviewed in 
(Aspenström, 1999b)), like the Wiskott-Aldrich syndrome protein (WASP) (Snapper 
and Rosen, 1999) and its relatives N-WASP and Scar/WAVE.  
 
3.5. Cdc42 can induce actin polymerization activating Arp2/3 via N-WASP (Fig. 7).  
 In a cell-free system from Xenopus oocytes, Cdc42 was shown to induce de novo 
actin polymerization (Ma et al., 1998a; Moreau and Way, 1998). Using biochemical 
approach Kirschner and coworkers have demonstrated that N-WASP and Arp2/3 
complex are necessary and sufficient to transduce the signal from GTP-loaded Cdc42 to 
actin (Ma et al., 1998b; Rohatgi et al., 1999), for the first time reconstituting a 
molecular link between a Rho protein and induction of actin polymerization. A role of 
the Arp2/3 complex in Rho-protein induced actin polymerization was also demonstrated 
in extracts of Acanthamoeba (Mullins and Pollard, 1999). Arp2/3 is a complex of seven 
proteins of the molecular weight ranging from 16 to 47 kDa, two of which are actin-
related proteins 2 and 3, hence the name. The complex is ubiquitously expressed in 
eukaryotic cells and has been purified from amoebae (Machesky et al., 1994), yeasts 
(Winter et al., 1997), Xenopus (Ma et al., 1998a), human platelets (Welsch et al., 1997) 
and neutrophils (Machesky et al., 1997). Arp2/3 is able to bind to the sides of actin 
filaments bundling them (Mullins et al., 1997; Mullins et al., 1998a). Moreover, Arp2/3 
can establish branching points, so called Y-junctions, on the filaments (Mullins et al., 
1998b) resulting in extremely branched filament organization in the leading edge of 
some cells (Svitkina and Borisy, 1999). But the key function of Arp2/3 is its ability to 
nucleate actin filaments (Mullins et al., 1998b; Welch et al., 1998), bypassing the rate-
limitig step in de novo actin polymerization (see Pollard and Cooper, 1986). Bound with 
high affinity to the pointed end of the filament, Arp2/3 allows rapid elongation at the 
barbed end. The ability of Arp2/3 to nucleate barbed-end actin polymerization is 
dramatically increased by WASP (Yarar et al., 1999) and its relatives Scar/WAVE 
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(Machesky et al., 1999) and N-WASP (Rohatgi et al., 1999), which bind the p21 subunit 
of Arp2/3 (Machesky and Insall, 1998). WASPs are targets of GTP-loaded Cdc42 and 
Rac and induce actin polymerization when overexpressed in cultured cells (Aspenström 
et al., 1996; Symons et al., 1996; Kolluri et al., 1996; Miki et al., 1996; Miki et al., 
1998a; Miki et al., 1998b). Their multidomain structure allows a complex regulation 
pattern (Featherstone, 1997). The fact that the C-terminal half of Scar/WAVE  
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Fig. 7. Cdc42 can stimulate de novo actin polymerization via a kinase-independent mechanism. 
Cdc42 (together with PIP2) induces a conformational change in N-WASP, unmasking the 
binding site for p21 of Arp2/3. Activated Arp2/3 then forms nuclei for new actin filaments, 
which are rapidly elongated at their barbed ends. Topology of the subunits of Arp2/3 is based 
on the published model (Mullins et al., 1997).  
 
and N-WASP is more potent in Arp2/3 activation may indicate that the Arp2/3-binding 
domain of these proteins is normally hidden (Machesky et al., 1999; Rohatgi et al., 
1999). Binding of GTP-Cdc42 and phosphoinositides was shown to unmask the Arp2/3-
activating capacity of the full-length N-WASP, which leads to rapid actin 
polymerization, constructing a new paradigm of Rho-protein- induced actin 
polymerization at the plasma membrane (Rohatgi et al., 1999; Miki et al., 1998a). The 
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relevance of this paradigm in regulation of neutrophil chemotaxis is not clarified yet. N-
WASP expression is limited to brain, heart and lung (Miki et al., 1996), while 
Scar/WAVE expression is strictly limited to brain (Nagase et al. et al., 1996). Although 
WASP is expressed in hematopoetic cells (Snapper and Rosen et al., 1999), neutrophils 
from Wiskott-Aldrich syndrome patients chemotax normally in contrast to macrophages 
(Zicha et al., 1998). Recently, two new WASP family members, WAVE2-3, have been 
identified, of which WAVE2 is expressed ubiquitously including peripheral blood 
leukocytes (Suetsugu et al., 1999). 
 
 
V. Concluding remarks. 
 
 Chemotaxis is a multicomponent process, built up of a combination of many 
individual cell responses which are orchestrated in a virtually obscure way by a moving 
cell. Signalling to their activation is initiated by chemoattractant receptors, most of 
which in neutrophils belong to the superfamily of seven-transmembrane helix receptors. 
To induce chemotaxis, these receptors activate trimeric Gi proteins, dissociating them to 
Gαi and Gβγ subunits. The latter hands downstream the chemotaxis signalling courier. 
PI3Kγ is one of the proteins taking it up, but other proteins doing the same awaits 
identification. Through some more yet unrevealed partners, the signal achieves the 
members of Rho family G proteins. Through effectors like Rho-kinase, PAK, and 
WASP, Rho GTPases regulate a multitude of actin binding proteins. Myosin, gelsolin, 
cofilin, and Arp2/3 are among them, whose activities culminate at highly controlled in 
time and space actin rearrangements, staying behind cell motility. 
27 
 
RESULTS 
 
1. GTPγS-induced actin polymerisation in vitro: ATP- and phosphoinositide-      
 independent signalling via Rho-family proteins and a plasma membrane-
 associated guanine nucleotide exchange factor.  
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When stimulated with chemotactic agonists, neutrophils
double their F actin content within seconds (Howard and
Oresajo, 1985). This process was suggested to directly mediate
lamellipod formation during locomotion and shape changes
(Cooper, 1991; Theriot and Mitchison, 1991; Wymann et al.,
1990; Mitchison and Cramer, 1996). Actin polymerisation is
thought to be triggered by the removal of capping proteins from
the filament’s barbed (+, fast growing) ends, allowing the
addition of further monomeric G actin (Schafer and Cooper,
1995). 
In neutrophils, more than half of the total actin is in its
monomeric form and bound to thymosin b 4 (Safer et al., 1991;
Cassimeris et al., 1992) or profilin (Carlsson et al., 1977) in
1:1 complexes. While thymosin b 4 serves solely as a buffer for
G actin, profilin forms a productive complex that can directly
add actin to barbed, but not pointed ends (see Pantaloni and
Carlier, 1993, for references). It has been reported that the
interactions between actin and various binding proteins like
profilin (Lassing and Lindberg, 1985), CapZ (Heiss and
Cooper, 1991) and gelsolin (Janmey and Stossel, 1989;
Hartwig et al., 1996) can be disrupted by
polyphosphoinositides (e.g. PtdIns 4-P and PtdIns(4,5)P2).
How capping proteins are removed from the barbed ends to
allow the growth of actin filaments due to surface receptor
stimulation, however, is not clear. A major advancement in the
understanding of these processes was the observation of Hall
and coworkers, that constitutively activated small GTP-binding
proteins of the Rho family could trigger cytoskeletal
rearrangements (Ridley, 1994). While Rac induced membrane
ruffles (Ridley et al., 1992), Rho mediated the formation of
stress fibres (Ridley and Hall, 1992) and Cdc42Hs generated
filopodia (Nobes and Hall, 1995). That these proteins indeed
transduce signals from growth factor and seven transmembrane
helix receptors was demonstrated by dominant negative forms
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In a cell-free system from neutrophil cytosol GTP g S can
induce an increase in the number of free filament barbed
ends and massive actin polymerisation and cross-linking.
GTPg S stimulation was susceptible to an excess of GDP, but
not Bordetella pertussis toxin and could not be mimicked by
aluminium fluoride, myristoylated GTPg S.Gi a 2 or Gb 1g 2
subunits of trimeric G proteins. In contrast, RhoGDI and
Clostridium difficile toxin B (inactivating Rho family
proteins) completely abrogated the effect of GTP g S. When
recombinant, constitutively activated and GTP g S-loaded
Rac1, RhoA, or Cdc42 proteins alone or in combination
were probed at concentrations >100 times the endogenous,
however, they were ineffective. Purified Cdc42/Rac-
interactive binding (CRIB) domain of WASP or C3
transferase did not prevent actin polymerisation by GTP g S.
The action of GTP g S was blocked by mM [Mg2+], unless a
heat- and trypsin-sensitive component present in
neutrophil plasma membrane was added. Liberation of
barbed ends seems therefore to be mediated by a toxin B-
sensitive cytosolic Rho-family protein, requiring a
membrane-associated guanine nucleotide exchange factor
(GEF) for its activation by GTP g S under physiologic
conditions. 
The inefficiency of various protein kinase and
phosphatase inhibitors (staurosporine, genistein,
wortmannin, okadaic acid and vanadate) and removal of
ATP by apyrase, suggests that phosphate transfer reactions
are not required for the downstream propagation of the
GTPg S signal. Moreover, exogenously added
phosphoinositides failed to induce actin polymerisation and
a PtdIns(4,5)P2-binding peptide did not interfere with the
response to GTP g S. The speed and simplicity of the
presented assay applicable to protein purification
techniques will facilitate the further elucidation of the
molecular partners involved in actin polymerisation.
Key words: Actin, Polymerisation, Cytoskeleton, Small G protein,
Guanine nucleotide exchange factor, Signal transduction
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inhibiting agonist-induced actin rearrangements (Nobes and
Hall, 1995; Kozma et al., 1995; Ridley, 1994). The state of Rho
family proteins themselves is controlled by GTPase activating
proteins (GAP) (Lamarche and Hall, 1994), guanine nucleotide
dissociation inhibitors (GDI) and guanine nucleotide exchange
factors (GEF) (Boguski and McCormick, 1993). GEFs of the
Dbl family contain as minimal elements a Dbl homology (DH)
and a pleckstrin homology (PH) domain (see Cerione and
Zheng, 1996, for a recent review) of which the latter has been
suggested to interact with polyphosphoinositides (Harlan et al.,
1994). Some of the known GEFs act on several targets, e.g.
Dbl on Rho and Cdc42Hs (Hart et al., 1994; Cerione and
Zheng, 1996), Tiam-1 on Rac1 and Cdc42Hs (Michiels et al.,
1995), which might lead to a bifurcation of the incoming
upstream signals. Downstream of Rho family proteins, various
protein kinases are at work: Rho activates e.g. p164 Rho-
associated kinase (p164Rho-K/ROK a ), p160 Rho-associated
coiled-coil-containing protein kinase (p160ROCK) and protein
kinase N (p128PKN/PRK1/2) (see Tapon and Hall, 1997, for a
comprehensive list); Rac and Cdc42 interact with e.g. the
protein Ser/Thr p65PAK and Tyr kinase p120ACK (Manser et al.,
1994). While the latter two contain a CRIB (Cdc42/Rac-
interactive binding; Burbelo et al., 1995) domain as is also
present in WASP (Wiskott-Aldrich syndrome protein;
Aspenström et al., 1996; Symons et al., 1996), other Rac
targets like p67phox (Prigmore et al., 1995) or POR-1 (partner
of Rac-1; Van Aelst et al., 1996) interact differently. Of these
molecules, Rho-K has been shown to mediate lysophosphatidic
acid (LPA)/Rho-induced formation of stress fibers (Amano et
al., 1997) and WASP was reported to colocalize with Cdc42 in
F-actin rich patches (Symons et al., 1996). Moreover, white
blood cells of Wiskott-Aldrich syndrome patients show
distorted shapes and a reduced number of microvilli compared
to normal cells (Kirchhausen and Rosen, 1996). 
In spite of the advancements in Rho family protein
signalling, is it not clear how these events finally lead to the
elongation of actin filaments. From experiments carried out in
permeabilized, thrombin-stimulated platelets, Hartwig and
coworkers (1995) have recently proposed a model where
thrombin receptor-mediated Rac activation is coupled to
increased activity of phosphatidylinositol 4- and 5-kinases
(PI4K and PI5K) and the resynthesis of PtdIns(4,5)P2. Elevated
levels of PtdIns(4,5)P2 would then dissociate PI-sensitive
capping proteins from actin filament barbed ends and thus
trigger actin polymerisation. 
In contrast to platelets, neutrophils respond to G protein-
coupled receptor stimulation with a drop in PtdIns(4,5)P2
which correlates with the increase in F-actin. Moreover, actions
interfering with changes in PtdIns(4,5)P2, like the inhibition of
PLC
b
by cytosolic Ca2+ depletion (Bengtsson et al., 1988) or
the inhibition of PI3K by wortmannin (Arcaro and Wymann,
1993), do not influence actin polymerisation and repetitive
polymerisation/depolymerisation cycles observed at low
agonist concentrations (Wymann et al., 1989, 1990; Omann et
al., 1989; Arcaro and Wymann, 1993). 
To provide a tool to close the gaps in understanding of the
signalling leading from surface receptor stimulation to the
increase in cellular F actin, we have devised a simple and fast
in vitro assay that allows the detection of GTPg S-induced actin
polymerisation in the absence of lipids. The present results
demonstrate that GTPg S mediates filament elongation by the
liberation of barbed ends, and requires the presence of a
cytosolic, Rho family G protein and, in the presence of free
Mg2+, a membrane-associated guanine nucleotide exchange
factor (GEF) activity. 
MATERIALS AND METHODS
Materials
ATPg S, ADP, GTP, GDP, apyrase grade V, cytochalasin B, heparin,
sodium orthovanadate, pertussis toxin, and trypsin were from Sigma;
Lymphoprep from Nycomed; Benzonase from Merck; diisopropyl
fluorophosphate (DFP) was purchased from Aldrich; leupeptin from
Alexis Co.; pepstatin A, ATP, NAD+ from Fluka. Several batches of
GTPg S (tetralithium salt) were purchased from Sigma and Fluka.
Phalloidin, rhodamine phalloidin, and N-(1-pyrene)iodoacetamide
were from Molecular Probes; GDP b S, DNase I and UDP-glucose
from Boehringer Mannheim; genistein from ICN; G150 Sepharose
(medium grade) from Pharmacia; okadaic acid from Calbiochem; and
UDP-[14C]glucose was from Hartmann Analytic. PtdIns, PtdIns 4-P,
and PtdIns(4,5)P2 were from Fluka, dissolved in
chloroform/methanol, dried, and sonicated in water before use. 
Staurosporine was a kind gift from D. Fabbro, Ciba Geigy Ltd,
Basel; wortmannin was kindly provided by T. G. Payne, Sandoz
Pharma Ltd, Basel; rhodamine-labelled phosphoinositide-specific
peptide (corresponding to gelsolin amino acids 160-169; Janmey et
al., 1992) generously donated by P. Janmey, Brigham & Women’s
Hospital, Boston; and buffy coats were kindly prepared by the Swiss
Red Cross Transfusion Center, Fribourg. 
G
b 1g 2 complexes were purified from baculovirus infected Sf9 cells as
described (Kozasa and Gilman, 1995), myristoylated Gia 2 was purified
from Escherichia coli cotransfected with a Gia 2 expression plasmid and
N-myristoyl transferase (Lee et al., 1994; Mumby and Lider, 1994).
Plasmids and baculovirus for the latter procedures were kindly obtained
from A. G. Gilman, University of Texas, Dallas. RhoGDI, V12Rac1 and
V14RhoA (Ridley et al., 1992; Ridley and Hall, 1992) and C3 transferase
(kindly given by L. A. Feig, Tufts University, Boston; Dillon and Feig,
1995) were purified from E. coli as GST-fusion proteins. After thrombin
digestion, the proteins were purified as described. E. coli expressed
reference proteins (V12Rac1, V14RhoA, V12Cdc42 and N17Cdc42)
successfully used in microinjections were also obtained from A. Ridley,
LICR, London. WASP expression plasmids to produce GST-fusions of
WASP (amino acids 48-321), WASPD CRIB (48-321 without the CRIB
domain at 237-257) and WASP- CRIB (235-268, with a deleted WIP-
binding domain) were generously donated by U. Francke, Stanford
University, Stanford (Symons et al., 1996). Clostridium difficile toxin B
(Just et al., 1995) and Clostridium sordellii (strain 6018) lethal toxin (Just
et al., 1996; Genth et al., 1996) were a generous gift from I. Just,
University of Freiburg, Germany.
Neutrophil isolation and subcellular fractionation
Human neutrophils were isolated as described by Böyum (1968) and
remaining erythrocytes were lysed by ammonium chloride treatment.
Neutrophils were washed twice in 0.9% NaCl, 50 m M CaCl2 and
resuspended in Hepes-potassium buffer (HKB, 135 mM KCl, 10 mM
NaCl, 10 mM Hepes, 2 mM EDTA, pH 7.0, 108 cells/ ml) or Hepes-
sodium buffer (HNaB, 138 mM NaCl, 4.6 mM KCl, 20 mM Hepes,
2 mM EDTA, pH 7.4). Membrane fractions were prepared from cells
suspended in HKB without EDTA but supplemented with 3 mM
MgCl2/2 mM EGTA.
Cells were disrupted in the above buffers supplemented with 1 mM
PMSF, 0.5 mM diisopropyl fluorophosphate (DFP), 20 m M leupeptin,
18 m M pepstatin, 12.5 units/ml benzone nuclease, and 5% glycerol by
nitrogen cavitation (40 minutes, 35 bar) on ice. After centrifugation
for 10 minutes at 1,300 g the supernatant was cleared for 45 minutes
at 121,000 g. 
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To prepare plasma membranes and granules, the low speed
supernatant from above was fractionated by a discontinuous sucrose
gradient as described earlier (Abo and Segal, 1995). Plasma
membranes and cytosol performed successfully in a cell-free NADPH
oxidase assay (Abo and Segal, 1995). Samples were stored at - 80°C
without loss of activity.
Protein concentrations were determined with the Bradford (Bio-
Rad) assay using BSA as a standard. ATP concentrations were
determined using an ATP luciferase bioluminescence assay kit
(CLSII, Boehringer Mannheim). Total ATP was measured by the
release of bound nucleotides from proteins with 400 mM perchloric
acid. Free ATP was determined by the direct addition of cytosolic
samples to the luminescence assay. 
In protease sensitivity experiments, plasma membranes (1.3 mg/ml
of total protein) were incubated without or with 150 m g/ml trypsin for
2 hours at 37°C. DFP was added to 1 mM before membranes were
applied to the actin polymerisation assay. 
Analysis of actin aggregates
If not indicated otherwise, cytosol was diluted with HKB to 1.8 mg
total protein/ml, and incubated at 37°C in the absence or presence of
50 m M GTP g S for 20 minutes. These samples were either: (i) fixed
for microscopy with 10% p-formaldehyde for 10 minutes on ice, and
supplied with 0.6 m M rhodamine phalloidin at least one hour before
they were examined on a confocal microscope (Bio-Rad MRC 1024/
Nikon E800 optics), or (ii) centrifuged at 9,000 g, 5 minutes. The
sediments were washed twice with HKB, denatured and applied to a
10% SDS-PAGE gel. Major actin-binding proteins were subjected to
MALDI-TOF-MS on a PerSeptive Biosystem Voyager Elite mass
spectrometer after in-gel trypsin digestion (for references see Cottrell
and Sutton, 1996).
Actin polymerisation assay in a cell-free system
The property of rhodamine phalloidin enhancing its fluorescence by
approximately a factor of ten after binding to F actin (Huang et al.,
1992) was exploited to measure increases in the amount of F actin in
a cell-free system. The assay was set up to display a maximal
sensitivity in cytosolic fractions (data not shown). If not indicated
otherwise, reactions were carried out in a total volume of 35 m l HKB
(with free Mg2+ at less than 10 m M, as calculated according to
(Martell and Smith, 1974) with 1.8 mg cytosolic protein/ml. After the
indicated additions and preincubations (see below) either vehicle or
GTPg S was added for 20 minutes at 37°C. Aliquots of 10 m l were then
removed and added to 600 m l HKB with 16.5 nM rhodamine
phalloidin. Fluorescence was measured 20 minutes later in a Perkin
Elmer fluorescence spectrometer LS50B (Ex. 552 nm, slit 5 nm; Em.
580 nm, slit 20 nm). After subtraction of the background rhodamine
phalloidin fluorescence, the fluorescence intensity is linearly related
to the amount of F actin present (data not shown). 
Free barbed ends assay
ATP.actin from rabbit skeletal muscles was isolated as described
previously (Pardee and Spudich, 1982), labelled with N-(1-
pyrene)iodoacetamide according to the method of DiNubile and
Southwick (1988), and pyrenyl G actin was purified as in the method
of MacLean-Fletcher and Pollard (1980), its concentration being
determined according to the method of Carson et al. (1986). Cytosolic
reaction mixtures were treated for 15 minutes as described above.
Aliquots of 20 m l were subsequently mixed with 600 m l prewarmed
HKB containing 0.5 m M pyrenyl G actin, and the kinetics of pyrenyl
actin fluorescence was immediately followed at 27°C (Ex. 365 nm,
slit 3 nm; Em. 387 nm, slit 10 nm). Under these conditions the initial
rate of fluorescence increase is the measure of amount of free barbed
ends added (Carson et al., 1986). 
Bacterial toxins
Cytosolic fractions were preincubated with various toxins at 37°C
before addition of GTP g S. B. pertussis toxin (pre-activated with 1 mM
ATP and DTT for 15 minutes at 37°C) and C3 transferase were used
in the presence of 20 m M NAD+ for ADP-ribosylations. C. difficile
toxin B (Just et al., 1995) and C. sordellii (strain 6018) lethal toxin
(Just et al., 1996; Popoff et al., 1996; Genth et al., 1996) glucosylated
small G proteins with 50 m M UDP-glucose as a co-substrate. The
activities of toxin B and lethal toxin were tested at nM concentrations
on NIH 3T3 fibroblasts and were found to induce the expected
morphological changes (Just et al., 1996). 
Toxin B-mediated glucosylation was assessed using 50 nCi UDP-
[14C]glucose (50 m M final). After a 30 minute incubation at 37°C,
samples were analysed for 10% trichloroacetic acid (TCA)-insoluble
radioactivity or by SDS-PAGE followed by autoradiography. 
Preloading of recombinant G proteins with guanine
nucleotides
Gia 2 (0.19 mg/ml) was preloaded with 0.1-1 mM GTP g S in the
presence of 20 mM MgCl2 for 1 hour at 37°C (Carty and Iyengar,
1994). Rac1, RhoA and Cdc42 were preloaded with a 5-10 molar
excess of GTP or GTPg S in the presence of 10 mM EDTA for 20
minutes at RT, terminating the reaction by addition of 20 mM MgCl2
(Self and Hall, 1995).
RESULTS
GTPg S triggers F actin assembly and cross-linking
in vitro
When high speed cytosolic fractions from human neutrophils
were incubated with GTPg S, the formation of actin filaments
and aggregates was observed microscopically: F actin could be
detected by rhodamine phalloidin staining both before (data not
shown) and after fixation of GTP g S treated cytosol with p-
formaldehyde, which was added to prevent further actin
rearrangements (Fig. 1). While filament bundles and
aggregates were numerous and of considerable size due to
GTP g S addition (≤30 m m), untreated cytosols displayed only
occasionally aggregates of much smaller size (<<10 m m). To
determine changes in cross-linked F actin, GTP g S treated
cytosolic fractions and controls were centrifuged at low speed
and actin was quantified by Coomassie staining. Compared to
controls, GTP g S caused typically a 6.8 (±2.5, s.d., n=4)-fold
increase in sedimentable actin, resulting in the sedimentation
of about 16% of the total actin present in the cytosol. Two
major proteins co-sedimenting were identified as ABP-280 and
a -actinin.
Taking advantage of the observation of Huang et al. (1992)
that rhodamine phalloidin fluorescence increases about 10-fold
upon its binding to F actin we have developed a functional
reconstitution assay for actin polymerisation. Using the assay
we found that ‡ 1 mg of total cytosolic protein/ml in the
presence of ‡ 5 m M GTPg S was necessary to induce significant
actin polymerisation. Higher concentrations of GTPg S up to 50
m M further increased the total amount of F actin detected after
20 minutes of incubation and reached a plateau thereafter (Fig.
2A). When the time course of actin polymerisation in response
to different amounts of GTPg S was examined, we observed a
strong effect of increasing GTP g S concentrations on the rate of
actin polymerisation during the first 10 minutes of the reaction
(Fig. 2B). The polymerisation process reached its maximum at
about 10-20 minutes and F actin levels remained constant up
to 40 minutes to decrease slightly to 80 minutes. The de novo
polymerised actin seems therefore to remain stable, indicating
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that the system reaches a new equilibrium at higher F actin
levels due to GTPg S stimulation. This can be explained by the
observation that free barbed ends could not be detected beyond
30 minutes after GTP g S addition (data not shown), indicating
that the liberation of barbed ends is a transient process.
GTPg S is the only nucleotide to stimulate actin
polymerisation
Addition of 50 m M GTP g S to cytosolic reaction mixtures
increased the amount of filamentous actin by a factor of
5.17±0.59 (mean ± s.e.m., n>30). All tested batches of GTP g S
exhibited the same effect, which was not mediated by lithium
ions associated with GTP g S: LiCl up to 2 mM did not affect F
actin levels (data not shown). Other nucleotides tested (ATP,
ATPg S, ADP, GDP, GDPb S, all at 100 m M) failed to display
any stimulatory action on actin polymerisation (n‡ 3). GTP at
100 m M induced a slight increase in F actin, and was at 1 mM
about 50% as effective as GTPg S (data not shown). The
absence of a stimulatory action of 100 m M ATP or ATPg S on
the polymerisation process demonstrates that the effect of
GTPg S does not involve the transfer of its g -thiophosphate
group to ADP by a nucleoside diphosphokinase (Parks and
Agarwal, 1973). 
When an excess of GDP (1 mM) was added together with
GTP g S, the effect of the latter was completely inhibited, which
is a further indication of the specific action of GTP g S on a
signalling molecule (Fig. 3). ADP or UDP (1 mM) added
shortly before GTP g S had no effect, but prolonged
preincubations increasingly lowered basal and GTP g S-
controlled F actin levels (data not shown). 
GTPg S increases the number of free barbed ends
An excess (30 m M) of DNase I, sequestrating monomeric actin
V. L. Katanaev and M. P. Wymann
Fig. 1. GTPg S-mediated actin polymerisation and cross-linking.
Cytosols from human neutrophils at a concentration of 1.8 mg/ml of
total protein in HKB were incubated for 20 minutes in the absence
( - , - GTPg S) or presence of 50 m M GTP g S (+, +GTPg S).
(A,B) Samples for confocal microscopy were subsequently fixed
with p-formaldehyde and stained with rhodamine phalloidin for F
actin. (A) Largest aggregate found in sample; (B) representative field
of view. Bar, 50 m m. (C) Alternatively, the treated samples were
centrifuged at low speed, and washed sediments were subjected to
SDS-PAGE and Coomassie blue staining. Total protein applied
before sedimentation (T) corresponds to 1/10 of the material yielding
the sediments in first two lanes (Sedimented). Positions of molecular
mass standards are indicated to the right (in kDa). Data are
representative for ‡ 3 experiments. Asterisks indicate the positions of
ABP-280 and a -actinin (apparent molecular mass 105 kDa), as
identified by peptide mass fingerprinting analysis.
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Fig. 2. Effect of increasing concentrations of GTP g S on end point
and kinetics of actin polymerisation. (A) Reaction mixtures with 1.8
mg cytosolic protein/ml were incubated with the indicated
concentrations of GTP g S for 20 minutes before F actin was
quantified (mean ± s.e.m., n‡ 3). (B) Samples were incubated with
the indicated concentrations of GTPg S for the indicated times before
aliquots were removed for F actin determination (data representative
for 6 experiments). 
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(Mannherz et al., 1975), decreased basal F actin levels as
compared to untreated cytosolic reaction mixtures and
completely abolished the GTPg S-mediated actin polymerisation
(Fig. 3). Cytochalasin B, on the other hand, did not affect the
basal signal, but potently blocked the GTPg S-induced increase
in F actin. This suggests that the barbed ends (fast growing, +
ends) of actin filaments have to be accessible for GTPg S to be
able to trigger polymerisation. To test if the number of barbed
ends indeed increased, cytosolic reaction mixtures were
stimulated with 50 m M GTPg S for 15 minutes at 37°C and
aliquots were subsequently tested for barbed end nucleation
activity (Carson et al., 1986). While cytosol incubated in the
absence of GTPg S did not trigger an increase in pyrenyl actin
fluorescence, GTPg S treated samples led to a rapid
incorporation of pyrenyl actin into filaments, and thus to an
increase in fluorescence (Fig. 4). Cytochalasin B (5 m M) in the
measurement cuvette blocked this increase, while variations of
the actin concentration did not influence the initial rate of the
process. Altogether, this illustrates that GTPg S promoted an
increase of available barbed ends. Interestingly, no free barbed
ends could be detected 30 minutes after addition of GTPg S at
37°C (data not shown). However, when samples were collected
15 minutes after GTPg S addition and then kept on ice, cytosol
retained its nucleating activity for prolonged times. This might
indicate that at 37°C, but not 0°C, GTPg S triggers some
feedback reactions leading to recapping of barbed ends.
The role of protein-, lipid kinases and phosphatases
The effect of two broad band protein kinase inhibitors,
genistein targeting protein tyrosine kinases (Akiyama and
Ogawara, 1991) and staurosporine affecting Ser/Thr kinases
(Tamaoki, 1991), was examined. Both inhibitors (genistein at
50 m M and staurosporine at 500 nM) did not interfere with
GTPg S-mediated in vitro actin polymerisation. Wortmannin, at
nM concentrations a specific inhibitor of PI 3-kinases (Arcaro
and Wymann, 1993; Yano et al., 1993), affects at m M
concentrations some other lipid and protein kinases (see
Wymann et al., 1996, for references). Even at 1 m M, however,
the substance remained without effect (Table 1). 
When cytosol was exposed to 0.5 units/ml of apyrase
(converting ATP and ADP to AMP and Pi; Kettlun et al., 1982)
for 70 minutes on ice, >99% of the free ATP remaining after
cell fractionation (initially 2.5 m M) was hydrolysed resulting
in an [ATP] of about 22 nM. The amount of protein-bound ATP,
however, was only reduced from 2.1 m M to approx. 220 nM.
At the same time, GTPg S was still able to produce a >2-fold
increase in F actin, the partial inhibitory effect of apyrase being
best explained by the loss of actin-bound ATP. Similarly,
prolonged incubations with 1 mM ADP before GTPg S addition
decreased subsequent actin polymerisation, most likely also
interfering by the elimination of ATP.actin from the system.
The above, the inhibitor data and the fact that addition of 1 mM
ATP to cytosolic reaction mixtures did not enhance the GTP g S-
mediated increase in F actin (data not shown), suggest that
lipid- and protein kinase activities are not involved in the
GTP g S-mediated process.
Two protein phosphatase inhibitors, okadaic acid (Hardie et
al., 1991) and vanadate (Gordon, 1991), were tested on GTP g S-
stimulated actin polymerisation (Table 1). Okadaic acid at 0.5
m M did not display a significant effect, while vanadate at 3 mM
slightly reduced both, the basal and GTP g S-induced F actin
levels. The fold increase in polymerised actin triggered by
GTP g S, however, remained unchanged. Vanadate seems
therefore to mediate its weak action not via inhibition of
protein phosphatases, but rather by its direct interaction with
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Fig. 3. Inhibition of GTP g S-mediated actin polymerisation by DNase
I, cytochalasin B, and GDP. Directly after the addition of vehicle
(control), or 30 m M DNase I, 5 m M cytochalasin B, or 1 mM GDP,
cytosolic reaction mixtures were incubated in the absence (open
bars) or presence of 50 m M GTP g S (closed bar) for 30 minutes at
37°C, before F actin contents were measured. Data is presented as
percentage of the control without additions (mean ± s.e.m., n‡ 3).
Fig. 4. Barbed end nucleation assay. Cytosolic reaction mixtures
were incubated with 50 m M GTP g S (solid lines) or vehicle only
(broken lines) for 15 minutes, before aliquots were transferred
directly (0 minutes) to the measurement cuvette containing 0.5 m M
pyrenyl G actin or kept on ice before the assay (for 30 minutes). The
fluorescence of pyrenylated rabbit skeletal muscle G actin after the
addition of 50 m M GTPg S is represented by the dotted curve. The
curves were set off from each other for clarity (representative for 5
experiments).
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actin filaments, as it has been reported before (Combeau and
Carlier, 1988). 
Involvement of Rho-family but not trimeric GTP-
binding proteins
The results presented above point to GTP-binding proteins
being the mediators of the observed rise in F actin. Candidates
might thus be either trimeric or small G proteins. To test the
importance of trimeric G proteins, cytosols were pretreated
with B. pertussis toxin, or aluminium fluoride, recombinant
G
b 1g 2 or GTP g S-loaded Gia 2 were added. None of these
treatments, however, showed any inhibitory or stimulatory
effect (see Table 1).
C. difficile toxin B (inactivating Rho proteins by
glucosylation using UDP-glucose as a co-substrate; Just et al.,
1995), on the other hand, completely inhibited GTP g S-
mediated actin polymerisation in a concentration dependent
way. This inhibition correlated with the incorporation of
[14C]glucose into total TCA-precipitatable protein and into a
20 kDa family of proteins (Fig. 5). Additionally, we found that
increasing amounts of recombinant RhoGDI eliminated the
action of GTP g S, but did not affect basal F actin levels (Fig.
6). Pretreatment of the cytosol with 10 m g/ml C. sordellii lethal
toxin, known to inactivate several ras-subfamily proteins and
Rac1 (Just et al., 1996), could not prevent the action of GTPg S
(Table 1). The stimulatory effect of GTPg S was also dependent
on the free Mg2+ concentration and was completely blocked at
1 mM (Fig. 7A), which is typical for small, but not for trimeric
G proteins (Self and Hall, 1995; Gilman, 1987). Altogether, the
above results show that the target of GTP g S is not a trimeric,
but a Rho family-related G protein. To elucidate the nature of
the small G protein, we supplied the cytosolic reaction
mixtures with Rho proteins purified from E. coli. At 10 m M
none of the constitutively activated and GTP g S-loaded
V12Rac, V14RhoA and V12Cdc42 proteins could trigger actin
polymerisation. Permutations of mixtures of these proteins
(total combined concentration was 12 m M added as 12, 6/6 or
4/4/4 m M sets) were equally ineffective. GST-WASP fusion
proteins were added to the cytosol to bind GTP-loaded Cdc42:
GST-WASP (amino acids 48-321) and WASP D CRIB (48-321,
a.a. 237-257 deleted, used as a negative control) at 3 m M, and
the GST fusion of the WASP CRIB domain (235-268) up to
30 m M all failed to interfere with GTPg S signalling. C3
transferase, ADP ribosylating RhoA-C (Dillon and Feig,
1995), did not produce any effect on the system at 5 m g. When
concentrations where elevated to 100 m g/ml, an approx. 40%
drop in GTP g S-mediated actin polymerisation could be
achieved. This reduction, however, was independent of the
presence of NAD+ and heat inactivation of C3 (Table 1). In the
presence of 25 m M PtdIns, reported to stimulate the access of
bacterial toxins to Rho proteins due to their dissociation from
RhoGDI (see Dillon and Feig, 1995, for references), virtually
no effect of C3 transferase was observed (data not shown).
Membrane-associated protein(s) reverse the
inhibitory action of Mg2+
As shown in Fig. 7A, free Mg2+ inhibits GTP g S-induced actin
polymerisation in a concentration dependent way. While the
basal level of F actin was not affected significantly, GTP g S-
mediated increases were totally abolished at 1 mM free Mg2+.
This behaviour of the cytosolic system suggests, that it does
not contain a guanine nucleotide exchange factor (GEF)
activity that would allow the nucleotide exchange on the
aftersought G protein at physiological Mg2+ concentrations. 
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Table 1. Treatments not affecting GTPg S-mediated actin polymerisation
Additions Max. concentrations used Action of treatment
Genistein 50 m M Broad protein tyrosine kinase inhibitor
Staurosporine 500 nM Broad protein Ser/Thr kinase inhibitor
Wortmannin 1 m M PI 3-kinase inhibitor
PPI-binding peptide 10 m M Binds PtdIns(4,5)P2
Na-orthovanadate 3 mM Broad protein phosphatase inhibitor
Okadaic acid 250 nM Broad protein phosphatase inhibitor
Aluminium fluoride* 20 mM NaF Activator of trimeric G proteins
10 m M AlCl3
B. pertussis toxin** 2 m g/ml ADP-ribosylation of Gia subunits
Gi a2 .GTPg S* 15 m g/ml Activated Gia2 subunits
G
b 1g 2* 20 m g/ml bg subunit of trimeric G proteins
C. sordellii lethal toxin 
strain 6018*** 10 m g/ml Glucosylation of Rac1, Ras, Rap, Ral
C3 transferase**,‡ 100 m g/ml ADP-ribosylation of RhoA, B, C
V12Rac1.GTPg S* 10 m M Constitutively activated Rac1
V14RhoA.GTPg S* 10 m M Constitutively activated RhoA
V12Cdc42.GTPg S* 10 m M Constitutively activated Cdc42
Permutations of Rho proteins§ tot. 12 m M See V12Rac1, V14RhoA, V12Cdc42
N17Cdc42¶ 5 m M Dominant negative form of Cdc42
GST-WASP-CRIB domain 30 m M Binds Cdc42.GTP and some Rac.GTP
Protein and lipid kinase and phosphatase inhibitors were preincubated with cytosol for 10 minutes at 37°C before GTPg S addition.
*Actin polymerisation was studied in the absence of further added GTP g S.
**Used with 20 m M NAD+.
***Used with 50 m M UDP-glucose and 0.1-0.4 mM free Mn2+ for up to 1 h, before complexation of divalent cations with EDTA and addition of GTPg S.
‡At the highest concentrations used, the C3 transferase preparations reduced polymerised actin by ca. 40%. This reduction, however, also occurred with heat
inactivated preparations.
§Added to a total concentration of 12 m M.  Combinations of 12, 6+6, 4+4+4 m M V12Rac1.GTPg S, V14RhoA.GTPg S and V12Cdc42.GTPg S were tested.
¶Was tested in the system containing plasma membrane and Mg2+ (see Fig. 7B for conditions). Identical results were obtained in the cytosolic system without
membranes and Mg2+.
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As many GEFs are membrane associated, we reconstituted
our system by the addition of neutrophil plasma membrane. As
demonstrated in Fig. 7B, addition of plasma membrane protein
to 100 to 300 m g/ml, but not neutrophil granule membranes
(data not shown), rescued the stimulatory effect of GTPg S in
the presence of 1 mM free Mg2+. While the response to GTP g S
reached a plateau at about 180 m g membrane protein/ml, the
basal levels of F actin slightly increased in a linear fashion. In
the absence of free Mg2+ we could not detect any influence of
plasma membrane preparations on actin polymerisation (data
not shown). Dominant negative N17Cdc42 (5 m M) added to the
system (+membranes and Mg2+) in order to test whether the
putative GEF would interact with Cdc42, could not prevent
actin polymerisation. 
As it has been reported before that PtdIns(4,5)P2 exhibits
GDP-dissociation activity on Cdc42 (Zheng et al., 1996), we
tested the effects of pure polyphosphoinositides in cytosolic
reaction mixtures. Unexpectedly, PtdIns, PtdIns4P and
PtdIns(4,5)P2 all inhibited GTP g S-mediated actin
polymerisation completely in the absence of free Mg2+ at 25,
80 and 25 m M, respectively, and none of the tested lipids
induced actin polymerisation by itself. Moreover, 10 m M of a
rhodamine-labelled PtdIns(4,5)P2-binding peptide derived
from gelsolin (Janmey et al., 1992) did not block the action of
GTP g S (higher concentrations of the peptide interfered with
the assay and caused actin polymerisation). If free Mg2+ was
set to 1 mM in cytosolic reaction mixtures, on the other hand,
lipids compensated the inhibitory action of free Mg2+ on
GTP g S-mediated action polymerisation (EC50s for PtdIns,
PtdIns4P and PtdIns(4,5)P2 were 10, 100, and 120 m M,
respectively), but did not induce an increase in F actin by
themselves (≤240 m M). The decrease in potency of PtdIns >>
PtdIns4P > PtdIns(4,5)P2 is unlikely to be related to a
previously observed GDP dissociation activity on Cdc42 and
fits better with the lipid-induced dissociation of Rho proteins
from RhoGDI (Chuang et al., 1993). 
When plasma membrane preparations were exposed to
trypsin or heat and then added to cytosol containing 1 mM free
Mg2+, the membrane-mediated rescue of the GTPg S-triggered
response was eliminated (Fig. 7B,C). Most of the membrane
associated activity could be preserved, if the serine protease
inhibitor DFP was added before trypsin. These results further
demonstrate that the active plasma membrane constituent
which permits the action of GTPg S in the presence of high free
Mg2+ is a protein and not a lipid. 
In summary, our results reveal that GTP g S triggers actin
polymerisation by the action of a toxin B-sensitive, RhoGDI-
binding Rho family-related protein, which requires under
physiologic conditions the presence of a membrane associated,
putative GEF activity.
Fig. 5. Inhibition of GTP g S-mediated actin polymerisation by C.
difficile toxin B. The indicated amounts of toxin B (ToxB) with 50
m M UDP-glucose as co-substrate were incubated with cytosol for 30
minutes at 37°C. (A) Aliquots were thereafter incubated with vehicle
(open circles) or 50 m M GTP g S (closed circles) before the F actin
content was determined. Covalent [14C]glucosylation of proteins was
assessed by the measurement of radioactivity present in the
trichloroacetic acid-insoluble material (grey squares; mean ± s.e.m.,
n=3; s.e.m. bars omitted where smaller than the symbols).
(B) Alternatively, samples were denatured and subjected to SDS-
PAGE before to the detection of [14C]glucosylated protein. The
location of molecular mass markers is indicated to the right
(representative for 3 experiments).
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Fig. 6. Recombinant RhoGDI inhibits the effect of GTP g S. The
indicated amounts of rhoGDI purified from E. coli were preincubated
with cytosolic reaction mixtures. Vehicle (open circles) or 50 m M
GTPg S (closed circles) were added subsequently. After 25 minutes at
37°C F actin was quantified (mean ± s.e.m., n=3). Values obtained in
the presence of GTPg S for RhoGDI dilution buffer only or RhoGDI
denatured by boiling are denoted by a closed triangle and square,
respectively. 
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DISCUSSION
GTPg S-mediated actin polymerisation: an in vitro
approach
Although numerous actin-interacting proteins have been
isolated, it is presently not clear how signals emerging from
cell surface receptors trigger actin polymerisation. It has been
recognised, however, that Rho family proteins relay these
signals and that constitutively activated Rac, Rho and Cdc42
cause cytoskeletal rearrangements by themselves (Ridley,
1994; Ridley and Hall, 1992; Nobes and Hall, 1995; Nobes et
al., 1995). Nevertheless, it is not understood how these small
G proteins might cause e.g. the liberation of barbed ends to
allow the elongation of actin filaments. This motivated us to
develop in vitro assays to elucidate the mechanisms of signal-
induced actin polymerisation. 
We observed that GTP g S addition to neutrophil cytosolic
fractions caused the appearance of F actin bundles and
networks that grew so large that they could be easily viewed
by light microscopy and sedimented by low speed
centrifugation. Size, stability and appearance of the networks
can be explained by the presence of ABP-280 (branching F
actin at high angles; Gorlin et al., 1990), a -actinin (an actin
bundling and network-forming crosslinker; Otto, 1994) and
further unidentified actin-binding proteins. As cytosol after
high speed centrifugation contains only filaments of less than
20 actin monomers (DiNubile and Southwick, 1988), these
observations illustrate the dramatic effect of GTPg S on the
elongation of actin filaments.
Based on the previously described increase in rhodamine
phalloidin fluorescence upon binding to F actin (Huang et al.,
1992) we have composed an optimized assay to determine F
actin changes in cytosolic samples. In comparison to other
methods, we have drastically reduced both the amount of
rhodamine phalloidin used and lowered the amount of total
cytosolic protein required to about 40 m g/sample. The major
advantage of the assay is, however, that the F actin content can
be determined directly after sample treatment and that no
centrifugation, washing steps or release of labelled phalloidin
are required. The in vitro assay presented here is therefore the
first fast and simple enough to be used along with protein
purification schemes designed to identify molecules involved
in the actin polymerisation process. 
GTPg S liberates barbed ends
GTP g S-mediated actin polymerisation could be demonstrated
before in permeabilized neutrophils (Therrien and Naccache,
1989; Bengtsson et al., 1990; Downey et al., 1990; Redmond
et al., 1994) and was shown to be driven by the availability of
free barbed ends (Tardif et al., 1995). In our cell-free system,
both the end point levels and the rate of GTP g S-induced actin
polymerisation increased with the amount of stimulator added
to cytosol. Together with the observations that GTP g S
increases the availability of free barbed ends and that
cytochalasin B blocks GTPg S-mediated actin polymerisation,
this suggests that GTPg S transiently removes capping proteins
from free barbed ends or forms them de novo, similarly to what
probably happens in vivo upon stimulation. 
The role of protein-, lipid kinases and phosphatases,
and ATP 
To elucidate the role of protein and lipid kinases, we attempted
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Fig. 7. Inhibition of GTP g S-triggered actin polymerisation by free Mg2+ and reversal by membrane proteins. (A) Increasing amounts of MgCl2
were added to cytosolic reaction mixtures yielding the indicated free [Mg2+]. Subsequently, samples were supplemented with 50 m M GTPg S
(closed circles) or vehicle only (open circles) and incubated as above. (B) Cytosolic samples containing 1 mM free Mg2+ were combined with
plasma membranes with the indicated quantity of membrane protein, before GTP g S or vehicle was added. Alternatively, membranes denatured
by boiling were used in the presence of GTP g S (filled square). (C) Cytosolic samples as in B were supplemented with plasma membranes
pretreated in the absence (-) or presence of trypsin (+) or trypsin and diisopropyl fluorophosphate (+/DFP). In all membrane samples DFP was
brought to 1 mM before being added to cytosolic reaction mixtures. After all described incubations, F actin was quantified as above (mean ±
s.e.m., n‡ 3; deviations omitted where smaller than symbols).
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to block the GTP g S-mediated actin polymerisation with broad
band inhibitors for protein tyrosine kinases (genistein;
Akiyama and Ogawara, 1991), Ser/Thr protein kinases
(staurosporine; Tamaoki, 1991) and PI 3-kinases (wortmannin;
see Wymann et al., 1996). Even the use of elevated inhibitor
concentrations did not interfere with the polymerisation
response. This finding clearly excludes a variety of src- and
EGF receptor-like tyrosine kinases, members of the protein
kinase C family, and PI 3-kinase and related proteins from
being downstream elements for the primary target of GTPg S
in cytosolic fractions. This contrasts with the proposed
involvement of a protein tyrosine kinase downstream of Rho
in bombesin and lysophosphatidic acid-induced stress fibre
formation in fibroblasts (Ridley and Hall, 1994). 
As a variety of kinases might still escape the treatments
above, apyrase was used to remove ATP from cytosol to
eliminate phosphorylation reactions completely. Free ATP in
cytosol was already lowered to about 2.5 m M after cell
fractionation and decreased by a factor of >100 due the
addition of apyrase. The GTPg S-induced actin polymerisation
response was lowered in parallel to about 1/3. As protein-bound
ATP decreased to approximately 1/10 of the initial
concentration within the same time, it must be assumed that
ATP was also lost from actin. It is most likely that this loss of
the nucleotide interfered with the ability of actin to polymerise,
but that ATP was not required for downstream kinase reactions.
This is in agreement with the observations that addition of mM
ATP did not enhance GTP g S-induced actin polymerisation and
that mM ADP only showed inhibitory activity when incubated
for prolonged periods allowing ATP/ADP exchange on actin.
Redmond et al. (1994) have shown previously in streptolysin-
O permeabilized neutrophils that degradation of extracellular
ATP does not abrogate GTPg S-stimulated increases in F actin.
A further argument against the involvement of phosphorylation
reactions is that the process takes place in an excess of EDTA,
leaving most kinases inactive due to their dependence on
divalent cations. These findings exclude the participation of a
number of protein and lipid kinases that were proposed to act
downstream of Rho family proteins (see Introduction).
Additionally, these results exclude an involvement of Rac-
induced PtdIns(4,5)P2 synthesis as described by Hartwig and
coworkers (1995) in permeabilized platelets.
In neutrophils and platelets, okadaic acid was reported to
alter cell shape and to inhibit agonist-mediated changes in F
actin (Kreienbuhl et al., 1992; Downey et al., 1993; Yano et
al., 1995). While it was suggested that this occurs without the
involvement of myosin light chain phosphorylations, it was
shown in fibroblasts that RhoA regulates myosin phosphatase
through Rho-kinase (Kimura et al., 1996). In vitro actin
polymerisation by GTPg S as shown here, on the other hand,
was not affected by okadaic acid, nor o-vanadate, suggesting
that the effects of protein phosphatases observed in neutrophils
would be localised up-, but not downstream of the target of
GTPg S.
The cytosolic target of GTPg S
As GTPg S can act as an activator for trimeric and small G
proteins, we modulated in vitro actin polymerisation by
stimulators and inhibitors for both protein families. B. pertussis
toxin, which inhibits Gi a subunits by ADP-ribosylation, was
shown previously to inhibit agonist mediated F actin increases,
but did not interrupt the stimulation conferred by GTPg S in
permeabilized neutrophils (Redmond et al., 1994). Likewise B.
pertussis toxin left the GTPg S-mediated actin polymerisation
in the cell free system intact. Activators of trimeric G protein
controlled pathways, aluminium fluoride, GTP g S-loaded
myristoylated Gia 2 subunits, and Gb 1g 2 complexes also failed
to stimulate actin polymerisation in cytosolic reaction
mixtures. Although trimeric G proteins certainly mediate
agonist-induced actin polymerisation in intact cells (Shefcyk et
al., 1985), they are not necessary to carry on the GTPg S signal
in the cytosol. All this is in agreement with the fact that trimeric
G proteins require an excess of free magnesium for their
activation both in vivo and in vitro (Gilman, 1987), and could
thus not exchange GDP for GTP g S under the standard
conditions of the assay.
It has been reported that C. difficile toxin B glucosylates a
broad range of Rho family proteins (Rho, Rac, Cdc42, but not
Ras) at the residue corresponding to threonine 37 in RhoA (Just
et al., 1995). Moreover, it was demonstrated that microinjected
glucosylated RhoA produced a dominant negative effect and
disassembled actin filaments in fibroblasts (Just et al., 1995).
When toxin B was tested in the cell free actin polymerisation
assay for its potential to interfere with GTP g S stimulation, it
was found that the dose dependent inhibition correlated with
the incorporation of [14C]glucose into protein and in particular
with the labelling of a 20 kDa protein family. C. sordellii lethal
toxin with Rac1, Ras, Rap and Ral as targets (Just et al., 1996;
Genth et al., 1996), on the other hand, was not effective. 
As a further strategy to block Rho family protein signalling
we used recombinant RhoGDI to complex the putative small
G protein, and RhoGDI was indeed capable to block the action
of GTP g S at 50 m M. The effect of RhoGDI on exocytosis in
mast cells (Mariot et al., 1996) or on receptor-mediated
endocytosis in HeLa cells (Lamaze et al., 1996) was previously
taken as proof for the involvement of Rho-related proteins in
these cell responses. Together with the inhibitory action of
toxin B, our data clearly demonstrate the involvement of a Rho
family member in the GTP g S-mediated actin polymerisation
response.
The membrane associated GEF activity
We found that the actin polymerising action of GTPg S was very
sensitive to free magnesium ions. This fits well with the fact
that small G proteins can exchange their loaded guanine
nucleotide in vitro as long as Mg2+ is complexed, but that the
GDP/GTP exchange is hindered if this requirement is not met
(Self and Hall, 1995). In vivo, at mM free Mg2+ concentrations,
the nucleotide exchange is accelerated by guanine nucleotide
exchange factors (GEFs; Boguski and McCormick, 1993). Our
data illustrate that the cytosolic fractions are devoid of a GEF
activity that could mediate nucleotide exchange on the target
G protein mediating actin polymerisation. 
GEFs are often localised to membrane fractions (Bokoch et
al., 1994; Whitehead et al., 1995; Chardin et al., 1996; Paris et
al., 1997) and re-addition of plasma membranes to the system
at 1 mM Mg2+ indeed rescued the effect of GTP g S, while
neutrophil granule membranes remained ineffective. On the
other hand, it has been shown that PtdIns(4,5)P2 can accelerate
the dissociation of GDP from human Cdc42 (Zheng et al.,
1996) and stimulate GEFs by binding to pleckstrin homology
domains (Paris et al., 1997). Working with Xenopus egg
1592
extracts, Ma and coworkers (1998) have proposed that 4,5-
phosphorylated phosphoinositides trigger actin polymerisation
either by direct action on small G proteins or serving as
docking site for GEFs. 
The sensitivity of the plama membrane activity to heat and
trypsin demonstrated here, however, illustrates clearly that
either the GEF itself or an essential proteinous GEF activator
is associated with the plasma membrane and that carried over
lipids do not act by themselves. 
In the absence of free Mg2+ phosphoinositides inhibited
GTPg S-induced actin polymerisation. The reason for this is not
clear, but it supports the notion that eventually present, but
undetectable traces of cytosolic phosphoinositides are not
essential to promote actin polymerisation. This is agreement
with the negative results obtained with a gelsolin-derived
PtdIns(4,5)P2-binding peptide and excludes the involvement of
processes like PtdIns(4,5)P2 synthesis as they were proposed
to be of importance in permeabilized platelets downstream of
Rac (Hartwig et al., 1995).
When free Mg2+ was present, the above situation was
reversed, and phosphoinositides now restored the ability of
GTPg S to polymerise actin even in the absence of plasma
membrane. The order of potency for PtdIns, PtdIns 4-P and
PtdIns(4,5)P2 best correlated with the previously reported
capacity of the lipids to dissociate Rac/RhoGDI complexes
(Chuang et al., 1993). That dissociation indeed occurred was
confirmed by the increased availability of targets for toxin B-
mediated [14C]-glucosylation (data not shown). Although
hypothetical, it is tempting to speculate that PtdIns releases a
further small G protein from RhoGDI, which would, in contrast
to the primary GTPg S target, possess a suitable GEF activity
in the cytosol. As the cytosol reflects a very disorganised
neutrophil which was once capable of performing specialised
tasks like chemotaxis and phagocytosis, it is likely that the
randomised system represents the multitude of signalling
pathways necessary to concert the cell’s actions.
While this work was being prepared for submission,
Zigmond and coworkers (1977) published data supporting a
role for a small G protein in a cell free actin polymerisation
system. Using cytosol from D. discoideum mutants lacking
trimeric G protein subunits they showed in an elegant way that
these are not the targets for GTP g S. Furthermore, they
successfully induced actin polymerisation in vitro with 100 nM
Cdc42 purified from Sf9 insect cells, but not from E. coli. In
our study, 10 m M concentrations, exceeding 100 times the ones
in cytosolic fractions for Rac and Rho and 1,000 times for
Cdc42 were still found to be unsuccessful in inducing actin
polymerisation. 
While isoprenylation seems to be important for membrane
translocation and GEF-mediated GDP/GTP exchange
(Bockoch et al., 1994), non-isoprenylated Rho family proteins
usually interact with and activate their downstream partners
normally. When produced in E. coli, Rho bound to and
stimulated the activity of protein kinase N (Watanabe et al.,
1996); Rac reconstituted cell-free NADPH oxidase (Abo and
Segal, 1995); and Cdc42 induced N-WASP-mediated F actin
depolymerisation (Miki et al., 1998) and IQGAP1-mediated F
actin crosslinking (Fukata et al., 1997). The failure of massive
amounts of recombinant Rac, Rho and Cdc42 to induce actin
polymerisation in a pure cytosolic system, the fact that C3
transferase, N17Cdc42, the WASP-CRIB domain (this work)
and a Cdc42-binding PAK-derived peptide did not block
GTP g S action (Zigmond et al., 1997), indicate that the
endogenous small G protein might be different from the ones
above.
The availability of a simple assay system for signal-induced
F actin using fully fractionated material will certainly help to
further elucidate the molecular mechanisms leading to actin
polymerisation and allow a better definition of the cell
compartements involved in the process.
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ulations of CD45R1 cells in spleens or of
CD45R1 and CD431 cells in bone marrow
(10). Unlike wild-type mice, however, mice
lacking PI3Kg produced few antibodies con-
taining the l light chain when immunized with
T cell–independent (TI) antigen hydroxylnitro-
phenyl (NP)–Ficoll (Fig. 4A). By contrast, mice
lacking both PLC-b2 and PLC-b3 consistently
produced larger amount of TI antigen-specific
antibodies composed of the immunoglobulin l
light chain (TI-IglL) than did wild-type mice
(Fig. 4A). It appears that the PLC pathway, in
this case, opposes the PI3K pathway. Enhance-
ment in TI-IglL production appeared to be pri-
marily dependent on the PLC-b3 deficiency
(Fig. 4A). Neither PLC nor PI3K deficiency
affected the production of TI-Igk (Fig. 4B) or of
T cell–dependent (TD) antigen NP–chicken
gamma globulin (NP-CCG)–specific antibodies
composed of either l or k light chains (10).
Together these data suggest that the production
of TI-IglL may be subjected to regulation by G
protein–mediated signaling pathways. Because
no differences were detected between wild-type
and PI3Kg-deficient mice in the amount of total
serum IglL and in the number of B cells carry-
ing cell surface lL (10), we think that PI3Kg
deficiency is more likely to affect antigen-de-
pendent processes than early development of B
cells.
Mice lacking PLC-b3 developed spontane-
ous multifocal skin ulcers usually starting at the
age of 6 months or older (Fig. 4C). The lesions
were localized mainly behind ears or on the
neck, but sometimes also appeared on the face.
Similar phenotypes were observed with mice
lacking both PLC-b2 and PLC-b3. Histological
examination of the lesion tissues revealed hy-
perinfiltration of leukocytes in the lesion tissues
(Fig. 4, D and E). Most of the infiltrated leuko-
cytes had morphological characteristics of mac-
rophages and lymphocytes. No ulcerative le-
sions were observed in wild-type mice, mice
heterozygous for the disrupted PLC-b3 genes,
or other transgenic lines including PLC-b2– and
PI3Kg-null mice that were housed in the same
rooms under the same conditions. This ulcer-
ative phenotype is consistent with the idea that
the PLC pathways act to inhibit some important
responses mediated by chemoattractants.
In summary, this study with mouse lines
deficient in two prominent chemoattractant-ac-
tivated signaling pathways confirms that both
PI3Kg and PLC-b2/-b3 have important roles in
chemoattractant-induced responses. The study
also revealed roles for these proteins in leuko-
cyte functions, including the involvement of
PI3Kg in the production of TI-IglL and the PLC
pathway in down-modulation of chemotaxis and
production of TI-IglL and in hyperinflamma-
tory conditions.
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Central Role for
G Protein–Coupled Phosphoinositide
3-Kinase g in Inflammation
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Phosphoinositide 3-kinase (PI3K) activity is crucial for leukocyte function, but
the roles of the four receptor-activated isoforms are unclear. Mice lacking
heterotrimeric guanine nucleotide-binding protein (G protein)–coupled PI3Kg
were viable and had fully differentiated neutrophils and macrophages. Che-
moattractant-stimulated PI3Kg2/2 neutrophils did not produce phosphatidyl-
inositol 3,4,5-trisphosphate, did not activate protein kinase B, and displayed
impaired respiratory burst and motility. Peritoneal PI3Kg-null macrophages
showed a reduced migration toward a wide range of chemotactic stimuli and
a severely defective accumulation in a septic peritonitis model. These results
demonstrate that PI3Kg is a crucial signaling molecule required for macrophage
accumulation in inflammation.
Chemoattractant-mediated recruitment of
leukocytes is a key step in the progress of
acute and chronic inflammation. Chemokines
and chemotactic peptides, such as N-formyl-
Met-Leu-Phe ( f MLP), C5a, and interleu-
kin-8 (IL-8), bind to G protein–coupled re-
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ceptors (1). Receptor activation induces the
release of Gbg subunits from trimeric G pro-
teins. In phagocytic cells, this triggers a series
of signaling events that culminate in direc-
tional cell movement, phagocytosis, degran-
ulation, and superoxide generation (1). The
production of phosphatidylinositol 3,4,5-
trisphosphate [PtdIns (3,4,5)P3] appears to
have an essential role, because inhibitors of
PI3K prevent these responses (2). Leukocytes
express all the four known class I PI3K iso-
forms (PI3Ka, b, g, and d), but it is presently
not clear which enzyme(s) relay inflammato-
ry signals (3).
To assess the physiologic role of the
PI3Kg isoform, we generated PI3Kg-defi-
cient mice by homologous recombination.
The targeting vector disrupted the PI3Kg
gene by the insertion of an IRES (internal
ribosomal entry site)-LacZ and a neomycin
resistance cassette in the first coding exon
(exon 2) (4). Embryonic stem (ES) cell
clones showing heterozygous gene disruption
were used to generate germ line chimeras (5).
Mice homozygous for the PI3Kg-targeted
allele were viable, fertile, and displayed a
normal life-span in a conventional mouse
facility. Whereas wild-type (WT) mice ex-
pressed PI3Kg in neutrophils, macrophages,
and splenocytes, homozygous mutant cells
showed no expression of the protein. In the
same cells, the lack of PI3Kg did not alter the
expression of other class I PI3Ks (namely a,
b, and d) (Fig. 1A) (6).
Peripheral blood cell counts of PI3Kg-
deficient mice showed no statistically signif-
icant differences in the hematocrit or in the
distribution of lymphocytes, monocytes, ba-
sophils, and eosinophils compared with those
in WT animals. By contrast, PI3Kg-null mice
had about twice as many of circulating poly-
morphonuclear neutrophils (PMNs) as WT
mice (Table 1). Microscopic examination of
blood smears did not show any morphologi-
cal abnormality in any leukocyte population.
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Table 1. Blood parameters. Data are the mean 6 SE of 15 mice from each group.
Parameter WT PI3Kg2/2
Hematocrit (%) 47.30 6 0.72 47.8 6 1.03
Neutrophils (103/ml) 0.66 6 0.10 1.23 6 0.13*
Lymphocytes (103/ml) 2.18 6 0.29 1.26 6 0.17
Monocytes (103/ml) 0.08 6 0.02 0.08 6 0.02
Eosinophils (103/ml) 0.004 6 0.001 0.008 6 0.003
Basophils (103/ml) 0.008 6 0.002 0.006 6 0.002
Platelets (103/ml) 415 6 25 410 6 35
*P , 0.001 (StudentÕs t test).
Fig. 1. PI3K downstream sig-
naling by sevenÐtransmem-
brane helix receptors. (A) Fail-
ure of PI3Kg2/2 hematopoi-
etic cells to express PI3Kg.
Murine PI3Kg was detected in
WT bone marrowÐderived
neutrophils (N¯), thioglycol-
late-elicited peritoneal mac-
rophages (M¯), macrophage-
depleted splenocytes (Spl.),
and cells from the upper Per-
coll layer [light bone marrow
fraction (6), LBM; consisting
mainly of lymphocytes and
monocytes] by immunoblot-
ting with monoclonal anti-
bodies produced against the
NH2-terminal part of human
PI3Kg. PI3Ka, b, and d were
detected with antibodies de-
scribed in (6). Murine hemato-
poietic 32D cells (32D) and
human embryonic kidney
(HEK) 293 cells were applied
as positive and negative con-
trols. (B) Neutrophil PI3K ac-
tivity after C5a (10 nM), f MLP
(1 mM), and IL-8 (100 nM)
stimulation. Lipids were ex-
tracted from PMNs labeled
with inorganic phosphate (32Pi) at the indicated times, deacylated, and separated by HPLC (2). To obtain the
kinetic proÞle in the left panel, peaks as shown in the right panel (15-s stimulation) were integrated, and
the ratio of PtdIns(3,4,5)P3/PtdIns(4,5)P2 was calculated as a percentage (n $ 3, mean 6 SE). The elution
times of the deacylation products of PtdIns(4,5)P2 and PtdIns(3,4,5)P3 are indicated by (4,5) and (3,4,5),
respectively. (C) PKB phosphorylation in response to heptahelical receptor agonists. Bone marrowÐderived
PMNs (106/ml) of the indicated genotypes were incubated for 10 min at 37¡C and subsequently stimulated
with 1 mM f MLP, 10 nM C5a, or 10 nM IL-8 for 30 s. Samples were probed for the presence of PI3Kg, PKB phosphorylated on Ser-473, and total PKB. (D)
PKB phosphorylation by G proteinÐindependent signaling pathways. Human serumÐopsonized zymosan (C3bi and immunoglobulin GÐcoated) and GM-CSF
(100 ng/ml) were used to stimulate neutrophils for 15 and 5 min, respectively. C5a stimulation was done as in (C). (E) G proteinÐdependent intracellular
calcium release. Fura-2Ðloaded PMNs obtained from wild-type (wt) and PI3Kg-null mice were stimulated with IL-8 (50 nM), C5a (1 nM), platelet activating
factor (PAF, 100 nM), and f MLP (100 nM).
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Fluorescence-activated cell sorter (FACS)
analysis of bone marrow PMNs and resident
peritoneal macrophages with antibodies to
distinct cell surface markers (Gr-1 and
CD11b for PMNs; CD11b, F4/80, CD80, and
CD86 for macrophages) revealed matching
cell distribution and expression patterns in
WT and PI3Kg-null mice, indicating that dif-
ferentiation of myeloid cells is independent
of PI3Kg (7).
The coupling of PI3Kg to seven–transmem-
brane receptor signaling was assessed in mor-
phologically mature bone marrow PMNs. Phos-
phoinositides were analyzed by metabolic la-
beling with 32P–inorganic phosphate and sub-
sequent analysis of deacylated lipids on high-
performance liquid chromatography (HPLC).
After stimulation of cells with C5a, f MLP, or
IL-8, PtdIns(3,4,5)P3 was produced in WT but
not in PI3Kg2/2 cells (Fig. 1B). The serine-
threonine protein kinase B (PKB/Akt) is a ma-
jor target of PI3K (8). Whereas C5a, fMLP, and
IL-8 triggered PKB phosphorylation in re-
sponse to chemoattractants in WT cells, in
PI3Kg-null PMNs PKB phosphorylation did
not rise above background levels (Fig. 1C).
Serum–opsonized zymosan and granulocyte-
macrophage colony-stimulating factor (GM-
CSF), by contrast, were still capable of signal-
ing to PKB (Fig. 1D). Therefore, protein ty-
rosine kinase–dependent processes successful-
ly activate PI3Ka, b, or d isoforms in PI3Kg-
null cells. The intact calcium release initiated
by f MLP-, C5a-, platelet-activating factor
(PAF), and IL-8 receptors (Fig. 1E) illustrates
that PI3Kg-independent G protein–coupled sig-
naling pathways are not affected. PI3Kg is thus
the sole PI3K isoform coupled to f MLP, C5a,
and IL-8 receptors.
PI3Kg functions in cytoskeletal remodel-
ing and leukocyte mobility (9). In addition,
the chemotactic response to agonists of G
protein–linked heptahelical receptors is cor-
related with PI3K-dependent activation of
PKB (10). We thus examined the ability of
mutant PMNs to adhere and migrate. Mutant
cells showed no increase in cell adhesion on
fibronectin in response to IL-8 (11). Because
adhesion and cytoskeletal remodeling are
prerequisites for cell motility, the chemotac-
tic response to IL-8, f MLP, and C5a was
assayed. PMNs from PI3Kg-null mice dis-
played a reduction in chemotaxis in response
to IL-8, f MLP, and C5a in vitro (Fig. 2A).
The in vivo impact of this chemotactic defect
was assessed by measurement of agonist-
induced PMN infiltration into subcutaneous
air pouches. IL-8 at doses of 0.3 and 1 mg
caused recruitment of 60% fewer PMNs in
PI3Kg-null mice than in WT animals after 2
and 4 hours (Fig. 2B). The response to car-
rageenan, a pleiotropic inflammatory stimu-
lus (12), was not altered in PI3Kg-null mice
(Fig. 2B). These data indicate that lack of
PI3Kg leads to impaired recruitment of
PMNs in response to chemokines.
Of the various neutrophil responses, the ag-
onist-induced respiratory burst is the most sen-
sitive to PI3K inhibitors (2). Resting neutro-
phils only weakly respond with a respiratory
burst to seven–transmembrane receptor ago-
nists, but can be “primed” with tumor necrosis
factor–a, GM-CSF, or lipopolysaccharide
(LPS) to markedly increase their response (13).
Consistent with these data, WT murine bone
marrow–derived PMNs responded to f MLP
after a prolonged incubation with LPS, whereas
PI3Kg-null cells remained less responsive (Fig.
2C). Prolonged adhesion restored the sensitivity
of PI3Kg-null neutrophils to f MLP in a wort-
mannin-sensitive manner (7). Activation of the
NADPH (nicotinamide adenine dinucleotide
phosphate, reduced) oxidase by serum–opso-
nized zymosan or phorbol 12-myristate 13-ac-
etate (PMA) was intact in PI3Kg2/2 cells (Fig.
2, D and E). These results, and the reported
sensitivity of f MLP and zymosan-induced res-
piratory burst to wortmannin (2), suggest that
f MLP triggers PtdIns(3,4,5)P3 production re-
quired for the respiratory burst exclusively by
way of PI3Kg. The zymosan signal (comple-
ment 3bi-mediated stimulation) or priming
events, on the other hand, act by way of protein
tyrosine kinases on p85-associated PI3Ks, thus
relieving an essential requirement for PI3Kg
(e.g., for the activation of PKB; see Fig. 1D).
PI3Kg-null macrophages, obtained from
peritoneal exudate of thioglycollate-treated
mice, were tested in an in vitro chemotaxis
assay with various chemoattractants. First,
we evaluated the chemotactic response to-
ward endotoxin-activated mouse serum
(EAMS) as a source of chemotactic comple-
ment fractions. In this assay, the chemotactic
response of PI3Kg-null cells was reduced by
60% (Fig. 3A). In contrast, peritoneal macro-
phages showed a similar migration toward
PMA, indicating that the defect resided in
receptor signaling rather than in leukocyte lo-
comotion ability. To further characterize the
migratory deficiency observed with EAMS, we
stimulated PI3Kg-deficient macrophages with
G protein–coupled serpentine receptor agonists
such as RANTES (regulated on activation, nor-
mal T cell expressed and secreted), macrophage
inflammatory protein–5 (MIP-5), macrophage-
derived chemokine (MDC), stromal cell–de-
rived factor–1 (SDF-1), and C5a. Migration
toward all of these chemotactic agents was
reduced in mutant macrophages. Chemotaxis of
PI3Kg2/2 macrophages was decreased in re-
sponse to C5a (85% reduction), SDF-1 (85%),
RANTES (80%), MDC (70%), and MIP-5
(52%) compared with WT cells (Fig. 3A).
PI3Kg2/2 peritoneal macrophages also exhib-
ited an 85% reduction in chemotaxis toward
vascular endothelial growth factor (VEGF), an
agonist known to bind a tyrosine kinase recep-
tor (Fig. 3A) (14). This observation is consis-
tent with the report that VEGF-stimulated mi-
gration can be inhibited by pertussis toxin (15)
and establishes a crucial role of PI3Kg in this G
protein–mediated response. Upon stimulation
with G protein–coupled receptor agonists
RANTES, MIP-5, SDF-1, C5a, and f MLP,
mutant and WT macrophages showed similar
increases in intracellular Ca21 release (Fig.
3B). Consistent with a specific PI3K signaling
defect, PI3Kg2/2-purified resting peritoneal
macrophages showed no increase in PKB phos-
phorylation after C5a stimulation (Fig. 3C).
Fig. 2. Chemotaxis and respiratory burst of PMNs.
(A) Chemotaxis to IL-8 (50 nM), f MLP (100 nM),
and C5a (3 nM) was measured with ßuorescently
labeled cells (18). The data (mean 6 SE, n 5 6 to
13) are expressed as the percentage of total cells
that migrated. Indicated P values were calculated
by ANOVA and represent comparisons of WT and
PI3Kg-null populations. (B) Migration to air
pouches. IL-8 (1 and 0.3 mg/ml in sterile apyro-
genic saline) and carrageenan (1% in sterile apy-
rogenic saline) were injected into 6-day-old air
pouches (12). Mice were killed 2 or 4 hours later
and the exudate collected in 1 ml of saline. Re-
sults are the mean 6 SE of PMN counts from Þve
to six different mice per group. (C to E) Respira-
tory burst in PMNs. (C) PMNs were preincubated
in the absence or presence of lipopolysaccharide
(LPS, 100 ng/ml) before stimulation with 1 mM
f MLP (mean 6 SE; n 5 8 to 13). (D) Resting
PMNs were stimulated with human serumÐopso-
nized zymosan (mean 6 SE; n 5 3). (E) Resting
PMNs were stimulated with 100 nM PMA
(mean 6 SE; n 5 6). Chemiluminescence was
measured according to published methods (19),
and data represent integrated responses ( f MLP, 3
min; opsonized zymosan, 30 min; PMA, 30 min).
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A model of aseptic peritonitis induced by
intraperitoneal injection of thioglycollate was
used to evaluate the impact of the lack of
PI3Kg on the onset of an inflammatory re-
sponse in vivo. The number of thioglycollate-
elicited peritoneal leukocytes was measured
at various time points in mutant and control
mice. There was a 36% decrease in total
PI3Kg2/2 peritoneal leukocytes (n 5 7; P 5
0.09) at 120 hours, but no differences were
present at earlier time points (4 and 48 hours).
In contrast, induction of septic peritonitis by
injection of Gram-positive and Gram-nega-
tive bacteria resulted in an impaired inflam-
matory response in PI3Kg-deficient mice.
FACS analysis and microscopic inspection of
the elicited cell populations indicated that the
lack of PI3Kg affected the recruitment of
both neutrophils and macrophages. The num-
ber of peritoneal PI3Kg-null macrophages as
early as 12 hours after bacteria administration
was reduced by 90% compared with that in
WT animals (Fig. 4A). Similar results were
obtained with Gram-positive bacteria such as
Staphylococcus aureus [5 3 108 colony-
forming units (CFU)]. Microscopic analysis
of peritoneal leukocytes revealed that
PI3Kg2/2 macrophages did normally phago-
cytose bacteria. Because macrophage recruit-
ment is essential to purge peritoneal infec-
tions, we tested whether PI3Kg-deficient
mice were able to clear peritoneal bacteria
after administration of sublethal doses of S.
aureus (16). Forty-eight hours after intraperi-
toneal injection of 5 3 107 CFU per mouse,
bacteria persisted in the abdominal cavity of
PI3Kg2/2 mice, with a concentration 10
times that of WT mice (Fig. 4B).
Our data are consistent with a central role
of PI3Kg in linking G protein–coupled recep-
tor signaling to PtdIns(3,4,5)P3 production,
which in turn rigorously governs cell motility
in macrophages and to some extent in neu-
trophils. The control of macrophage infiltra-
tion in chronic inflammatory diseases such as
rheumatoid arthritis, pulmonary fibrosis, ath-
erosclerosis, and autoimmune disorders is a
major task of present pharmacological research.
Our results indicate that PI3Kg might be a
suitable target for development of drugs that
could specifically modulate phagocyte func-
tions without generating severe side effects.
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Requirement for DARPP-32 in
Progesterone-Facilitated Sexual
Receptivity in Female Rats
and Mice
S. K. Mani,1* A. A. Fienberg,2† J. P. O’Callaghan,3 G. L. Snyder,2
P. B. Allen,2 P. K. Dash,4 A. N. Moore,4 A. J. Mitchell,1 J. Bibb,2
P. Greengard,2 B. W. O’Malley1
DARPP-32, a dopamine- and adenosine 39,59-monophosphate (cAMP)–regu-
lated phosphoprotein (32 kilodaltons in size), is an obligate intermediate in
progesterone (P)–facilitated sexual receptivity in female rats and mice. The
facilitative effect of P on sexual receptivity in female rats was blocked by
antisense oligonucleotides to DARPP-32. Homozygous mice carrying a null
mutation for the DARPP-32 gene exhibited minimal levels of P-facilitated sexual
receptivity when compared to their wild-type littermates. P significantly in-
creased hypothalamic cAMP levels and cAMP-dependent protein kinase activity.
These increases were not inhibited by a D1 subclass dopamine receptor an-
tagonist. P also enhanced phosphorylation of DARPP-32 on threonine 34 in the
hypothalamus of mice. DARPP-32 activation is thus an obligatory step in
progestin receptor regulation of sexual receptivity in rats and mice.
Progesterone (P) and dopamine (DA) facili-
tation of sexual receptivity in female rats
requires intact, intracellular progestin recep-
tors (PRs) (1). Wild-type female mice exhibit
high levels of P- and DA-facilitated lordosis,
whereas homozygous females carrying a null
mutation for the PR gene show minimal re-
productive behavior (2, 3). These observa-
tions substantiate a critical role for the PR as
a transcriptional mediator for the signal trans-
duction pathways initiated by P and DA.
DA, signaling through the D1 subclass of
receptors in the neostriatum, induces increas-
es in the levels of adenosine 39,59-monophos-
phate (cAMP) and activates cAMP-depen-
dent protein kinase (PKA) (4). Dopamine-
and cAMP-regulated phosphoprotein-32
(DARPP-32) is phosphorylated by PKA. In
its phosphorylated state, this molecule, by
inhibiting the activity of protein phospha-
tase–1 (PP-1), increases the state of phospho-
rylation of many substrate proteins, leading
to the induction of physiological responses
(4). To determine whether DARPP-32 might
be involved in P and DA actions on the
hypothalamus, we examined its role in the
facilitation of sexual receptivity in female
rats and mice (5).
Antisense oligonucleotides to the PR in-
hibit P-facilitated lordosis in female rats (6,
7). We used a similar strategy to examine the
role of DARPP-32 in P- and DA-facilitated
sexual receptivity. Ovariectomized, estradiol
benzoate (EB)–primed, Sprague-Dawley fe-
male rats with stereotaxically implanted
stainless steel cannulae in the third cerebral
ventricle (5) exhibited high levels of P-facil-
itated lordosis in the presence of males (Fig.
1A). This P-facilitated lordosis response was
significantly reduced in the animals that re-
ceived antisense oligonucleotides to DARPP-
32 but not in control animals receiving sense
oligonucleotides to DARPP-32 (Fig. 1A).
In a parallel experiment, intracerebroven-
tricular (icv) administration of the selective
D1 agonist SKF 38393 also facilitated a lor-
dosis response in EB-primed rats. The re-
sponse was reduced by antisense but not by
sense oligonucleotides to DARPP-32 (Fig.
1A). In contrast, antisense oligonucleotides to
DARPP-32 had no effect on serotonin-facil-
itated sexual receptivity in these animals
(Fig. 1B). These results were confirmed with
two separate sets of oligonucleotides to
DARPP-32 mRNA and their matched sense
oligonucleotide controls.
DA and P facilitation of sexual receptivity
were also examined in mice carrying a null
mutation for the gene encoding DARPP-32
(8). Wild-type and DARPP-32 knockout
mice show similar levels of hypothalamic
PRs (9). Ovariectomized wild-type, heterozy-
gous, and homozygous female mice were
tested for a lordosis response in the presence
of wild-type DARPP-32 males 30 min after P
administration (3, 5). Icv P after EB priming
resulted in high levels of lordosis in wild-type
and heterozygous mice, whereas homozy-
gous mice exhibited significantly lower lev-
els of lordosis (Fig. 2A). The lordosis re-
sponse of the wild-type mice to the treat-
ments did not differ from those of the paren-
tal mouse strains C57BL/6 and 129SvEv,
indicating that the behavioral alterations ob-
served in knockout mice were not due to
variations in genetic background.
Icv administration of SKF 38393 48 hours
after EB priming also facilitated a reliable
lordosis response in the parental strains and
in wild-type and heterozygous female mice.
Homozygous mutant mice, however, re-
sponded to the icv injection of SKF 38393
with minimal levels of lordosis (Fig. 2B). The
lordosis response did not significantly differ
between wild-type, heterozygous, and ho-
mozygous mice upon icv injection of seroto-
nin (Fig. 2B), corroborating the DARPP-32
antisense experiments in rats indicating that
DARPP-32 is not an integral part of the
serotonin signaling pathway. This is consis-
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4. Unpublished observations.
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1. Towards the morphological analysis of the actin cytoskeleton induced by Rho 
proteins in the neutrophil cytosol. Role of Arp2/3 complex.  
 GTPγS stimulates actin polymerization in the neutrophil cytosol (Zigmond et al., 
1997; Katanaev and Wymann, 1998a). In addition to this, massive cross-linking of 
newly polymerized filaments is observed (Katanaev and Wymann, 1998a). α-actinin, 
ABP-280 (filamin), and other actin-binding proteins are responsible for this 
phenomenon (Katanaev and Wymann, 1998a). To visualise GTPγS-induced actin-rich 
structures with high resolution, together with Carine Galli (Institute of Experimental 
Physics, University of Fribourg) we applied atomic force microscopy (AFM, for a 
review see Engel et al., 1999). Individual actin filaments were detected by this approach 
(Fig. 1A-F) with length ranging from <0.1 to >1 µm. Several actin structures were 
repeatedly observed in numerous images, including bundles (Fig. 1A) and cross-links of 
actin filaments at different angles (Fig. 1B-E).  
 Two-headed rod-like structures of α-actinin dimers (Djinovic-Carugo et al., 
1999) may be responsible for formation of F-actin bundles as those seen on Fig. 1A. 
Interestingly, examination at higher resolution identified some filaments which were 
densely decorated with short rods going perpendicular to the filament (Fig. 1F, marked 
as "α-actinin?"). The length of the rods measured by AFM was 22.9 ± 2.6 nm (mean ± 
sem, n=8), very close to that predicted by the analysis of α-actinin segment crystal 
structure (Djinovic-Carugo et al., 1999). Moreover, belobed structures seen on the tips 
of some rods are very similar to those observed at certain angles with electron 
microscopy analysis of α-actinin (Winkler et al., 1997).  
 Various forms of actin filament cross-links were repeatedly observed by AFM 
(Fig. 1B-E). These included X- and Y-like intersections of filaments. Quite frequently 
the latter were formed by two filaments branching out from the same point on the stem 
filament (Fig. 1C). Y-like branches are also seen at a higher resolution on Fig. 1F. 
Cross-section analysis revealed that most of the branchings observed lied in the same 
plane and were not formed by a simple overlap of two independent filaments. This 
indicates an involvement of actin binding proteins which cross-linked the filaments. 
About 40% of cross-links in macrophages were attributed to ABP-280 (Hartwig and 
Shevlin, 1986). This is a dimeric protein whose flexible "leaf spring" configuration 
allows high angle branching of the filaments (Gorlin et al., 1990). Its characteristic short 
needle-like structure forming an angle between two actin filaments as that viewed by 
electron microscopy in (Hartwig et al., 1980) was frequently observed in our AFM 
images (Fig. 1F, marked as "ABP-280?"). The dimensions of this structure, ca. 70 nm in 
length and ca. 4 nm in width, is very close to those of ABP-280 seen in (Hartwig et al., 
1980).  
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 In addition to ABP-280, Arp2/3 complex may be responsible for formation of Y-
like intersections presented on Fig. 1 D-F (Mullins  et al., 1998b). Arp2/3 is enriched in 
the leading edge of migrating cells, where it is proposed to function in either initiation or 
branching of filaments (Mullins et al., 1997; Svitkina and Borisy, 1999; Weiner et al., 
1999).To test whether Arp2/3 complex is enriched in the GTPγS-induced F-actin 
networks, low speed sediments of the cytosol treated with or without GTPγS were 
probed with anti-Arp3 antiserum after separation on polyacrylamide gels. As described 
previously (Katanaev and Wymann, 1998a), 3-5 times more actin is found in the 
precipitates obtained from GTPγS-treated cytosol than from control ones. When amount 
of the sample from the control-treated cytosol loaded on the gel was increased to obtain 
equal quantities of actin in both samples, no difference in the association of Arp3 with 
the samples was seen (Fig. 1G). Moreover, there was clearly more Arp3 per actin in the 
cytosol itself than in the low speed precipitates. This is in a sharp contrast with the 
association of e.g. α-actinin and ABP-280 with the actin cytoskeleton. These proteins 
are clearly enriched in the GTPγS-induced low speed precipitates in comparison with 
untreated cytosol or the precipitates from control-treated cytosol (Katanaev and 
Wymann, 1998a). These data demonstrate that GTPγS does not enrich the Arp2/3 
complex in newly formed actin cytoskeleton. The fact that the complex is nevertheless 
present in the cytosolic cytoskeleton suggests that Arp2/3 may still play a role in the 
GTPγS-induced actin polymerization. 
 The AFM analysis of the cytosolic actin cytoskeleton may prove to be very 
promising. In order to identify the molecular nature of these or those structures in the 
actin filament networks induced by Rho proteins in cell lysates, comparison with AFM 
images of purified actin binding proteins and their complexes with actin would have to 
be done. This could give insights into the mechanisms controlling cellular actin 
polymerization.  
 
 Fig. 1. GTPγS-induced actin cytoskeleton. Cytosols from human neutrophils 
were incubated for 20 min in the presence of GTPγS unless indicated otherwise, and 
centrifuged at low speed. Samples were subsequently resuspended in 1/10th of the 
original volume before application to silicium plates and AFM analysis (A-F) or 
washed, separated with SDS-PAGE and transferred to a membrane (G). (A-E) 
Representative F-actin structures observed with 2 nm resolution: a bundle of filaments 
(A), an X-like intersection (B), a Christmas tree-like structure (C), and Y-like 
branchings (D,E). Scale bar, 20 nm. The colour scale represents the vertical dimension. 
(F) Three-dimensional reconstitution of actin cytoskeleton observed with the resolution 
of 1.2 nm. Scale bar, 100 nm. Big spheres to the left-bottom and right-top of the image 
are contaminations. Short rods decorating a filament to the top-right have shapes and 
dimensions of α-actinin. A thin link connecting two actin filaments in the lower part of 
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the image has a shape and dimensions of ABP-280. (G) Anti-Arp3 antiserum (Machesky 
et al., 1997; kindly provided by A. Segal, University College London) or Coomassie 
staining were used to visualize Arp3 and actin, respectively. Three times more material 
from the sediment of control- than of GTPγS-treated cytosol was loaded on the gel to 
equalize the amount of actin from the two sediments. Total protein applied before 
sedimentation (T) contains half actin as that loaded with the sediments. 
 
 
2. CIP4 inhibits GTPγS-induced actin polymerization in the neutrophil cytosol. 
 In a search for the GTPase(s) mediating GTPγS-induced actin polymerization in 
the neutrophil cytosol, we tested the effects of recombinant CIP4, a 545-amino acid-long 
protein identified in a yeast two-hybrid screen as a candidate binding partner of Cdc42 
and, to a less extent, Rac (Aspenström, 1997). In cultured fibroblasts, CIP4 dissociates 
stress fibres and antagonizes the effects of serum, PDGF, or bradykinin on stress fibre 
formation (Aspenström, 1997). CIP4 at 2 µM inhibited the GTPγS-induced actin 
polymerization in the neutrophil cytosol by ca. 50% (Fig. 2A). This inhibition was 
mediated by the central region of CIP4 (amino acids 293-481), known to contain the 
Cdc42-binding sequence as well as the site of homology to the erzin/radixin/moesin 
(ERM) proteins (for a review see Mangeat et al., 1999). The N-terminal half of the 
protein was ineffective in the inhibition of actin polymerization. When higher 
concentrations of CIP4 were used (8 µM), an insignificant increase in the inhibitory 
capacity of the protein was found. In contrast to CIP4, the Cdc42-binding region of 
WASP (Symons et al., 1996) did not affect GTPγS-induced actin polymerization (Fig. 2, 
see also Katanaev and Wymann, 1998a). Noteworthy, neither the full-length CIP4 nor 
its domains tested could induce actin polymerization on their own (not shown).  
 In contrast to its inhibitory effect on GTPγS-induced actin polymerization in the 
cytosol alone, CIP4 did not interfere with the GTPγS response in the cytosol 
supplemented with plasma membranes (Fig. 2B). These data might mean that different 
signalling pathways are activated by GTPγS in the cytosol and in the cytosol/membrane 
interface. A CIP4-sensitive protein would then be involved in actin polymerization 
initiated in solution, but another protein would play the role in the presence of plasma 
membranes. Alternatively, plasma membranes migh somehow compensate for the 
inhibitory action of CIP4 on the GTPγS-induced actin polymerization.  
 The partial inhibition of GTPγS-induced cytosolic actin polymerization by CIP4 
was also seen when SDS-PAGE analysis of low speed sediments was performed (Fig. 
2C). Together with a ca. 50% reduction of the actin band in the sediments, a 
concomitant decrease in α-actinin and ABP-280 content was seen. Surprisingly, CIP4 
induced a strong increase of another high molecular weight protein cosedimenting with 
actin (Fig. 2C), which co-migrated with myosin (not shown). Approximately 20 times 
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more myosin per actin was present in the sediments of neutrophil cytosol stimulated 
with GTPγS in the presence of CIP4.  
 The presented results indicate that a CIP4-binding protein mediates GTPγS-
induced actin polymerization in the cytosol of neutrophils. Affinity purification with 
CIP4 may be used to identify this protein(s).  
 
 Fig. 2. CIP4 inhibits GTPγS-induced actin polymerization in the neutrophil 
cytosol. GTPγS was added to the neutrophil cytosol in the presence of 2 mM EDTA 
(A,C) or MgCl2 + 0.1 mg/ml plasma membranes (B). Recombinant WASP CRIB 
(Cdc42/Rac interactive binding) domain to 30 µM (hatched bars) or full-length CIP4 or 
its N-terminal or central domains to 2-8 µM (double hatch) were included. GTPγS-
induced actin polymerization was measured by rhodamine phalloidin fluorescence 
enhancement and expressed as % of control, where recombinant proteins were omitted 
(buffer, open bars). Alternatively, actin cytoskeletons induced by GTPγS in the absence 
or presence of 2 µM central domain of CIP4 were analyzed by low speed sedimentation 
and SDS-PAGE (C). Proteins cosedimenting with actin are marked. GST fusions of 
CIP4 variants were bacterially expressed and kindly provided by P. Aspenström, 
Ludwig Institute for Cancer Research, Uppsala. GST-CRIB of WASP (amino acids 237-
268) was expressed in bacteria using an expression plasmid kindly provided by U. 
Franke, Stanford University.  
 
 
3. Rho as a candidate GTPase for GTPγS-induced actin polymerization. 
 As noted previously in (Katanaev and Wymann, 1998a), high concentrations of 
recombinant C3 transferase could reduce by 40% GTPγS-induced actin polymerization 
in the cytosol. Moreover, the toxin was able to inhibit by ca. 70% the response to GTPγS 
initiated in the presence of plasma membranes (Fig. 3A). These data put forward Rho as 
a possible target of GTPγS in the neutrophil cytosol, and may indicate differential use of 
this protein in the induction of actin polymerization depending on whether plasma 
membranes are present or not.  
 At concentrations up to 10 µg/ml, recombinant RhoA could not induce 
significant actin polymerization in the cytosol (Katanaev and Wymann, 1998a). 
However, when longer incubation times (1 hour, not shown) or higher concentrations of 
RhoA (20-30 µg/ml) were used, actin polymerization was stimulated (Fig. 3B). This 
effect of recombaninat RhoA was reproduced with different preparations of the protein 
and was abolished upon heat-inactivation of RhoA (data not shown). However, RhoA 
could induce actin polymerization equally well in the GTPγS- and GDPβS- loaded 
forms (Fig. 3B).  
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 The paradox that GTPγS-induced actin polymerization is sensitive to C3 
transferase but recombinant Rho induces actin polymerization in a GTP-independent 
manner can be reconciled in the following way. RhoGDI associates about ten times 
stronger with GDP- than GTP-bound Rho (Sasaki et al., 1993). Additionally, 
phosphatidylinositol 5-kinase (PI5K), unlike many other Rho binding proteins, binds 
Rho and Rac independently from their nucleotide (Tolias et al., 1995; Ren et al., 1996; 
Tolias et al., 1998). ADP-ribosylation of Rho by C3 transferase is known to increase 
strongly the affinity of PI5K for Rho (Ren et al., 1996). Finally, GDP-Rac has been 
shown to form in vivo a complex comprising RhoGDI, PI5K, and diacylglycerol kinase 
(Tolias et al., 1998). If Rho could also exist in such a complex in neutrophil cytosol, 
GTPγS addition might lead to Rho activation and liberation from the complex due to 
weaker affinity of GTP-Rho for RhoGDI. GTP-loading of Rho in a complex with 
RhoGDI requires, in addition to an exchange factor, ERM proteins which are able to 
interact directly with RhoGDI (Takahashi et al., 1997). One might speculate that Rho, 
when liberated from the complex, is able to induce actin polymerization independently 
from whether it is bound to GTP or GDP. The binding of Rho to GTP might thus be 
necessary only for the dissociation of Rho from the complex.  
 
 Fig. 3.  Rho may mediate the effect of GTPγS on actin. (A) GTPγS-induced actin 
polymerization in cytosol or cytosol supplemented with plasma membranes was 
analyzed as above after 30 min pretreatment without (open bars) or with (double hatched 
bars) 100 µg/ml C3 transferase in the presence of 20 µM NAD+. Recombinant C3 
transferase was purified as in (Dillon and Feig, 1995) using an expression plasmid 
kindly provided by L.A. Feig, Tufts University, Boston. (B) Actin polymerization was 
induced in the cytosol by increasing concentrations of recombinant V14RhoA (kindly 
provided by A. Ridley,  Ludwig Institute for Cancer Research, London) preloaded with 
GTPγS or GTPβS as described (Self and Hall, 1995). The experiment was performed in 
the presence of 2 mM MgCl2, condition where GTPγS alone does not induce actin 
polymerization (Katanaev and Wymann, 1998a). In the presence of 2 mM EDTA, 
GTPγS (black bar) stimulated actin polymerization comparable to that induced by high 
concentrations of Rho. 
 
 
4. An attempt to purify an actin polymerization stimulatory activity from the neutrophil 
cytosol. 
 As described in (Katanaev and Wymann, 1998a), GTPγS induces actin 
polymerization in the neutrophil cytosol only when the concentration of free magnesium 
ions is low. Otherwise, the presence of neutrophil plasma membranes is required to 
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allow the GTPγS-induced actin polymerization. These data are explained by possible 
membranous localization of the guanine nucleotide exchange factor (GEF) for the 
cytosolic Rho protein mediating the effect of GTPγS.  
 We found conditions which allowed preparation of the neutrophil cytosol 
capable of GTPγS-induced actin polymerization even in the presence of 2 mM MgCl2. 
These conditions include neutrophil breakage at higher cell concentration (2*108 
cells/ml) and the presence of 2 mM MgCl2 in the breakage buffer. Addition of aliquots 
of this cytosol (called "donor cytosol" hereafter) resulted in restoration of the GTPγS-
induced actin polymerizing activity in the cytosol previously inactive in the presence of 
2 mM MgCl2 (called "recipient cytosol" hereafter; data not shown).  
 The donor cytosol was used in an attempt to purify the actin polymerization 
stimulatory activity (APSA). The scheme of purification is shown on Fig. 4A. Donor 
cytosol protein (5 mg) precipitation with ammonium sulphate was used as the first step 
to enrich the APSA. The pellet obtained after precipitation with 40% saturated 
ammonium sulphate contained most of the APSA of the donor cytosol. The pellet was 
dissolved in 10 mM Tris-HCl pH 7.5 in the volume to obtain the ammonium sulphate 
concentration of 5 mM and loaded onto DEAE-sepharose equilibrated with 5 mM 
ammonium sulphate, 10 mM Tris-HCl, pH 7.5 (Buf A). Bound material was eluted with 
continuous gradient of 0-500 mM KCl in Buf A (Fig. 4B). Most proteins were eluted by 
100-200 mM KCl. When the elution fractions were tested for the APSA in the recipient 
cytosol in the presence of  2 mM MgCl2, the APSA activity was localized to the 
material eluted with ca. 40 mM KCl and containing relatively low protein (Fig. 4B).  
 To our surprise, we found that the APSA eluted from the DEAE column may not 
be a protein. First, the activity was resistant to heat treatment (100°C, 10 min, not 
shown). Second, the activity passed through 10 kD cut-off pores during ultrafiltration 
(not shown). These properties of the APSA were used to further purify it: after 
incubation at 100°C and centrifugation, the supernatant was ultrafiltered. The 
flowthrough was loaded onto an HPLC Partisil SAX 10 micron column equilibrated 
with water, and eluted with a continuous gradient of 0-1 M KH2PO4 (Fig. 4C). Fractions 
absorbing at 260 nm were collected. Two peaks of absorbency were seen in the eluate: 
the first corresponding to the material eluted at ca. 680 mM , and the second- 750 mM 
KH2PO4. The second peak was found to contain the APSA (Fig. 4C).  
 To assess the purity of the APSA preparation and molecular weights of 
substances present in it, the preparation was analyzed by electro-spray mass-
spectrometry after proton ionization (performed by Prof. T. Yenni, Institute of Organic 
Chemistry, Univ. Fribourg). The results are presented on Fig. 4D. Among the substances 
present in the APSA preparation, four were absent in the sample from peak 1 of the 
HPLC (see Fig. 4C). Their molecular weight are 445.8, 581.7, 679.7, and 717.7. After 
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search in public databases, some candidate molecules were found with such molecular 
weights and properties which could allow them to be purified from the neutrophil 
cytosol by the procedures applied in our experiments.  
 The presented results describe a partial purification of a low molecular weight 
activity stimulating GTPγS-induced actin polymerization in the presence of magnesium 
ions. The starting material used in the purification was cytosol of human neutrophils. 
These cells were isolated in several steps, including several washings (see Protocol III-
1), which makes it unlikely, although not completely impossible, that the activity is a 
contamination coming from extracellular milieu or from blood collection equipment. We 
can not be sure that the activity comes from one of the molecules detected by the mass-
spectrometry and does not escape the detection. Further purification and more analysis 
with different techniques would have to be done to identify the active substance. It is 
very unlikely that the substance is some agent chelating MgCl2 and thus allowing 
GTPγS-induced actin polymerization, since millimolar concentrations of such a chelator 
would be required, while relatively low amount of material was used in purification, and 
low signals were detected after DEAE-chromatorgaphy, HPLC, and mass-spectrometry. 
Noteworthy, the APSA did not induce any actin polymerization on its own in the 
cytosol. This excludes an involvement of some ions, like Ca2+, which induces strong 
pointed-end actin polymerization (data not shown; DiNubile, 1998).  
 In conclusion, the presented results might indicate an involvement of a low 
molecular weight substance in stimulating Rho protein-induced actin polymerization in 
the neutrophil cytosol. The molecular nature of the substance is not clear yet. 
 
Fig. 4. Partial purification of the actin polymerization stimulatory activity (APSA) from 
neutrophil cytosol. (A) Purification scheme. (B) Ion-exchange chromatography on 
DEAE-sepharose. After loading in 5 mM ammonium sulphate, 10 mM Tris-HCl, pH 7.5 
(Buf A), the material was eluted in a gradient of 0-500 mM KCl in Buf A. Protein 
concentration in elution fractions is shown in empty circles, APSA in black squares. (C) 
APSA preparation from previous steps was loaded on the HPLC Partisil SAX column 
and eluted with a gradient of 0-1 M KH2PO4. Eluate absorbing at 260 nm was collected. 
Peak 2 of the eluate contained APSA. (D) ES-MS analysis of the material in the HPLC 
peak 2. Mass-to-charge values of four substances present in peak 2 but absent in peak 1 
are encircled.  
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PROTOCOLS 
 
I. Molecular biology techniques. 
 
1. Restriction endonuclease digests 
1) Mix: 2 µl 10x buffer (see enzyme charts), 1 µl enzyme (2-3 U/µg DNA), 1-4 µg 
DNA, water to 20 µl. Glycerol must be at ≤5% (see star activity charts in e.g. NEB 
catalogue).  
2) Incubate 1-3 h 37°C. When high temperatures or prolonged incubations are used, 
evaporation must be prevented (mineral oil, tube lead heating).  
3) If necessary inactivate the restriction enzyme by heating at 65°C for 20 min or/and by 
phenol/chloroform extraction. For the latter, add equal volume of phenol, stir 
rigorously, and centrifuge 12000 g 2 min 4°C. Repeat the liquid phase extraction with 
phenol: chloroform (1:1) and chloroform. Adjust NaCl to 200 mM or Na-acetate to 
300 mM. Precipitate DNA by 2 vol ethanol, ≥15 min ≤4°C. Centrifuge 12000 g 10 
min 4°C. Carefully rinse the DNA pellet with 75% ethanol. Dissolve DNA.  
4) Analyse the efficiency of digestion by agarose gel-electrophoresis (see I-4).  
 
2. Dephosphorylation of 5' DNA ends with calf intestinal alkaline phosphatase (CIP). 
1) Suspend ca. 0.5 µg DNA in 1mM ZnCl2, 1mM MgCl2, 10 mM Tris-HCl pH 8.3. 
2) Incubate at 37°C after addition of CIP: 1U CIP per 100 pmoles of protruding 5' 
termini for 30 min, or for 15 min per 2 pmoles of blunt or recessed 5' termini, for 
which 1U more is added for further 45 min at 55°C. Note: 2 µg of a linearized 
plasmid DNA 5kb in length contains ca. 1.4 pmoles of 5'-ends.  
3) Add EDTA/SDS to 5 mM/ 0.5% for 1h 65°C. Extract with phenol/ chloroform, 
precipitate/ wash with ethanol.  
 
3. Blunting DNA ends. 
1) Mung-bean nuclease (MBN) can be used to remove ss extensions: dissolve DNA in 
50 mM Na-acetate, 30 mM NaCl, 1 mM ZnCl2; add 0.5-1 U MBN/ µg DNA, incubate 
30 min 37°C. Note: high [MBN] or long incubation will increase the risk of ds DNA 
end loss.  
2) Klenow DNA polymerase (KDP) can be used to fill up 5'-overhands: DNA at ca. 50 
µg/ml in 10 mM Tris-HCl pH 7.5, 5 mM MgCl2, 7.5 mM DTT (KDP is also 50% 
active in standard restriction buffers) is mixed with 1U KDP per µg DNA and 200 
µM each dNTPs. New sticky ends may be created omitting some dNTPs. Incubate 30 
min 25°C. Stop by transfer to 75°C in 10 mM EDTA, 300 mM NaCl.  
3) Other enzymes such as T4 DNA polymerase or nuclease S1 can be also used. 
 
4. Agarose gel-electrophoresis. 
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1) Prepare 0.8-2% agarose gels (0.8% for 1000-5000 bp, 2% for 100-1000 bp DNA). 
Melt the weighed amount of agarose in TAE (40 mM Tris-acetate pH 8.0, 1mM 
EDTA) and 0.3 µg/ml ethidium bromide. Pour on glass plates and put in the combs 
before agarose solidifies. Keep pre-made gels at 4°C in himudity for weeks.  
2) Mix DNA samples with ca. 1/10th of 0.4% bromphenol blue, 0.4% xylene cyanol FF, 
50% glycerol and load on the gel. >2 ng and <500 ng DNA has to be present in one 
band for the sake of resolution. Also load a DNA marker. 
3) Add ca. 10 µl of 10 mg/ml ethidium bromide to the negative electrode of the tank. 
Run the electrophoresis at 80V before and at 100-120V after the samples have entered 
the gel. When the gel is devided into 3 approx. equal parts by the two dyes, stop the 
run. Visualize DNA under UV.  
4) Work very clean when preparative electrophoresis is done. A gel with big slots is 
used. When finished with the electrophoresis, cut out in a minimal volume the band of 
interest. Mince in pieces. Put in a 0.5-ml tube with a hole in the bottom onto a clot of 
glass wool. Insert the tube into 1.5-ml tube, centrifuge 12000 g ≥10 min untill all 
liquid arrives to the lower tube. Extract with phenol/ chloroform and precipitate DNA 
as in I-1.  
5) Alternatively, low-melting point agarose can be used for preparative electrophoresis. 
The tube with agarose is frozen in liquid nitrogen for 2-3 min and centrifuged for 15 
min 12000 g RT. Precipitate DNA from the liquid as in I-1.  
 
5. Ligation.  
1) DNA fragments should be present in equimolar concentrations (ca. 0.5 fmole/µl).  
2) Additionally, 20 µl of ligation mixture should contain 1 mM ATP, 1 mM DTT, 10 
mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.2 mg/ml BSA, 0.4-0.8 U T4 DNA ligase.  
3) To ligate sticky ends, incubate at 0-4°C for 3h-ON. 
4) To ligate blunt ends, incubate at 10-16°C ON-24h.  
5) To improve the efficiency of blunt end ligation, decrease [ATP] to 0.5 mM, or include 
condensing agents like 15% PEG (polyethylene glycol) 8000 or 1-1.5 µM 
hexamminecobalt chloride.  
 
6. Preparation of competent bacteria.  
1) Transfer a colony of freshly grown bacteria from an LB-agar plate to 50 ml LB 
medium and grow ON at 37°C with agitation (300 cycles/min). 
2) Add a ml from above to a fresh 50 ml LB flask. Grow until OD600=0.8 (≤108 
cells/ml).  
3) Transfer to centrifugation bottles, precool on ice, 10 min. Centrifuge 5300 g 10 min 
4°C.  
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4) Resuspend the pellet in 20 ml ice-cold sterile 50 mM CaCl2, store on ice, 20 min- 
1.5h.  
5) Centrifuge 5300 g 10 min 4°C. 
6) Resuspend the pellet very gently in 4 ml ice-cold 50 mM CaCl2, store on ice for ≤ 
48h.  
7) Add ice-cold sterile glycerol to 15%, freeze 200 µl aliquots in liquid nitrogen, store at 
-80°C. The expected transformation efficiency is ≥5*106 colonies/µg supercoiled 
DNA.  
 
7. Bacterial transformation 
1) Add ≤50 ng DNA (≤10 µl) to 200 µl competent bacteria. Gently swirl to mix.  
2) Incubate for 30 min on ice.  
3) Heat shock for 90 sec in a 42°C-warm water bath. Incubate on ice for 10 min.  
4) Optional: gently mix with 800 µl 37°C-warm LB (no antibiotics), incubate 1h 37°C.  
5) Plate ≤200 µl bacteria per LB-agar plate with antibiotic. Grow ON 37°C.  
 
8. Minipreparation of plasmid DNA. 
1) Inoculate 15-ml tubes with 2 ml LB- antibiotic by single bacterial colonies.  
2) Grow for several hours at 37°C with agitation. Put to 1.5 ml tubes. Centrifuge*. 
3) Resuspend the pellet in 200 µl STET (8% sucrose, 0.1% Triton X-100, 50 mM 
EDTA, 50 mM Tris-HCl pH 8.0), mix intensively. Add RNase (DNase-free) to 10 
µg/ml. 
4) Add 20 µl of 20 mg/ml lysozyme, keep 5 min RT. 
5) Boil for 45 sec, centrifuge*. Take away the genomic DNA pellet with a toothpin.  
6) Add 8 µl of 5% cetyltrimethylammonium bromide to the liquid. Mix and centrifuge*.  
7) Add 300 µl 1.2 M NaCl to the pellet, keep 15 min RT. Precipitate/ wash with ethanol. 
8) Dissolve dried pellet in 50 µl TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). Verify the 
correct clone by electrophoresis and restriction analysis.  
9) * All centrifugations are done at RT for 10 min at 12000 g. 
10) As an alternative to this minipreparation method, the plasmid maxipreparation 
technique described below can be scaled down. 
 
9. Plasmid maxipreparation by LETR. 
1) LETR buffer (keep in aliquots at -20°C for months): 2 mg/ml lysozyme, 100 mM 
EDTA, 50 mM Tris-HCl pH 8.0, 0.1 mg/ml RNase (DNase-free).  
2) Grow bacteria in 500 ml LB-antibiotic in 5 lt flasks ON. Centrifuge 5300 g 15 min 
4°C.  
3) Resuspend the pellet in 20 ml LETR. Transfer to 50ml tubes. Incubate at RT for 30 
min. 
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4) Add 200 µl 10% Triton X-100, incubate 10-30 min RT. Centrifuge 1400 g 30 min 
4°C.  
5) Phenol-chloroform extraction as in I-1. Precipitate with 0.1 volume 3M NaCl and 0.6 
volume isopropanol. Rinse with 75% and then 100% ethanol. Dry, dissolve in 0.5 ml 
TE. 
6) Determine DNA concentration: one unit of OD260 = 50 µg/ml ds DNA. Measure 
OD260/ OD280, if it is less than 2, some protein, phenol, or chloroform contamination 
is present. 
 
10. DNA sequencing.  
1) Denature ds DNA: Mix 5 µg DNA with 100 µl TE and 10 µl 2M NaOH/ 2mM 
EDTA, incubate 30 min 37°C. Add 1/10th of 3M Na-acetate, precipitate/wash with 
ethanol. Dissolve in 7 µl water.  
2) Anneal DNA with primers: Mix 7 µl DNA with 2 µl reaction buffer (5x stock: 200 
mM Tri-HCl pH 7.5, 100 mM MgCl2, 250 mM NaCl) and 1µl 1µM primer (e.g. T3 or 
T7). Heat 2 min 65°C, then cool slowly to <35°C over 15-30 min. Chill on ice.  
3) Prepare 4 termination mixtures. ddA mix: 80 µM each of dATP, dGTP, dCTP, dTTP, 
50 µM NaCl, 8 µM ddATP. Similarly prepare ddG, ddC, and ddT mixtures. Put 2.5 µl 
of each mixtrure to a separate tube. Prewarm at 37°C. 
4) Labelling reaction: To ice-cold annealed DNA mixture (10µl) add:  
 1µl 0.1 M DTT  
 2 µl prediluted labeling mix (from a 5x stock: 7.5 µM each of dGTP, dCTP, dTTP)  
 0.5 µl [35S] dATP (e.g. 10 mCi/ml) 
 2 µl 1.6 U/µl Sequenase (e.g. from USB). Mix and incubate at RT for 2-5 min. 
5) Termination reactions: Transfer 3.5 µl of the labeling reaction to each of the 2.5-µl 
termination mixtures, mix, incubate 5 min 37°C.  
6) Stop the reactions by 4 µl Stop Solution (95% formamide, 20 mM EDTA, 0.05% 
bromphenol blue, 0.05% xylene cyanol FF).  
7) Heat the samples for 2 min 75°C immediately before loading onto sequencing gel.  
8) Prepare 50 ml solution of 8M Urea, 6% acrylamide, 0.3% N,N'-methylene-bis-
acrylamide (MBA) in TBE (90 mM Tris-borate, 2 mM EDTA, pH 8.0). Degaz. 
9) Add 1/100th of 10% APS (ammonium persulphate, freshly prepared) and 1/2000th of 
TEMED. Pour the solution into the glass plates, keeping them in a semivertical 
poistion.   
10) Prerun 30 min 34-40 W in TBE.  
11) Load samples for the long run, 3 µl each, in the order: GATC. Run at 50 W, until the 
bromphenol blue leaves the gel (ca. 1h).  
12) Load the samples for the short run in the neibouring wells. Run for ca. 1h more 
(until bromphenol blue has run 3 quaters of the gel).  
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13) Stop the run. Take away the upper glass. The gel on the lower glass is put to a tank 
and carefully poured with water: acetic acid: methanol (85:10:5) for 20 min. Lay a 
filter paper onto the gel, revert the sandwich and remove the remaining glass.  
14) Cover the gel with a Saran rap and dry. Mount for autoradiography or 
phosphoimaging. Read the sequence.  
 
11. Mouse PCR genotyping for the PI3Kγ gene (see Malumbreset al., 1997; Hirsch et 
al., in press).  
1) Clip 3mm of mouse tail tip. Keep at -20°C if not used immediately. 
2) Add 200 µl of the extraction buffer: 50 mM KCl, 1.5 mM MgCl2, 10 mM Tris-HCl 
pH 8.5, 0.45% Nonidet P-40 , 0.45% Tween 20, 100 µg/ml proteinase K. Incubate 2h 
55°C. Heat 15 min 95°C to inactivate proteinase K. Spin down briefly.  
3) Take 2.5 µl for a 50µl- PCR mixture containing:  
 H2O     10 µl 
 10x PCR Buffer*   5 µl 
 dNTPs 25 mM each   0.5 µl 
 PI3KgUP primer** 5 µM  10 µl 
 PI3KgDN primer** 5 µM  10 µl 
 NEOPA primer** 5 µM   10 µl 
 0.5 U/ml Taq Polymerase (Pharmacia) 2 µl*** 
*composition: 500 mM KCl, 100 mM Tris pH 8.8, 1 mg/ml BSA, 0.5% Tween 20, 15 
mM MgCl2. 
**primers: PI3KgUP:  5'-GGA GAA CTA TGA ACA ACC GG-3' 
   PI3KgDN:  5'-CAA CTT CCA GTA ATG CAG GC-3' 
   NEOPA:  5'-CTG CTC TTT ACT GAA GGC TC-3'. 
***Add the enzyme only after the PCR mixtures are prewarmed to 95°C (hot start). 
4) Run the PCR using the following cycle profile (Biometra UNO-Thermoblock; 
slope=2°C/sec; lid temp=99°C; use thin-wall PCR tubes): 
   95°C, pause; 
 10 cycles:(95°C, 30 sec/ 65°C-1°C each cycle, 30 sec/ 72°C, 30 sec); 
 25 cycles:(94°C, 30 sec/ 55°C, 30 sec/ 72°C, 30 sec); 
   72°C, 2 min; 
   4°C, pause. 
5) Load on a 2% agarose gel. Wild type and mutant alleles give 378 and 530 bp bands, 
respectively.  
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II. Protein biochemistry techniques. 
 
1. Protein SDS-polyacrylamide gel-electrophoresis (SDS-PAGE).  
1) Use 15% (w/v) acrylamide gels to separate low molecular weight proteins (10-30 
kDa), and 7.5% for heavy proteins (>100 kDa). Additionally, separation gels contain: 
650 mM Tris-HCl pH 8.8, 0.1% SDS, MBA being 3% of acrylamide. Before gel 
pouring, add APS to 0.07% and TEMED to 0.03%.  
2) Gradient separation gels are prepared using a gradient former with solutions of 
15/0.45% and 5/0.15% acrylamide/MBA containing 375 mM Tris-HCl pH 8.8, 0.1% 
SDS, 0.01% APS, 0.1% TEMED. Heavy gel (15%) also contains 25% glycerol.  
3) Stacking gel composition: 4% acrylamide, 0.12% MBA, 125 mM Tris-HCl pH 6.8, 
0.1% SDS, 0.1% APS, 0.1% TEMED. Keep prepared gels at 4°C in humidity. 
4) Mix the protein sample with the sample buffer to final concentrations of 
glycerol=10%, Trid-HCl pH 6.8=60 mM, SDS=2.5%, β-mercaptoethanol=5%, and 
bromphenol blue= 0.1%. Boil the mixture for 5 min before loading onto the gel. 
Optionally, include 4M Urea to the sample buffer or prolong boiling for up to 30 min. 
5) Run electrophoresis in 200 mM glycine, 25 mM Tris, 0.1% SDS with the current of 
10-20 mA (per a 8cmX 5cmX 0.8mm gel) before the sample enters the stacking gel, 
20-40 mA before it enters the separating gel, and 40-80 mA untill the dye exits the 
gel.  
6) Stain with Coomassie: soak for 5-15 min in a solution of Comassie Blue R-250 in 
water: methanol: acetic acid 43:50:7.  
7) Destain the gel in water: methanol: acetic acid with several changes each 10-20 min. 
8) Silver staining can be done alternatively to Coomassie staining or after it as follows: 
 fix the gel in 40%methanol/ 10% acetic acid for 30 min, 
 fix in 10% ethanol/ 5% acetic acid for 15 min, 
 repeat (this is the first step to be used after Coomassie staining/ destaining), 
 oxidize in 3.4 mM K2Cr2O7 and 3.2 N HNO3 for 5 min (use the solution once), 
 soak in water several times untill the yellow colour is removed from the gel, 
 soak in the silver reagent (12 mM AgNO3, freshly dilute from stock, light sensitive), 
 soak in water for 1 min, 
 develop in 0.28 M Na2CO3/0.6 mM formaldehyde till the colour changes (ca. 30 sec), 
 change the developer twice for 5 min, stop the reaction with 5% acetic acid.  
  
 
2. Western blotting.  
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1) Activate PVDF membrane with methanol for 1 min and preincubate in the transfer 
buffer (25 mM Tris, 192 mM glycine, 20% methanol, pH 8.3) for >10 min together 
with 6 pieces of Whatmann 3MM filter paper.  
2) After SDS-PAGE, put the gel on the membrane, 3 layers of filter below and above 
them.  
3) Electrotransfer in semi-dry mode for 1 h, 60 mA per 1 cm2. 
4) Agitate the membrane in the blocking solution (3% dry milk or BSA, 0.1% PEG 
35000 in PBS- 0.05% Tween 20) for 45 min. Stain the gel by Coomassie as in II-1. 
5) Wash the membrane 3 times for 5 min in PBS-Tween. 
6) Incubate the membrane for 45 min in 8 ml PBS-Tween with the primary antibodies, 
diluted normally 1000- if polyclonal, and 2000-fold if monoclonal. The diluted 
antibodies can often be reused after storage at 4°C in 0.02% NaN3. Wash the 
membrane 3 times. 
7) Incubate the membrane for 45 min in 8 ml PBS-Tween with normally 2000-fold 
diluted commercial secondary antibodies, peroxidase coupled. 
8) Wash thrice for 5 min in PBS-Tween, once more for 15 min.  
9) Agitate for 1-2 min in the SuperSignalTM Substrate (Pierce): mix 2.5 ml of nanopure 
water, Luminol/Enhancer, and Stable Peroxide Solution.  
10) Expose the membrane for 1-10 min to the HyperfilmTM ELCTM (Amersham). 
Develop for ≥1 min, fixate for ≥1 min.  
11) To reuse with another antibody: incubate the membrane 30 min 50°C in strip buffer 
(62.5 mM Tris pH 6.7, 2% SDS, 0.1 M β-mercaptoethanol) with agitation, follow by 
several washes in PBS-Tween before addition of antibodies. 
12) Stain 1-2 min in Coomassie, destain 2-3 min in 80% methanol, 2% acetic acid.  
 
 
3. Purification of GST-WASP proteins as an example of affinity protein purification.  
1) Inoculate a 5-lt flask with 500 ml LB-100 µg/ml ampicillin by 50 ml ON culture of 
M15 bacteria transformed with pGEX5-WASP48-325 (see Symons et al ., 1996).  
2) Grow until OD600 reaches 0.6-0.8 (ca. 2 h). Add isopropyl β-D-thiogalactopyranoside 
to 1 mM. Grow for additional 2-6 h. 
3) Prepare 1 ml of 50% Glutathione Sepharose 4B in PBS: resuspend the sepharose 
stock, take 0.67 ml to a 50 ml Falcon tube, centrifuge 500 g 5 min 4°C, aspirate the 
supernatant, resuspend in 30 ml PBS, centrifuge, repeat with fresh PBS, add to the 
drained sepharose 0.5 ml PBS (8 mM Na2HPO4, 1.4 mM KH2PO4, 2.6 mM KCl, 136 
mM NaCl). 
4) Transfer the bacterial culture to a 0.5 lt tube and centrifuge 7700 g 10 min 4°C. 
5) Discard the supernatant. Resuspend the pellet in 25 ml of ice-cold PBS (50 µl PBS 
per 1 ml of the culture).Transfer to a 50 ml Nalgene tubes. 
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6) Sonicate the suspension using a rod-sonifier in 6 bursts of 1 min interrupted by ≥1 
min intervals of staying on ice. Ensure the suspension is not warmed up during 
sonication. Check the completence of cell lysis microscopically; continue sonication 
if necessary. 
7) Add Triton X-100 to 1% to the lysate, incubate 30 min 4°C on a rotatory shaker.  
8) Centrifuge 12000 g 10 min 4°C. Trasfer the supernatant to a 50 ml Falcon tube.  
9) Add 500 µl 50% slurry of Glutathione Sepharose 4B equilibrated with PBS to the 
sonicate. Incubate on a rotary shaker, 4°C 1.5 h.  
10) Centrifuge 500 g 5 min 4°C. Wash the sepharose pellet twice with 25 ml PBS.  
11) To the sedimented matrix, add 250 µl of the Glutathione Elution Buffer (10 mM 
reduced glutathione, 0.5 mM EDTA, 1 mM DTT, 50 mM Tris-HCl, pH 8.0). Mix 
gently to resuspend the matrix. Incubate on a rotary shaker at 4°C for 20 min. 
12) Centrifuge 500 g 5 min 4°C. Keep the supernatant in a separate tube on ice.  
13) Repeat the elution and centrifugation steps twice. Pool the three eluates. Determine 
the concentration by Bradford. Concentrate if necessary by ultrafiltration or as in II-4. 
14) Similarly to the purification of GST-fused proteins (the system provided by 
Promega), the Quagen-system based purification of (His)6-tagged recombinant 
proteins is achieved. In this case Ni-NTA-agarose is used as the resin for affinity 
purification. 
 
4. Purification of plasma gelsolin (brevin) (see Kurokawa et al., 1990). 
1) Collect fresh bovine blood and allow blood clotting for 1h at RT. Centrifuge 5000 g 
15 min, collect the serum, which can be stored at -20°C for months. 
2) Prepare saturated ammonium sulphate (SAS) by mixing 1kg ammonium sulphate 
(AS) with 1 lt of water. Heat up to 60°C for 1h with occasional mixing. Cool to RT 
and let stay ≥12h before use. Keep at RT. AS concentration in SAS is about 4M and is 
changed very little between 0°C and 25°C.  
3) Add to 400 ml serum Tris-HCl pH 8.0 to 50 mM, NaN3 to 0.02%, DTT to 1 mM. 
4) Add dropwise SAS to a saturation of 35%, and continue stirring for 30 min on ice. 
5) Centrifuge 1000 g 15 min 4°C. Add to the supernatant SAS to 50%, stir 30 min on 
ice. 
6) Centrifuge 1000 g 15 min 4°C, wash the pellet twice with SAS 50%/Tris 25 mM pH 
8.0. 
7) Resuspend the pellet in a minimal volume of buf A (NaCl 45 mM, Tris-HCl 25 mM 
pH 8.0, 1 mM EGTA, 0.02% NaN3, 1 mM DTT) and dialyze at 4°C with three 
changes of buf A untill removal of AS is complete (confirm by BaCl2).   
8) Load sample on equilibrated DE-52 column (Whatman, approx. 2.5 x 20-30 cm) and 
wash column with buf A until the absorption returns to background (ca. 8 bed 
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volumes). All buffers for the chromatography must be filtered through 0.2 µm pore 
filters and cooled to 4°C before use. 
9) Wash the column with two bed volumes of buf B (30 mM NaCl, 25 mM Tris-HCl pH 
8.0, 0.1 mM EGTA, 0.02% NaN3, 1 mM DTT).   
10) Elute brevin with buf C (30 mM NaCl, 25 mM Tris-HCl pH 8.0, 2 mM CaCl2, 
0.02% NaN3, 1 mM DTT, ca. 4 bed volumes). Expected yield: 15 mg of brevin/400 
ml of serum. 1.538 OD280= 1 mg/ml of brevin. 
11) Wash the column with buf D (1 M NaCl, 25 mM Tris-HCl pH 8.0, 1 mM EGTA, 
0.02% NaN3, 1 mM DTT, 5 bed volumes) and reequilibrate with buf A. Store column 
in buf A + 10% methanol + 0.02% NaN3 at 4°C. 
12) Concentrate brevin with PEG if necessary. The solution is placed into a dialysis sac 
with an appropriate pore size. The sac is rapped in the powder of PEG 35000 and 
incubated with agitation for 1-2h. PEG will take up the fluid from the sac (be sure not 
to dry it). 
   
5. Determination of ammonium sulphate (AS) concentration in protein samples.  
1) Add 200 µl of 100 mM BaCl2 solution to each cuvette (a reference cuvette, 7 cuvettes 
for the standard curve, and the sample cuvette(s)) to end up with 20 mM solutions 
after all components are combined.  
2) Add 800 µl or less of 50 ppm antifoam A to the cuvettes. The volume to be added is 
calculated so that the final volume in all cuvettes after addition of all components is 1 
ml. Mix the content of the parafilm-closed cuvettes by inversions. 
3) Add 0-1-2-4-8-16-32 µl of the 100 mM AS solution to the cuvettes to end up with 0-
0.1-0.2-0.4-0.8-1.6-3.2 mM AS, or the necessary volume of the sample (1-15 µl). Mix 
the content of the cuvettes by inversions immediately after addition of AS or the 
sample.  
4) Measure OD450 of the cuvettes after equal time intervals (15-30 min), mixing each 
cuvette by 3 inversions immediately before the measurement.  
5) Build a standard curve of OD450 dependence on [AS]. Calculate [AS] in the sample.  
6) Note: It is critical to add a small - below 30 µl - volume of the AS or the sample 
solution to a big (ca. 800 µl) volume of 20 mM BaCl2. Changes in the order or the 
relative volumes of the additions may lead to deviation of the standard curve from the 
straight line.  
7) Note: The presence of antifoam A allows a closer match of the results obtained with 
protein-containing AS solutions to the standard curve built on protein-free AS serial 
dilutions. BSA to the final concentrations up to 200 µg/ml could be added to the 
cuvettes with a negligible effect on AS concentration measurement under these 
conditions.  
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6. Preparation of muscle acetone powder. 
1) Do all procedures at 4°C and using cool solutions and equipment. 
2) Excise dorsal lateral muscles and hind leg muscles of a freshly sacrificed rabbit and 
chill them on ice. Wash the muscles in water and grind them. 
3) Extract the minced muscles stirring for 10 min with 1 lt of KCl 0.1 M, 0.15 M 
KH2PO4 pH 6.5. Filter through four layers of cheese-cloth. Discard the filtrate. 
4) Extract with 2 lt of NaHCO3 0.05 M for exactly 10 min, filter.  
5) Extract with EDTA 1 mM, pH 7.0, 1 lt, for 10 min. Filter. 
6) Two extractions with water (2 lt each for 5 min.). Extract five times with acetone. 
7) Dry the extracted residue obtaining the "acetone powder". Store for months at -20°C. 
 
7. Purification of actin from acetone powder (see Pardee and Spudich, 1982; MacLean-
Fletcher and Pollard, 1980). 
1) Extract 10 g of the acetone powder by stirring in 200 ml water, 4°C, 30 min.   
2) Centrifuge the extract 5000 g 10 min 4°C. Reextract the residue in 100 ml of water, 
centrifuge and pool the supernatants. 
3) Centrifuge at 10-20'000 g for 1h at 4°C. Collect carefully the supernatant. 
4) Add to 9 parts of the supernatant 1 part of Pol. 10x (Tris-HCl 20 mM, 500 mM KCl, 
20 mM MgCl2, 10 mM ATP, 10 mM DTT). Actin should start to polymerize 
(apparent increase in solution viscosity). Polymerize for 2h-ON at 4°C. 
5) High salt wash to remove tropomyosin: solid KCl is slowly added to a concentration 
of 0.6 M and the solution is gently stirred for exactly 30 min at 4°C. 
6) Ultracentrifuge* F-actin. Homogenize the pellet into 120 ml of 0.6 M KCl, 2 mM 
MgCl2, 1 mM ATP and ultracentrifuge*. Rince the F-actin pellet with water.  
7) Add 1ml water and keep on ice for 1h. Homogenize F-actin in 30 ml water totally. 
Dialize at 4°C with three changes of buf G (0.1 mM ATP-Tris pH ca.7).   
8) Ultracentrifuge*, keep the supernatant.  
9) To obtain pure actin monomers depleted from dimers or other oligomers, run on a gel-
filtration (Sephadex-150) column equilibrated with buf G at 4°C.  
10) Use G-actin within 2 weeks or keep it at -80°C (with a loss of acivity). 
11) Measure actin concentration in solution by absorbance, OD290= 0.65 cm2mg-1.  
12) For long storage, repolymerize G-actin: to 9 parts add 1 part of Pol. 10x.  Polymerize 
for 24-48h. Ultracentrifuge*. Keep F-actin at 4°C.  
13) * Ultracentrifugations are carried out for 1.5h at 150'000 g, 4°C. 
 
8. Labelling actin with pyrenyl (see DiNubile and Southwick, 1988). 
1) Polymerize actin as above but without DTT.  
2) Dropwise, with constant stirring of 10 ml F-actin, add 200 µl N-pyrenyliodoacetamide 
(Molecular Probes, dissoled in DMSO to 14 mg/ml). 
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3) Incubate ON RT on a rotatory shaker. Quench the labelling reaction by 50 µl 0.2 M 
DTT. 
4) Centrifuge twice 2500 g 15 min 4°C. Save the supernatant. 
5) Centrifuge 150,000 g 1.5h 4°C, store the pellet at 4°C, protected from light. 
6) Depolymerize pyrenyl F-actin, purify actin monomers by gel-filtration as in II-7. 
Measure actin concentration as follows: 1 mg/ml pyrenyl G-actin= [OD290-
(0.33*OD344)] / 0.637 (see Carson et al., 1986).  
 
9. Determination of concentrations of free and protein-bound ATP. 
1) Measure free ATP in solution by luciferase bioluminescence kit (Boehringer 
Mannheim).  
2) Total ATP in complex solutions (neutrophil cytosol, actin samples) is measured 
releasing the protein-bound nucleotides with 400 mM perchloric acid followed by 
centrifugation and adjustment of the supernatant pH with KOH.  
3) Protein-bound ATP is calculated as the difference between total and free ATP.  
 
10. Purification of low-molecular weight actin polymerization- stimulatory activity 
(APSA) from neutrophil cytosol. 
1) In contrast to normal conditions of neutrophil cytosol preparation (see IV-2), to 
prepare the cytosol-donor for the APSA, higher cell concentration (2*108 
neutrophils/ml) and the presence of 2 mM MgCl2 in the breaking buffer are required. 
The resulting cytosol (protein concentration: 5-6 mg/ml) is able to polymerize actin in 
response to GTPγS even in the presence of Mg2+ (see Katanaev and Wymann, 
1998a).  
2) Treat 1 ml donor cytosol with 40% SAS for 40 min at 4°C on rotary shaker, 
centrifuge 1800 g 10 min 4°C.  
3) Dissolve the precipitate in 300 µl 10 mM Tris-HCl, pH 7.5, keep 40 min on ice, 
centrifuge 1000 g 10 min 4°C.  
4) Determine [AS] as in II-5, dilute the supernatant with 10 mM Tris pH 7.5 to 5 mM 
AS. 
5) Load the sample onto a DEAE-sepharose column (bed volume ca. 50 ml) pre-
equilibrated with buf A: 10 mM Tris-HCl pH 7.5, 5 mM AS.  
6) Run the chromatography with the flow rate 0.1 ml/min. Use a conductivity meter to 
assess the gradient. Wash the column with: 5 ml buf A; 10-ml gradient of buf A to 
50% buf B (buf A + 1mM KCl); 3 ml 50% buf B; step to 100% buf B; 5 ml buf B; 
step to 0% buf B; 20 ml buf A. Collect 1-ml fractions. 
7) Analyze the collected fractions for the APSA: 10 µl of fractions per 35 µl of the actin 
polymerization reaction mixture containing 2mM MgCl2 using normal neutrophil 
cytosol as the recipient (see IV-9). Ensure that the final concentration of KCl in the 
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reaction mixtures is the same (115 mM) knowing the [KCl] of each fraction by the 
conductivity meter. 
8) Boil the active fraction for 5 min. Centrifuge 10000 g 10 min RT. Ultrafiltrate the 
supernatant through a Microcon membrane (cut-off 10 kDa). Collect the flow-
through. 
9) Load the sample onto the water-equilibrated Partisil SAX 10 micron HPLC column 
(bed volume ca. 4 ml).  
10) Run the HPLC using freshly 0.2 µm-filtered buffers (buf A= water, buf B= 1M 
KH2PO4 pH 4.0): 2 min 100% buf A, 10 min the gradient of 0-100% buf B, 2 min 
100% buf B. Flow rate- 2.1 ml/min. Collect fractions adsorbing at 260 nm. Analyze 
the activity.  
11) Analyze the purity and molecular mass(es) of the active fraction using ES-MS after 
proton ionization (run on the FT-ICR Bruker Daltonics Bio APEX II mass 
spectrophotometer, Spectrospin AG, by Prof. Yenni, Inst. Organic Chemistry, Univ. 
Fribourg).  
12) To assess the possible chemical nature of the substances present in the active HPLC 
fraction, address public chemical databases (www.chemfinder.com/; 
www.matrixscience.com/cgi/index.pl?page=/search_form_select.html; 
www.americanpeptide.com/). Purchase the candidate chemicals and analyze them for 
the APSA in the neutrophil cytosol. 
 
 
III. Hematology techniques. 
 
1. Isolation of human blood neutrophils (see Böyum, 1968).  
1) Buffy Coats were prepared at the Swiss Red Cross Transfusion Centre, Hôpital 
Cantonale, Fribourg. 
2) Solutions: all besides Lymphoprep should be filter sterile; ensure their osmolarity is 
290-300 mosmols. Keep at 4°C. 
 ACD (acid citrate dextrose: 10.1 mM glucose, 30 mM citric acid, 0.63% NaCl, pH 6.5 
by 3M NaOH); 
 Shock solution 10x: 1.55 M NH4Cl, 100 mM KHCO3, 1 mM EGTA, pH 7.4; 
 Ficoll: 500 ml LymphoprepTM (Nycomed Pharma AS, Oslo, Norway) + 29 ml 3.2% 
trisodium citrate (to 0.186%).  
3) Add one half (ca. 30 ml) of a ≤24h-old Buffy Coat to 10 ml of ACD, mix by 
inversion. 
4) Centrifuge 1000 g 5 min RT. Remove platelet-rich plasma. Collect light red layer on 
top of red pellet: add 7 ml to 11 ml of PBS with 13.64 U/ml heparin, mix by 
inversion. 
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5) Overlay on top of 10 ml Ficoll. Centrifuge 500 g 20 min 18°C, swing-out rotor, brake 
off. Erythrocytes and granulocytes are precipitated by this technique; lymphocytes are 
concentrated as one layer in Ficoll. Completely remove them. 
6) Resuspend the pellets in 2 ml ice-cold 1x Shock solution, transfer to new tubes, fill up 
with Shock solution to 40 ml. Keep on ice for 10 min.  
7) Centrifuge 400 g 5 min 4°C. Repeat the osmotic shock if erythrocyte lysis is 
incomplete: 20 ml Shock solution, 3 min on ice. 
8) Wash neutrophils twice with 0.9% NaCl, 50 µM CaCl2 (or PBS), 300 g 5 min 4°C.  
9) Count cells with a hemocytometer, estimate viability by Trypan Blue (0.1%) 
exclusion. Keep the cells in an appropriate buffer, 10°C, up to 10h.  
 
2. Mouse bone marrow isolation. 
1) Kill a mouse by cervical dislocation. Cut out intact femurs and humeri. Remove the 
flesh. Cut the bones with scissors at the two ends.  
2) Fill a sterile 2ml syringe with a thinnest needle (27G3/4, 0.4x19 mm, grey mark, 
Microlance) with ca. 1.5 ml RPMIc (RPMI from GibcoBRL, completed with 10% 
foetal calf serum [GibcoBRL, heat-inactivated: 30 min 56°C], 100 U/ml penicilline, 
and 100 µg/ml streptomycine). Flush the inner space of the bones with this, moving 
the needle to and fro inside the bone, collect the wash-out into an ice-cold tube. 
3) Centrifuge 1200 g 4 min 4°C. Resuspend each pellet in 150 µl ice-cold shock solution 
(see III-1). Pool the suspensions from the same mouse. Wash each tube with 50 µl 
shock solution, add to the pool. Keep on ice for 5 min. Centrifuge. Resuspend in 1 ml 
PBS. 
 
3. Mouse peritoneal exudate collection. 
1) Seize a mouse tightly in your left hand, its belly up. It should not be able to move at 
all when you sting it with the neddle! 
2) Injection. Fill a 1ml syringe with a medium needle (21G2 0.8 x 50 mm, green mark, 
Microlance) with 1 ml thioglycolate broth (25 g/lt water, boil and dissolve 
completely, sterilise, heat to boiling and cool just before use). Keeping the needle at 
ca. 30° to the mouse belly, pierce by some mm avoiding the bladder in the middle of 
the belly. Move the needle gently further, no resistance should be met if the 
peritoneum is reached. Inject the broth at steady pace. Remove the needle: no blood 
nor broth should go out. 
3) Sacrifice the mouse by cervical dislocation after ca. 1 day if neutrophils, and after 3-5 
days if macrophages are needed.  
4) Spray the body with 70% ethanol, dry. Open the belly's skin without breaking the 
peritoneum wall. Inject 5ml of PBS with a 5ml syringe and green needle into mouse' 
peritoneum. Remove the needle and massage the mouse' belly. Picking up the 
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peritoneum wall with a pincer, make a little hole into the peritoneum with scissors. 
Deepen a 1ml syringe, no needle, into the cut, and collect the liquid to a fresh tube 
kept on ice. At least 4.5 ml should be obtained.  
5) Centrifuge 1200 g 4 min 4°C. Resuspend in 1 ml PBS. 
 
4. Mouse whole blood collection. 
1) Kill a mouse by servical dislocation. Immediately open the peritoneum and reveal the 
vena cava, which is the thickest blood vessel going vertically close to the dorsal part 
of the animal between the two kidneys.  
2) With a 1ml sterile syringe armed by 21G2 0.8x50 mm needle (green mark, 
Microlance), prewashed with 13.64 U/ml heparin solution in PBS, pierce the vessel to 
the direction of the mouse' tail. The needle should be located within the vessel. Start 
gently collecting the blood. The vena can close if the heart is not beating. Put ca. 1 ml 
blood to a RT sterile 15 ml Falcon tube containing ca. 0.3 vol of the heparin solution. 
Mix immediately.  
3) Centrifuge the blood 650 g 2 min RT, swing-out rotor, brake off. Collect platelet-rich 
plasma. Collect leukocyte-containig light red layer on top of the red pellet, keep on 
ice.  
4) Lyse the contaminating erythrocytes as in III-2. Centrifuge 400 g 5 min 4°C and 
resuspend the pellet in the desired buffer, e.g. PBS. 
 
5. Purification of mouse neutrophils and macrophages by percoll gradient centrifugation. 
1) 80% Percoll: 8 vol of Percoll (Pharmacia) are mixed with 1 vol sterile PBS, and 1 vol 
of sterile sodium phosphate buffer (0.2 M, pH 7.4) containing 1.49 M NaCl (see Watt 
et al., 1979). 60% and 40% Percoll are prepared from 80% Percoll and PBS. 
2) Load 1ml of the bone marrow from III-2 or peritoneal exudate from III-3 on top of 
3ml 60% Percoll on top of 3ml 80% Percoll in a 15-ml Falcon tube, if neutrophils are 
needed. If macrophages are required, use 40%/60% Percoll instead. All solutions are 
ice-cold. 
3) Centrifuge 540 g 30 min 4°C, swing-out rotor, brake off. 
4) Collect mature neutrophils between the 80 and 60% Percoll layers; collect peritoneal 
macrophages between 40% and 60% layers. The Percoll gradient for the collection of 
mature neutrophils was chosen after analysis of actin polymerization in response to 
fMLP in cells isolated from more narrow discontinious Percoll density centrifugation 
and confirmed by cell colouration.  
5) Wash the cells thrice in PBS, count, resuspend in RPMIc, 3-5*106 cells/ml. Keep on 
ice. 
 
6. Colouration of blood cells. 
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1) Put a drop of cell suspension on a very clean glass. Distribute this drop evenly over 
the glass with a single strike of a cover slip. Dry the cells on fire, don't burn them! 
2) Pour and distribute evenly over the glass 1-2 ml of the May-Grünwald or 10% 
Giemsa solution in PBS. Leave for 1-2 min. Wash away the unbound dye with water. 
3) Wait till the glass dries, analyse under the microscope. 
 
7. Mouse platelet aggregation assay. 
1) Recentrifuge platelet-rich plasma (PRP, see III-4) 1500 g 20-30 min RT. Collect the 
platelet-poor plasma (PPP) to a separate tube and keep at RT.  
2) With a hemocytometer determine cell concentration in PRP diluting it ca. 100 times 
with buffer. Add PPP to PRP to adjust platelet concentration. 
3) To concentrate platelets or remove plasma proteins, centrifuge PRP 500 g 10 min RT, 
resuspend the pellet in 138 mM NaCl, 6 mM KCl, 0.66 mM KH2PO4, 0.64 mM 
K2HPO4, 1.2 mM MgCl2, 5.6 mM glucose, 20 mM Hepes-NaOH pH 7.4 (see 
DiNubile and Southwick, 1988) + 1.2 mM CaCl2 + 0.5% BSA.  
4) Prewarm the platelet aggregometer (normal spectrophotometer with a magnetic 
stirrer) and the platelet suspension (not less than 0.1*109/ml, ideal is 0.5-0.6*109/ml) 
or PRP to 37°C. Record the basal line for 3-5 min.  
5) Stimulate the stirred suspension with 1-2 U/ml thrombin, 10-20 µM ADP, or others. 
Measure light transmittance for ca. 10 min. The read-out system has to be equilibrated 
to allow high sensitivity in-scale measurements. The best is to adjust 100% 
transmittance to that of PPP or the buffer, if the signal is expected to be sufficiently 
high. 
 
8. Quantifying actin polymerization in neutrophils (see Katanaev and Wymann, 1998b). 
1) Human neutrophils prepared as in III-1 or mouse neutrophils or macrophages 
prepared as in III-5 are resuspended to 1-5*106 cells/ml HTBG (138 mM NaCl, 4.6 
mM KCl, 20 mM Hepes-NaOH pH 7.5, 10 mM glucose). 105 cells are prewarmed for 
10 min at 37°C.   
2) Add the stimulus in HTBG as 1/10th of cellular volume. Mix gently. 
3) For human neutrophils, stimulation is stopped by adding together p-formaldehyde to 
4% (from 10% stock) and octyl-β-D-glucopyranoside (OG, from 4% stock) to 1%. 
The suspension is immediately vortexed and kept at RT for 15 min. 
4) For mouse cells, p-formaldehyde is added first, while OG is added 15 min later. 
5) PBS to 600 µl and rhodamine phalloidin to 15 nM are added for 30-40 min. 
6) Fluorescence is measured in a 1ml quartz cuvette on a Perkin-Elmer fluorescence 
spectrophotometer LS50B (ex. 552/5 nm; em. 580/20 nm). HTBG + p-
formaldehyde/OG + PBS/rhodamine phalloidin is measured as the background.  
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9. Visualizing F-actin in neutrophils. 
1) Control or stimulated neutrophils were mixed with an equal volume of the staining 
solution (7.3% p-formaldehyde, 183 µg/ml L-α-lysophosphatidylcholine, 1.2 µM 
rhodamine phalloidin, 18% methanol in the neutrophil buffer).  
2) Incubate on ice, protected from light, for 4-20h. Apply 5-10 µl to a coverslip.  
3) Mount for fluorescence or confocal microscopy. Use rhodamine filters. 
 
10. Analysis of actin-gelsolin complexes in neutrophils (see Howard et al., 1990).  
1) Resuspend neutrophils in 25 mM HEPES-NaOH, 50 mM NaH2PO4, 150 mM NaCl, 4 
mM KCl, 1 mM MgCl2, 1.2 mM CaCl2, 10 mM glucose, pH 7.15 - a hypertonic 
buffer. In isotonic buffers neutrophils have no actin-gelsolin complexes. 
2) Vortex control or stimulated cells with an equal volume of 2x Lysis buffer (20 mM 
imidasole-HCl, 2% Triton X-100, 80 mM KCl, 20 mM EGTA, 7 mM diisopropyl 
fluorophosphate, pH 7.15). Put on ice. 
3) Centrifuge the lysate 12000 g 15 min 4°C. The supernatant can be kept at -80°C. 
Recentrifuge before use in this case. 
4) Add ca. 1/50th of the 50% suspension of CNBr beeds coupled to monoclonal anti-
gelsolin antibodies (clone 2C4 (Chaponnier et al., 1986)).  
5) Incubate at 4°C on a rotatory shaker for 2h. Centrifuge 12000 g 2 min 4°C. 
6) Wash successively with 1x Lysis buffer, TBS (10 mM Tris-HCl pH 7.4, 100 mM 
NaCl) supplemented with 0.3 M MgCl2 and 1 mM EGTA, and TBS alone.  
7) Solubilyze the bead-bound proteins with Urea-containing sample buffer and analyse 
on 10% SDS-PAGE as described in II-1.  
 
11. Measuring leukocyte adhesion to protein-coated glass surfaces. 
1) Incubate human neutrophils at 5*107/ml HTBG or mouse neutrophils at 5*106/ml 
RPMIc with 2 µg/ml calcein AM for 30 min. Wash and resuspend in RPMIc to 3*106 
(mouse) and 1*107 (human) cells/ml. Keep the calcein-loaded cells at RT before use.  
2) Study cell adhesion on 12-well glass slides (Marienfeld, well diameter = 7 mm). 
Precoat the wells with 20 µl fibronectin (20 µg/ml, ON 4°C) or fibrinogen (1 mg/ml, 
1-2h 37°C) in PBS. To coat with fibrin, refill fibrinogen-coated wells with 20 µl 1U 
thrombin/ml PBS, incubate 10 min 37°C. Drain the glass slides with a tissue and 
prewarm to 37°C. 
3) Apply 20 µl calcein-loaded cells per well. Incubate 8-10 min 37°C, 5% CO2 in 
humidity. 
4) Stimulate the cells for 3 min with 1 µl stimulus. Transfer the slides to a container with  
138 mM NaCl, 4.6 mM KCl, 20 mM Hepes-NaOH pH 7.5, 2 mM MgCl2, 2 mM 
CaCl2 and wash at 20 rpm on a horizontal shaker for 8 min at RT.  
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5) Before complete drying, the slides are put to the microplate-sized holder. The holder 
is home-made of aluminium, and has the size of a typical microplate. It allows 
simultaneous measurements of 4 slides, or 48 wells in total. Holder parameters (to be 
used with the KC4 program of the reader): length 127.0 mm, width 85.4 mm, top left 
X 14.4 mm, top left Y 10.9 mm, bottom right X 114.5 mm, bottom right Y 55.7 mm, 
number of columns 12, number of rows 6, well diameter 6 mm.  
6) Measure the fluorescence of remaining cells (Fr) from the bottom in a Bio-Tek FL600 
Fluorescence Plate Reader, Bio-Tek Instruments, Inc., ex. 485/20 nm, em. 530/25 nm. 
Also measure before as well as immediately after cell application to detect the 
background fluorescence (Fb) and the fluorescence of 100% loaded cells (F100), 
respectively. The percent of adherent cells is quantified as 100 * (Fr-Fb) / (F100-Fb).  
 
 
12. Measuring leukocyte chemotaxis (see Frevert et al., 1998). 
1) Load neutrophils with calcein AM as in III-11. 
2) Load 29-30 µl buffer or chemoattractants into the wells of the NeuroProbe 
chemotactic chambers (3.2 µm diameter sites, 30 µl 96-well). Load 20 µl of cells or 
cell medium into some wells to measure 100% and 0% of migrated cells, respectively. 
3) Load a 3µm-pore track-etched polycarbonate membrane (8 mm2 exposed filter areas) 
above the chamber. If the wells are filled with the correct volume (27-31 µl), the 
menisci of the loaded liquid will form an aquaous seal between the chamber and the 
membrane.  
4) Overlay 20 µl cells (1-5*106 / ml) per each filter site as a liquid drop. If chemokinesis 
is studied, add to the cells chemoattractants at the same concentration as in the lower 
wells. 
5) Chemotaxis is run during 1.5 h at 37°C, 5% CO2 in humidity.  
6) Remove nonmigrated cells from the membrane with a cell scraper. 
7) Measure the number of migrated cells fluorometrically (see III-7) for the unassambled 
set of the chamber and the membrane.  
8) To follow cell migration into vs through the membrane, centrifuge the chemotaxis set 
300 g 5 min RT, desassemble and measure separately the lower chamber and the 
membrane. 
 
13. Mouse neutrophil priming with LPS and the respiratory burst measurements (see 
Wymann et al., 1987).  
1) Isolate mouse bone marrow neutrophils as in III-5. Bring to 107 cells per ml RPMIc 
(with serum!!). Keep on ice. 
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2) Dissolve LPS (lipopolysaccharide, from Salmonella typhosa, Sigma (cat.n. L-7136, 
lot n. 121H4025), prepared by TCA extraction) in water to 10-20 µg/ml, keep at -
20°C (stable for several months). 
3) Incubate 20 µl neutrophils (200,000 cells) with water or 100 ng/ml LPS in 880 µl 
RPMI (without serum!!) for 50 min at 38°C. Important: the incubation must be done 
in polypropylene tubes (Treff, 1.5 ml). Incubation in polystyrene chemiluminescence 
tubes will lead to strong cell priming due to cell-surface interactions.  
4) Continue the incubation for 10 min adding 100 µl of fresh 10x Reaction Buffer (in 
HTBG, 20 U/ml horseradish peroxidase, 0.2 mM luminol from a 20 mM stock in 
DMSO [keep at -20°C protected from light]). Meanwhile prewarm the 
chemiluminescence tubes in the 37°C-warm luminescence reader (Lumicon, 
Hamilton). 
5) Transfer the cell suspension to polystyrene chemiluminescence tubes immediately 
before starting respiratory burst measurements. Measure not more than two tubes at 
once with stimuli like fMLP; for PMA or zymozan all six tubes can be measured at 
the same time. Add fMLP with a 10 µl syringe while recording chemiluminescence. 
Add PMA and zymozan by a pipette "off-line". Shake cell suspensions with zymozan 
occasionally.  
6) Set 3-5 sec as the counting interval, don't forget to set the multiple (M) measurement 
regime. The respiratory burst is detected as luminol-dependent chemiluminescence 
which reflects the instantaneous levels of H2O2. Relatively high amounts of 
peroxidase are included to i) catalyze H2O2- induced oxidation of luminol to 
luminescent 3-aminophthalate and ii) rapidly remove the peroxide, increasing the time 
resolution of respiratory birst measurements. 
 
14. Free intracellular [Ca2+] measurements with fura-2 in mouse neutrophils (see  
Grynkiewicz et al., 1985). 
1) Isolate mouse bone marrow neutrophils as in III-5. Bring them to 107 cells per ml 
HTBG. Load with 5µM fura-2 (from freshly prepared 5 mM stock in DMSO) for 45 
min at RT on a rotary shaker. Wash the cells thrice with warm HTBG and keep at RT 
before use. 
2) Take 106 cells per 4 ml plastic fluorescence cuvette; add HTBG to 3ml; add CaCl2 to 
1 mM. Omitting CaCl2 will lead to inability of repeated stimulations to effectively 
induce [Ca2+] rises in mouse neutrophils. Preincubate in the 37°C- warm fluorescence 
spectrophotometer (Perkin Elmer LS 50 B) for 5 min with magnetic stirring. 
3) Start one-wavelength fluorescence recording, ex. 340/15 nm, em. 380/20 nm, in the 
time drive regime with the minimal increment time. Stir the cell suspension with a 
magnet. 
100 
4) Stimulate the cells with the following sequence of agonists (another sequence will 
lead to no [Ca2+]i rises after the 3rd or 2nd stimulus): 50 nM IL-8, 1 nM C5a, 100 nM 
PAF, 1 µM fMLP. Clear rises in fluorescence should be observed. 
5) Before finishing the recording, lyse the cells by 1% Triton X-100. This will lead to 
liberation of intracellular fura-2 and its immediate complexing with extracellular 
Ca2+, giving maximal fluorescence Fmax. Afterwards, add EDTA to 4 mM to 
complex all Ca 2+, giving the minimal fluorescence Fmin. Determine Fmax and Fmin 
for each experiment.  
6) Calculate the free intracellular Ca2+ concentration at each time point by the formula 
[Ca2+]i = Kd [(F - Fmin) / (Fmax - F)], where F is the fluorescence at each time point, and 
Kd is the dissociation constant for the fura-2 / Ca2+ interaction and equals 224 nM.  
 
15. MAPK activation in neutrophils.  
1) Resuspend mouse bone marrow neutrophils to 1*106/ml of HTB-glucose. Prewarm 
106 cells for 10 min at 37°C before stimulation with DMSO or fMLP for 30 sec.  
2) Transfer the cells to ice for 1-2 min and centrifuge 10000 g 1 min 4°C. The pellet can 
be kept at -80°C after freezing in liquid nitrogen.  
3) Dissolve the pellets in 15 µl of Urea-containing sample buffer and boil 20 min with 
occasional mixing, before loading all material for 12% SDS-PAGE (see II-1). 
4) Western blot (see II-2) using Anti-ACTIVETM MAPK pAb (Promega) as the primary 
antobody (recognizing dually phosphorylated Thr183GluTyr sequence in p44/ERK1 
and p42/ERK2) and Anti-Rabbit peroxidase coupled IgG (Sigma) as the secondary 
antibody. 
 
16. Statistical analysis with ANOVA (ANalysis Of VAriance). 
1) ANOVA is used to analyse the data coming from experiments giving different 
absolute values but similar tendencies. For example, wild type and PI3Kγ knock-out 
neutrophils in many independent experiments chemotax differently, although the 
absolute chemotaxis values are not always the same due to unequivalency of different 
cell preparations. In this case, simple analysis like T tests may show high P values. 
ANOVA, in contrast, can better resolve the significance of this kind of data.  
2) Different programs can be used to run ANOVA, StatView is one of them. To compare 
different chemotaxis experiments, arrange the data in the following way: 
 exp. N genotype IL-8 50 nM 
Type: String Category Real 
Source: User Entered User Entered User Entered 
Class: Nominal Nominal Continuous 
Format:   Free Format Fixed 
Dec. Places:   3 
1 exp.1 +/+ 8.731 
2 exp.1 +/+ 9.373 
3 exp.2 +/+ 34.348 
4 exp.2 +/+ 37.456 
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5 exp.1 -/- 4.956 
6 exp.1 -/- 5.016 
7 exp.2 -/- 14.477 
8 exp.2 -/- 16.247 
Unpaired or paired T test analysis will estimate the difference between the chemotaxis of 
wild-type and knock-out neutrophils from these data as P value = 0.1907 or P value = 
0.0816, respectively; nonsignificant.  
3) To run the ANOVA, ANOVA post-hoc tests should be chosen from the analysis 
menu. In the appearing table, the "IL-8 50nM" column has to be chosen as the 
"Dependent Variable", while the columns "genotype" and "exp. N" have to be 
assigned as "Factor(s)". For the sake of presentation, the "genotype" column should 
be put first as "Factor(s)". In the resultant view window, the results of the analysis are 
nicely presented in the following way, showing the P value = 0.0002, or the difference 
being extremely significant: 
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4) ANOVA can be used not only to compare sets of data for one certain condition (e.g. 
chemotaxis to 50 nM IL-8), but also to compare whole ranges of responses (e.g. 
chemotaxis of wild-type and knock-out neutrophils to different concentrations of one 
or more attractants). To answer whether chemotaxis of knock-out and wild-type cells 
to increasing concentrations of IL-8 is statistically different, all the data have to be put 
to one column, respective genotypes to another, and the types of experiments (exp.1: 
10nM, exp.1: 50 nM, exp. 2: 10 nM, exp.2: 200 nM, etc) to the third. Running the 
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analysis like above for the chemotaxis data coming from seven independent 
experiments with three different IL-8 concentrations gives the folowing results: 
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, proving that besides variations in the absolute chemotaxis values and chemoattractant 
concentration from one experiment to the other, the difference between chemotaxis of 
wild-type and PI3Kγ knock-out neutrophils to IL-8 is extremely significant.  
 
 
IV. Cell biology techniques. 
 
1. Testing effects of Clostridium toxins on fibroblast cultures. 
1) An 1ml aliquot of NIH3T3 cells from -80°C is rapidly defrozen in the 37°C-warm 
water bath with vigirous shaking and immediately mixed with 1 ml of the medium 
(DMEM completed with 10% foetal calf serum [GibcoBRL, heat-inactivated: 30 min 
56°C], 100 U/ml penicilline, 100 µg/ml streptomycine, and 2 mM glutamine), and put 
to a 50ml cell culture bottle together with 4 ml more of DMEMc.  
2) After ca. 3h of growth (37°C, 5% CO2) when ca. 80% cells are attached, the medium 
is changed and the cells are grown until confluence. 
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3) To split the cells, aspirate the medium and rinse the bottle with 2 ml PBS. Add 500 µl 
trypsin/EDTA (0.5/0.2 mg/ml) to the cells, incubate for 3-5 min at 37°C. When 
detached, transfer the cells to a sterile tube, rinse the bottle with 2 ml DMEMc, 
transfer it to the same tube. Rinse the bottle with 2 ml PBS, discard. Put 1/10th of the 
cell suspension from the tube to the original bottle, grow till confluence (ca. 2 days).  
4) Split again, load also 5-8*104 cells to wells of the 24-well plate. Grow for ca. 2 days 
to semiconfluence. Change the medium (0.5 ml) before the experiment. 
5) Load 1-10-100-1000 ng/ml Clostridium difficile toxin B (see Just et al., 1995) or C. 
sordellii (strain 6018) lethal toxin (see Just et al., 1996) to each well. The toxins were 
kindly supplied in dry ice by Prof. I. Just, Univ. Freiburg, Germany, and diluted in 50 
mM Tris-HCl pH 7.5, 500 mM NaCl.  
6) Count the percentage of cells becoming round after 1-15 h treatment. 
 
2. Preparation of human neutrophil cytosol, plasma membranes, and granules (see 
Katanaev and Wymann, 1998a). 
1) Human neutrophils prepared as in III-1 are resuspended to 108 cells per ml Hepes-
potassium buffer (HKB, 135 mM KCl, 10 mM NaCl, 10 mM Hepes, 2 mM EDTA, 
pH 7.0) supplemented with 1 mM PMSF, 0.5 mM diisopropyl fluorophosphate, 20 
mM leupeptin, 18 mM pepstatin, 12.5 U/ml benzone nuclease, and 5% glycerol.  
2) Disrupt the cells by nitrogen cavitation (40 min/35 bar) on ice. Centrifuge 1300 g 10 
min. 
3) Ultracentrifuge the supernatant 121,000 g 45 min 4°C, producing the neutrophil 
cytosol.  
4) To prepare crude neutrophil membranes, loade the cells on top of 30% (w/w) sucrose 
on top of 50% sucrose. Centrifuge 200,000 g, brake off, at the slowest acceleration 
rate.  
5) To purify plasma membranes and granules, use 15%, 34%, and 45% sucrose layers. 
Collect the cytosol on top of sucrose, plasma membranes at 15/34% interphase, and 
granules at 34/45% interphase (see Abo and Segal, 1995). 
6) Freeze the preparations in aliquots in liquid nitrogen and keep at -80°C for months. 
 
 
3. Measuring cell-free NADPH oxidase activity.  
1) Calibrate appropriately the reader (Unicam SP 1700 Ultraviolet Spectrophotometer), 
set the wavelength to 550 nm.  
2) Prewarm the Reaction buffer (10 µM FAD, 100 µM oxidized cytochrome C, 10 mM 
Hepes-NaOH, 10 mM NaCl, 135 mM KCl, 1 mM EGTA, 1 mM MgCl2, pH 8.0) to 
25°C. 
3) Preincubate cytosol or cytosol + membranes as and if necessary. 
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4) Add, mixing after each addition, to 1 ml plastic cuvettes:  
 950 µl Reaction buffer  
 15 µl 10 mM SDS (to 150 µM)  
 1 µl 10 mM GTPγS (to 10 µM)  
 1.3 µl 10% NaN3 (to 2 mM)  
 20 µl crude membranes (to 100 µg/ml)  
 15 µl cytosol (to 50 µg/ml). Preincubate at RT for 2-5 min. 
5) Add to the reference cuvettes (already containing all the components present in 
sample cuvettes) 5 µl 10mg/ml superoxide dismutase (to 50 µg/ml). 
6) Start the reaction by adding 12 µl of NADPH stock (to 120 µM), mix the contents of 
the cuvettes and immediately start the measurement. 
7) Measure the initial rate of superoxide production (ca. 10 min of measurement). 
 
4. Measuring [14C]-UDPG incorporation into Rho-proteins by Clostridium  toxins as an 
example of assaying covalent binding of small molecules to proteins in complex 
mixtures. 
1) Dry the necessary amount of [14C]-UDPG (254 mCi/mmol) under vacuum.  
2) Incubate the cytosol with 10 µg/ml toxin B or lethal toxin (see IV-1) (add Mn2+ in 
case of lethal toxin), 10 µM [14C]-UDPG and 40 µM cold UDPG for 30 min. 
3) Mix the tubes, take aliquots of 10 µl and put them to the centers of 1.5*1.5 cm2 
labelled squares predrawn on a sheet of Whatmann 3MM paper. Let the paper dry at 
RT. 
4) Soak the paper for 10 min in 10% TCA (trichloroacetic acid, w/v) on a shaker. Repeat 
with fresh TCA. Repeat again for 5 min. 
5) Repeat with acetone. Let the paper dry at RT. 
6) Cut the paper into the predrawn squares, put into liquid scincillator and count the 
radioactivity in a liquid scintillation analyzer (2200CA Tri-CARB, Packard). 
 
 
5. Actin polymerization in the cell-free system from neutrophil cytosol (see Katanaev 
and Wymann, 1998a). 
1) The cell-free system (20-100 µl) contains the following components:  
 neutrophil cytosol protein- 1.6-1.8 mg/ml 
 Hepes-NaOH pH 7.0-  10 mM 
 NaCl-    10 mM 
 KCl-    115 mM 
 EDTA-   2 mM free. 
2) In certain experiments MgCl2 to 2 mM free (instead of EDTA) and plasma 
membranes to 0.1 mg protein/ml can be added.  
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3) Stimulate actin polymerization by 50 µM GTPγS or other agents for 5-30 min at 
37°C. 
 
6. Analysis of actin-gelsolin interaction in the cell-free systen from neutrophil cytosol. 
1) 1 µM recombinant (His)6-tagged or GST-tagged gelsolin prepared basically as 
explained in II-3 is added to the cell-free system (100 µl). 
2) After the required preincubations at 37°C, 20 µl 50% suspension of Ni-NTA agarose 
(to bind His6-tag) or GSH-sepharose (to bind GST-tag) are added. Alternatively, 10 
µl 50% suspension of anti-gelsolin beads described in III-10 are added. 
3) After 2h incubation at 4°C on a rotatory shaker and 2 min centrifugation, 12000 g 
4°C, the beads are washed successingly with 1ml buf A (10 mM Tris-HCl pH 7.5, 100 
mM KCl, 10 mM EGTA), buf B (10 mM Tris, 100 mM KCl, 1 mM EGTA, 300 mM 
MgCl2), and buf C (10 mM Tris, 100 mM KCl), denatured, and analyzed on 12% 
SDS-PAGE gels. 
 
7. Analyzing actin cross-linking in the cell-free system. 
1) Treat the mixtures as above and centrifuge 9000 g 5 min RT. Wash the sediments 
twice with HKB, denature and apply to 10% SDS-PAGE gels. Analyze actin bands by 
densitometry after Coomassie staining. Major proteins cosedimenting with actin are 
identified by peptide-mass fingerprinting with MALDI-TOF-MS on a PerSeptive 
Biosystem Voyager Elte mass spectrophotometer after in-gel trypsin digestion (see 
Cottrell and Sutton, 1996). The MALDI-TOF-MS was run by G.Hughes and S. 
Frutiger, Univ. Geneva. 
2) Alternatively, resuspend the sediments in 1/10th of the original volume and apply 20 
µl to AFM (atomic force microscope) -grade silicium plates for 1 min. After 4 brief 
washes with buffer and one with water, the samples are analyzed in air by AFM 
(Digital Instruments Inc., Santa Barbara, USA) by C. Galli, Inst. Experimental 
Physics, Univ. Fribourg. The analysis is performed in Tapping Mode™ (Zhong et al., 
1993) in order to minimise the force applied to proteins by the microscope's tip. 
3) For the fluorescence or confocal microscopy, the actin polymerization is stopped by 
incubation with 10% p-formaldehyde on ice, 10 min, before staining with 0.6 µM 
rhodamine phalloidin for ≥1h, protected from light. 
 
8. Assaying free actin filament barbed ends in the neutrophil cytosol. 
1) GTPγS is used to stimulate the cell-free system for optimally 15 min. 
2) Add 20 µl aliquots to 600 ml prewarmed HKB with 0.5 mM pyrenyl G-actin (see II-
8). 
3) Immediately measure the kinetics of pyrenyl actin fluorescence at 27 °C (ex. 365/3 
nm; em. 387/10 nm) on a Perkin-Elmer fluorescence spectrophotometer LS50B. 
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4) Under these conditions the initial rate of fluorescence increase is the measure of 
amount of free barbed ends added (Carson et al.., 1986).  
 
9. Measuring actin polymerization in the cell-free system.  
1) Briefly vortex the mixture from IV-6, add 10 µl to 600 µl HKB (or PBS) containing 
15 nM rhodamine phalloidin, vortex briefly. 
2) Keep at RT for 20 min. 
3) Fluorescence (F) is measured as in III-8. Buffer with rhodamine phalloidin alone is 
also measured for the background fluorescence (F0). F-actin levels are related to 
∆F=F-F0. Absolute F-actin concentrations can also be calculated as explained in 
(Katanaev and Wymann, 1998b). 
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